TW202246470A - Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element - Google Patents

Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element Download PDF

Info

Publication number
TW202246470A
TW202246470A TW111107847A TW111107847A TW202246470A TW 202246470 A TW202246470 A TW 202246470A TW 111107847 A TW111107847 A TW 111107847A TW 111107847 A TW111107847 A TW 111107847A TW 202246470 A TW202246470 A TW 202246470A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
group
crystal alignment
polymer
formula
Prior art date
Application number
TW111107847A
Other languages
Chinese (zh)
Inventor
結城達也
福田一平
橋本淳
山之内洋一
Original Assignee
日商日產化學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日產化學股份有限公司 filed Critical 日商日產化學股份有限公司
Publication of TW202246470A publication Critical patent/TW202246470A/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Nonlinear Science (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mathematical Physics (AREA)
  • Polymers & Plastics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

Provided is a liquid crystal alignment agent characterized by containing at least one polymer (A), which is selected from the group consisting of: polyimide precursors having a repeating unit (a1) represented by formula (1); and polyimides that are imidized products of the polyimide precursors. (1) In formula (1), X1represents a tetravalent organic base. Y1 is represented by formula (H) and is a divalent organic base having three or more benzene rings. (H) In formula (H), A represents a C4-C10 alkylene group. Ar1 and Ar1' each independently represent a benzene ring, a biphenyl structure or a naphthalene ring. An arbitrary hydrogen atom on the Ar1 ring and Ar1' ring may be substituted with a monovalent group.

Description

液晶配向劑、液晶配向膜、以及液晶顯示元件Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

本發明係關於液晶配向劑、液晶配向膜及液晶顯示元件。The invention relates to a liquid crystal alignment agent, a liquid crystal alignment film and a liquid crystal display element.

自以往,液晶顯示裝置廣泛作為個人電腦、智慧手機、行動電話、電視接收機等的顯示部使用。液晶顯示裝置,例如具備:夾持在顯示元件基板與彩色濾光片基板之間之液晶層、對於液晶層施加電場之畫素電極及共通電極、控制液晶層之液晶分子之配向性之配向膜、開關對於畫素電極供給之電信號之薄膜電晶體(TFT)等。液晶分子之驅動方式已知有:TN方式、VA方式等縱電場方式、IPS(面內開關,In Plane Switching)方式、FFS(邊緣場開關,Fringe Field Switching)方式等橫電場方式。Conventionally, liquid crystal display devices have been widely used as display units of personal computers, smartphones, mobile phones, television receivers, and the like. Liquid crystal display devices, for example, include: a liquid crystal layer sandwiched between a display element substrate and a color filter substrate, pixel electrodes and common electrodes that apply an electric field to the liquid crystal layer, and an alignment film that controls the alignment of liquid crystal molecules in the liquid crystal layer , Thin film transistor (TFT) that switches the electrical signal supplied to the pixel electrode, etc. Known methods for driving liquid crystal molecules include longitudinal electric field methods such as TN method and VA method, transverse electric field methods such as IPS (In Plane Switching) method, and FFS (Fringe Field Switching) method.

現在,工業上最普及的液晶配向膜,係藉由將形成在電極基板上之由聚醯胺酸及/或將其予以醯亞胺化而得之聚醯亞胺構成之膜之表面以綿、尼龍、聚酯等布沿一方向摩擦之所謂摩擦處理來製作。摩擦處理係簡便且生產性優異之工業上有用的方法。但是伴隨液晶顯示元件之高性能化、高精細化、大型化,摩擦處理產生之配向膜之表面之傷痕、起塵、機械力、靜電所致之影響,更而配向處理面內之不均勻性等各種問題變得明顯。作為替代摩擦處理之配向處理方法,已知有藉由照射經偏光之放射線來賦予液晶配向能力之光配向法。針對光配向法,已有人提出利用光異構化反應之方法、利用光交聯反應之方法、利用光分解反應之方法等(例如:參照非專利文獻1、專利文獻1、專利文獻2)。 [先前技術文獻] [專利文獻] At present, the most popular liquid crystal alignment film in the industry is formed by coating the surface of a film made of polyamide acid and/or polyamide imide formed on an electrode substrate with cotton , Nylon, polyester and other cloths are rubbed in one direction to produce the so-called friction treatment. Rubbing treatment is an industrially useful method that is simple and excellent in productivity. However, along with the high performance, high definition, and enlargement of liquid crystal display elements, the scratches, dust, mechanical force, and static electricity on the surface of the alignment film caused by rubbing treatment will cause inhomogeneity in the alignment treatment surface. Various problems become apparent. As an alignment treatment method instead of the rubbing treatment, there is known a photoalignment method of imparting alignment ability to liquid crystals by irradiating polarized radiation. Regarding the photo-alignment method, methods using photoisomerization reaction, photocrosslinking reaction, and photolysis reaction have been proposed (for example, refer to Non-Patent Document 1, Patent Document 1, and Patent Document 2). [Prior Art Literature] [Patent Document]

[專利文獻1]日本特開平9-297313號公報 [專利文獻2]日本特開2004-206091號公報 [非專利文獻] [Patent Document 1] Japanese Patent Application Laid-Open No. 9-297313 [Patent Document 2] Japanese Patent Laid-Open No. 2004-206091 [Non-patent literature]

[非專利文獻1]「液晶光配向膜」木戸脇、市村,機能材料,1997年11月號,Vol.17,No.11,13~22頁[Non-Patent Document 1] "Liquid Crystal Photoalignment Film" Kidowaki, Ichimura, Functional Materials, November 1997, Vol.17, No.11, pages 13~22

(發明欲解決之課題)(Problem to be solved by the invention)

上述IPS驅動方式、FFS驅動方式之液晶顯示元件中使用的液晶配向膜,需要為了抑制因長期交流驅動而發生之殘影(以下也稱AC殘影)之高配向規制力。又,利用光配向法進行配向處理時,光照射量會成為影響能量成本、生產速度之因子,故宜能以少光照射量進行配向處理較佳。 但是本案發明人等檢討後,得知能夠以少光照射量達成液晶配向之液晶配向膜,獲得液晶配向膜面內之液晶之扭轉角度之變異(不均勻性)小的液晶配向膜之光照射量之範圍窄。所以,當為了達成液晶顯示元件之大畫面化時,獲得之液晶配向膜之一部分,液晶配向會變得不完全,當長時間實施影像顯示時,會有面內之明亮度發生變異,使顯示品位下降的顧慮。 The liquid crystal alignment film used in the liquid crystal display elements of the above-mentioned IPS driving method and FFS driving method needs high alignment regulation force in order to suppress image sticking (hereinafter also referred to as AC image sticking) caused by long-term AC driving. In addition, when using the photo-alignment method for alignment treatment, the amount of light exposure will become a factor affecting energy costs and production speed, so it is better to perform alignment treatment with a small amount of light exposure. However, after review by the inventors of this case, it is known that the liquid crystal alignment film that can achieve liquid crystal alignment with a small amount of light irradiation can obtain the light irradiation of the liquid crystal alignment film with a small variation (non-uniformity) of the twist angle of the liquid crystal in the liquid crystal alignment film plane. Quantitative range is narrow. Therefore, in order to achieve a larger screen of the liquid crystal display element, the liquid crystal alignment of a part of the obtained liquid crystal alignment film will become incomplete, and when the image is displayed for a long time, the brightness in the plane will vary, causing the display Concerns about declining grades.

本發明之目的在於提供可使獲得液晶配向膜面內之液晶之扭轉角度之變異(不均勻性)小之液晶配向膜之光照射量之範圍擴大而能夠以良好效率獲得品質好之液晶配向膜的液晶配向劑、由該液晶配向劑獲得之該液晶配向膜及使用了該液晶配向膜之液晶顯示元件。又,目的在於能使獲得可抑制AC殘影之液晶配向膜之光照射量之範圍擴大而能夠以良好效率獲得品質好之液晶配向膜的液晶配向劑、由該液晶配向劑獲得之該液晶配向膜及使用了該液晶配向膜之液晶顯示元件。 (解決課題之方式) The purpose of the present invention is to provide a liquid crystal alignment film that can obtain a liquid crystal alignment film with a small variation (inhomogeneity) in the twist angle of the liquid crystal alignment film, and expand the range of light irradiation to obtain a high-quality liquid crystal alignment film with good efficiency. The liquid crystal alignment agent, the liquid crystal alignment film obtained from the liquid crystal alignment agent, and the liquid crystal display element using the liquid crystal alignment film. In addition, the purpose is to expand the range of light exposure to obtain a liquid crystal alignment film that can suppress AC sticking, and to obtain a liquid crystal alignment agent of good quality with good efficiency, and the liquid crystal alignment obtained by the liquid crystal alignment agent. film and a liquid crystal display element using the liquid crystal alignment film. (How to solve the problem)

本案發明人等努力研究,結果發現藉由使用含有特定成分之液晶配向劑,能解決上述課題,乃完成本發明。具體而言,係以下列事項為要旨。As a result of diligent research, the inventors of the present invention found that the above-mentioned problems can be solved by using a liquid crystal alignment agent containing a specific component, and completed the present invention. Specifically, the following matters are the gist.

一種液晶配向劑,其特徵為含有聚合物(A),該聚合物(A)係選自由具有下式(1)表示之重複單元(a1)之聚醯亞胺前驅物及係該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種。A liquid crystal alignment agent, characterized by containing a polymer (A), the polymer (A) is selected from a polyimide precursor having a repeating unit (a1) represented by the following formula (1) and the polyimide At least one of the group consisting of polyimide which is an imide product of an amine precursor.

[化1]

Figure 02_image001
式(1)中,X 1表示4價有機基。Y 1係以下式(H)表示具有3個以上之苯環之2價有機基。R及Z各自獨立地表示氫原子或1價有機基。 [化2]
Figure 02_image003
式(H)中,L 1、及L 1’各自獨立地表示單鍵、-O-、-S-、-C(=O)-、-O-C(=O)-、或-C(=O)-NR-(R表示氫原子或1價有機基)。 A表示碳數4~10之伸烷基。 Ar 1、及Ar 1’各自獨立地表示苯環、聯苯結構、或萘環。Ar 1、及Ar 1’之環上之任意氫原子亦可被1價基取代。 又,本案整份說明書中,鹵素原子可列舉氟原子、氯原子、溴原子、碘原子等,*表示原子鍵。 (發明之效果) [chemical 1]
Figure 02_image001
In formula (1), X 1 represents a tetravalent organic group. Y 1 is a divalent organic group having three or more benzene rings represented by the following formula (H). R and Z each independently represent a hydrogen atom or a monovalent organic group. [Chem 2]
Figure 02_image003
In formula (H), L 1 and L 1' each independently represent a single bond, -O-, -S-, -C(=O)-, -OC(=O)-, or -C(=O )-NR-(R represents a hydrogen atom or a monovalent organic group). A represents an alkylene group having 4 to 10 carbon atoms. Ar 1 and Ar 1' each independently represent a benzene ring, a biphenyl structure, or a naphthalene ring. Any hydrogen atom on the ring of Ar 1 and Ar 1' may be substituted by a monovalent group. In addition, in the whole specification of this case, a halogen atom includes a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, etc., and * represents an atomic bond. (Effect of Invention)

依照本發明,可獲得使得到液晶配向膜面內之液晶之扭轉角度之變異(不均勻性)小之液晶配向膜之光照射量之範圍擴大而能以良好效率獲得品質好之液晶配向膜之液晶配向劑、由該液晶配向劑獲得之該液晶配向膜及使用了該液晶配向膜之液晶顯示元件。又,可獲得使獲得能抑制AC殘影之液晶配向膜之光照射量之範圍擴大而能以良好效率獲得品質好之液晶配向膜的液晶配向劑、由該液晶配向劑獲得之該液晶配向膜及使用了該液晶配向膜之液晶顯示元件。According to the present invention, it is possible to obtain a liquid crystal alignment film with a small variation (inhomogeneity) in the twist angle of the liquid crystal alignment film within the plane of the liquid crystal alignment film, and to expand the range of light irradiation and obtain a liquid crystal alignment film of good quality with good efficiency. A liquid crystal alignment agent, the liquid crystal alignment film obtained from the liquid crystal alignment agent, and a liquid crystal display element using the liquid crystal alignment film. In addition, it is possible to obtain a liquid crystal alignment agent that can obtain a liquid crystal alignment film of good quality by expanding the range of light exposure to obtain a liquid crystal alignment film capable of suppressing AC image sticking, and the liquid crystal alignment film obtained from the liquid crystal alignment agent. And a liquid crystal display element using the liquid crystal alignment film.

<聚合物(A)> 本發明之液晶配向劑,含有選自由具有下式(1)表示之重複單元(a1)之聚醯亞胺前驅物及係該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種聚合物(A)。又,聚合物(A)可由1種或2種以上構成。 <Polymer (A)> The liquid crystal alignment agent of the present invention is composed of a polyimide precursor selected from a polyimide precursor having a repeating unit (a1) represented by the following formula (1) and a polyimide compound of the polyimide precursor At least one polymer (A) in the group of . Moreover, a polymer (A) may consist of 1 type, or 2 or more types.

[化3]

Figure 02_image001
式(1)中,X 1表示4價有機基。Y 1係以下式(H)表示且具有3個以上之苯環之2價有機基。R及Z各自獨立地表示氫原子或1價有機基。 [Chem 3]
Figure 02_image001
In formula (1), X 1 represents a tetravalent organic group. Y 1 is a divalent organic group represented by the following formula (H) and having three or more benzene rings. R and Z each independently represent a hydrogen atom or a monovalent organic group.

聚合物(A)宜在聚合物(A)之主鏈方向具有上式(H)表示之2價有機基。又,聚合物(A)更宜在聚合物(A)之主鏈方向具有Y 1擁有之苯環。 聚合物之主鏈,係指由聚合物當中最長之原子鏈構成之部分。 而且,「聚合物(A)在聚合物(A)之主鏈方向具有上式(H)表示之2價有機基」,係指式(H)表示之2價有機基中最長之原子鏈係構成聚合物(A)之主鏈。換言之,「聚合物(A)在聚合物(A)之主鏈方向具有上式(H)表示之2價有機基」,係指式(H)表示之2價有機基之最長原子鏈的兩端係分別鍵結於和式(1)中之Y 1鍵結之2個氮原子。 又,係指Y 1擁有之全部苯環中之各苯環之至少2個碳原子構成聚合物(A)之主鏈。 The polymer (A) preferably has a divalent organic group represented by the above formula (H) in the main chain direction of the polymer (A). Also, the polymer (A) preferably has a benzene ring possessed by Y 1 in the main chain direction of the polymer (A). The main chain of a polymer refers to the part composed of the longest atomic chain in the polymer. Moreover, "the polymer (A) has a divalent organic group represented by the above formula (H) in the direction of the main chain of the polymer (A)" means the longest atomic chain system among the divalent organic groups represented by the formula (H) It constitutes the main chain of the polymer (A). In other words, "the polymer (A) has a divalent organic group represented by the above formula (H) in the direction of the main chain of the polymer (A)" means the two sides of the longest atomic chain of the divalent organic group represented by the formula (H). The ends are respectively bonded to 2 nitrogen atoms bonded to Y 1 in formula (1). Also, it means that at least 2 carbon atoms of each benzene ring among all the benzene rings possessed by Y1 constitute the main chain of the polymer (A).

在此,「具有3個以上之苯環之2價有機基」之苯環中,也包括構成縮合環之苯環。且當計數式(H)中之苯環之數目時,係依如下方式計數。 萘環係有2個苯環。 聯苯結構係有2個苯環。 Y 1中之苯環之數目,若為3個以上則無特殊限制,可為例如:3個以上8個以下,也可為3個以上6個以下。考量理想地獲得本發明之效果之觀點,也可為4個以上6個以下。 Here, the benzene ring of the "divalent organic group having three or more benzene rings" includes a benzene ring constituting a condensed ring. And when the number of benzene rings in the formula (H) is counted, it is counted as follows. The naphthalene ring system has 2 benzene rings. The biphenyl structure has 2 benzene rings. The number of benzene rings in Y1 is not particularly limited if it is 3 or more, and may be, for example, 3 or more and 8 or less, or 3 or more and 6 or less. Considering the viewpoint of obtaining the effects of the present invention ideally, there may be 4 or more and 6 or less.

[化4]

Figure 02_image003
式(H)中,L 1、及L 1’各自獨立地表示單鍵、-O-、-S-、-C(=O)-、-O-C(=O)-、或-C(=O)-NR-(R表示氫原子或1價有機基。)。 A表示碳數4~10之伸烷基,更佳為碳數4、6、8、或10之伸烷基,又更佳為碳數4或6之伸烷基。 Ar 1、及Ar 1’各自獨立地表示苯環、聯苯結構、或萘環。Ar 1、及Ar 1’之環上之任意氫原子亦可被1價基取代。 [chemical 4]
Figure 02_image003
In formula (H), L 1 and L 1' each independently represent a single bond, -O-, -S-, -C(=O)-, -OC(=O)-, or -C(=O )-NR-(R represents a hydrogen atom or a monovalent organic group.). A represents an alkylene group having 4 to 10 carbons, more preferably an alkylene group having 4, 6, 8, or 10 carbons, and more preferably an alkylene group having 4 or 6 carbons. Ar 1 and Ar 1' each independently represent a benzene ring, a biphenyl structure, or a naphthalene ring. Any hydrogen atom on the ring of Ar 1 and Ar 1' may be substituted by a monovalent group.

上述L 1、及L 1’中之基「-C(=O)-NR-」之R之1價有機基,可列舉碳數1~3之烷基、碳數1~3烷氧基、碳數2~3之烯基、碳數2~3之醯基、碳數1~3之烷基矽基、碳數1~3之烷氧基矽基、第三丁氧基羰基、或該等基擁有之氫原子之一部分被鹵素原子及羥基中之至少任一者取代而得之1價有機基。 The monovalent organic group of R in the group "-C(=O)-NR-" in L 1 and L 1' mentioned above includes alkyl having 1 to 3 carbons, alkoxy having 1 to 3 carbons, Alkenyl with 2~3 carbons, acyl with 2~3 carbons, alkylsilyl with 1~3 carbons, alkoxysilyl with 1~3 carbons, tertiary butoxycarbonyl, or the A monovalent organic group in which a part of hydrogen atoms possessed by an isogroup is substituted by at least one of a halogen atom and a hydroxyl group.

上式(H)中之Ar 1、及Ar 1’之環上之任意氫原子之取代基即1價基,可列舉鹵素原子、碳數1~3之烷基、氫原子之至少一部分被上述鹵素原子及羥基中之至少任一者取代之碳數1~3之烷基;碳數1~3之烷氧基、氫原子之至少一部分被上述鹵素原子及羥基中之至少任一者取代之碳數1~3之烷氧基;碳數2~3之烯基;碳數2~3之醯基;碳數1~3之烷基矽基、碳數1~3之烷氧基矽基、羥基、腈基等1價基。 Ar 1 in the above formula (H) and the substituent of any hydrogen atom on the ring of Ar 1' are monovalent groups, which include halogen atoms, alkyl groups with 1 to 3 carbon atoms, and at least a part of the hydrogen atoms described above An alkyl group with 1 to 3 carbon atoms substituted by at least one of a halogen atom and a hydroxyl group; an alkoxy group with 1 to 3 carbon atoms, at least a part of the hydrogen atoms is substituted by at least one of the above halogen atoms and hydroxyl groups Alkoxy group with 1~3 carbons; alkenyl group with 2~3 carbons; acyl group with 2~3 carbons; alkylsilyl group with 1~3 carbons, alkoxysilyl group with 1~3 carbons , hydroxyl, nitrile and other monovalent groups.

若舉上式(H)中之基「*-L 1-A-L 1’-*」之理想具體例,可列舉:基「*-(CH 2) n-*」、基「*-O-(CH 2) n-O-*」、基「*-C(=O)-(CH 2) n-C(=O)-*」、基「*-C(=O)-NR-(CH 2) n-O-*」、基「*-O-C(=O)-(CH 2) n-O-*」、基「*-O-C(=O)-(CH 2) n-O-C(=O)-*」、基「*-O-C(=O)-(CH 2) n-C(=O)-O-*」、基「*-S-(CH 2) n-S-*」、基「*-C(=O)-NR-(CH 2) n-NR-C(=O)-*」、基「*-C(=O)-O-(CH 2) n-O-C(=O)-*」、基「*-O-(CH 2) n-*」、基「*-S-(CH 2) n-*」、或基「*-NR-C(=O)-(CH 2) n-C(=O)-NR-*」(R表示氫原子或1價有機基,該1價有機基可列舉上述L 1、及L 1’之基「-C(=O)-NR-」之R例示之結構。)。該等之中,考量理想地獲得本發明之效果之觀點,上述基「*-L 1-A-L 1’-*」為基「*-(CH 2) n-*」、基「*-O-(CH 2) n-O-*」、基「*-O-(CH 2) n-*」較佳。 n為4~10之整數,較佳為4、6、8、或10之整數,更佳為4或6之整數。 If the ideal specific examples of the group "*-L 1 -AL 1' -*" in the above formula (H) are mentioned, it can be listed: the group "*-(CH 2 ) n -*", the group "*-O-( CH 2 ) n -O-*", group "*-C(=O)-(CH 2 ) n -C(=O)-*", group "*-C(=O)-NR-(CH 2 ) n -O-*", group "*-OC(=O)-(CH 2 ) n -O-*", group "*-OC(=O)-(CH 2 ) n -OC(=O) -*", group "*-OC(=O)-(CH 2 ) n -C(=O)-O-*", group "*-S-(CH 2 ) n -S-*", group " *-C(=O)-NR-(CH 2 ) n -NR-C(=O)-*”, group “*-C(=O)-O-(CH 2 ) n -OC(=O) -*", group "*-O-(CH 2 ) n -*", group "*-S-(CH 2 ) n -*", or group "*-NR-C(=O)-(CH 2 ) n -C(=O)-NR-*” (R represents a hydrogen atom or a 1-valent organic group, and the 1-valent organic group can include the above-mentioned groups of L 1 and L 1′ “-C(=O)-NR -"'s R example structure.). Among them, in view of obtaining the effect of the present invention ideally, the above-mentioned group "*-L 1 -AL 1' -*" is the group "*-(CH 2 ) n -*", the group "*-O- (CH 2 ) n -O-*" and the group "*-O-(CH 2 ) n -*" are preferred. n is an integer of 4-10, preferably an integer of 4, 6, 8, or 10, more preferably an integer of 4 or 6.

針對上式(1)中之Y 1,考量理想地獲得本發明之效果之觀點,為下式(h-1)~(h-4)中之任一者表示之2價有機基較佳。 [化5]

Figure 02_image009
式(h-1)~(h-4)中,R a1~R a4表示1價有機基。其具體例可列舉作為上式(H)中之Ar 1、及Ar 1’之環上之氫原子之取代基例示之結構。L表示上式(H)之基「*-L 1-A-L 1’-*」(*表示原子鍵。)。 m各自獨立地為0~6之整數,n各自獨立地為0~4之整數。R a1~R a4有多個存在時,各自可相同也可不同。 Y 1 in the above formula (1) is preferably a divalent organic group represented by any one of the following formulas (h-1) to (h-4) from the viewpoint of ideally obtaining the effect of the present invention. [chemical 5]
Figure 02_image009
In the formulas (h-1) to (h-4), R a1 to R a4 represent monovalent organic groups. Specific examples thereof include structures exemplified as substituents for hydrogen atoms on the rings of Ar 1 and Ar 1′ in the above formula (H). L represents the group "*-L 1 -AL 1' -*" of the above formula (H) (* represents an atomic bond.). m is each independently an integer of 0-6, and n is each independently an integer of 0-4. When a plurality of R a1 to R a4 exist, each may be the same or different.

上式(1)中,R、及Z之1價有機基可列舉:碳數1~20之1價烴基、該烴基之亞甲基替換為-O-、-S-、-CO-、-COO-、-COS-、-NR 3-、-CO-NR 3-、-Si(R 3) 2-(惟R 3為氫原子或碳數1~10之1價烴基。)、-SO 2-等而成之1價基A、上述1價烴基或上述1價基A之碳原子所鍵結之氫原子之至少1個取代為鹵素原子、羥基、烷氧基、硝基、胺基、巰基、亞硝基、烷基矽基、烷氧基矽基、矽醇基、亞磺酸基、膦基、羧基、氰基、磺基、醯基等而成之1價基、具有雜環之1價基。 上式(1)中,R、及Z之1價有機基又以碳數1~10之烷基、碳數2~10之烯基、碳數2~10之炔基、第三丁氧基羰基、或9-茀基甲氧基羰基較理想,碳數1~3之烷基更佳,甲基更理想。 針對R及Z,考量理想地獲得本發明之效果之觀點,各自獨立地為氫原子或碳數1~3之烷基較理想,氫原子或甲基更理想。 In the above formula (1), the monovalent organic groups of R and Z include: monovalent hydrocarbon groups with 1 to 20 carbons, and the methylene groups of the hydrocarbon groups are replaced by -O-, -S-, -CO-, - COO-, -COS-, -NR 3 -, -CO-NR 3 -, -Si(R 3 ) 2 - (except that R 3 is a hydrogen atom or a monovalent hydrocarbon group with 1 to 10 carbons.), -SO 2 - At least one of the resulting monovalent group A, the above-mentioned monovalent hydrocarbon group, or the hydrogen atom bonded to the carbon atom of the above-mentioned monovalent group A is replaced by a halogen atom, hydroxyl, alkoxy, nitro, amino, Mercapto, nitroso, alkylsilyl, alkoxysilyl, silanol, sulfinic acid, phosphino, carboxyl, cyano, sulfo, acyl, etc., with a heterocycle One of the valence bases. In the above formula (1), the monovalent organic groups of R and Z are alkyl with 1 to 10 carbons, alkenyl with 2 to 10 carbons, alkynyl with 2 to 10 carbons, tertiary butoxy A carbonyl group or a 9-fenylmethoxycarbonyl group is more preferable, an alkyl group having 1 to 3 carbon atoms is more preferable, and a methyl group is more preferable. R and Z are each independently preferably a hydrogen atom or an alkyl group having 1 to 3 carbons, and more preferably a hydrogen atom or a methyl group, in view of ideally obtaining the effect of the present invention.

針對上述聚合物(A),考量理想地獲得本發明之效果之觀點,也可為選自由更具有下式(2)表示之重複單元(a2)之聚醯亞胺前驅物及係該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種聚合物。換言之,上述聚合物(A)也可更具有下式(2)表示之重複單元(a2)及下式(2)表示之重複單元(a2)之醯亞胺化結構中之至少任一者。又,重複單元(a2)可由1種或2種以上構成。For the above-mentioned polymer (A), considering the viewpoint of ideally obtaining the effect of the present invention, it may also be a polyimide precursor selected from a repeating unit (a2) represented by the following formula (2) and the polyimide At least one polymer of the group consisting of polyimides of imides of imine precursors. In other words, the above-mentioned polymer (A) may further have at least any one of the repeating unit (a2) represented by the following formula (2) and the imidized structure of the repeating unit (a2) represented by the following formula (2). Moreover, the repeating unit (a2) may consist of 1 type or 2 or more types.

[化6]

Figure 02_image011
式(2)中,X 2表示4價有機基。Y 2表示下式(o-1)~(o-14)表示之2價有機基。R、及Z各和上式(1)之R、及Z為同義。 [chemical 6]
Figure 02_image011
In formula (2), X 2 represents a tetravalent organic group. Y 2 represents a divalent organic group represented by the following formulas (o-1) to (o-14). R, and Z are each synonymous with R, and Z in the above formula (1).

[化7]

Figure 02_image013
[化8]
Figure 02_image015
式(o-13)~式(o-14)中,2個m各自獨立。式(o-1)~(o-14)中之苯環、聯苯結構或萘環之環上之任意氫原子也可被1價基取代。 [chemical 7]
Figure 02_image013
[chemical 8]
Figure 02_image015
In the formula (o-13) to the formula (o-14), the two ms are independent of each other. Any hydrogen atom on the benzene ring, biphenyl structure or naphthalene ring in the formulas (o-1)~(o-14) can also be substituted by a monovalent group.

式(o-1)~(o-14)中之苯環、聯苯結構或萘環之環上之任意氫原子之取代基即1價基,可列舉:鹵素原子、碳數1~3之烷基、氫原子之至少一部分被上述鹵素原子及羥基中之至少任一者取代之烷基;碳數1~3之烷氧基、氫原子之至少一部分被上述鹵素原子及羥基中之至少任一者取代之烷氧基;碳數2~3之烯基;碳數2~3之醯基;碳數1~3之烷基矽基、碳數1~3之烷氧基矽基、羥基、腈基等1價基。The substituent of any hydrogen atom on the benzene ring, biphenyl structure or naphthalene ring in the formulas (o-1)~(o-14) is a monovalent group, which can include: halogen atom, carbon number 1~3 An alkyl group, an alkyl group in which at least a part of the hydrogen atoms are substituted by at least any one of the above-mentioned halogen atoms and hydroxyl groups; an alkoxy group having 1 to 3 carbon atoms, at least a part of the hydrogen atoms being replaced by at least one of the above-mentioned halogen atoms and hydroxyl groups One is substituted alkoxy group; alkenyl group with 2~3 carbons; acyl group with 2~3 carbons; alkylsilyl group with 1~3 carbons, alkoxysilyl group with 1~3 carbons, hydroxyl , nitrile group and other monovalent groups.

針對上述聚合物(A),考量理想地獲得本發明之效果之觀點,也可為選自由更具有選自由下式(2’)表示之重複單元(a2’)及下式(3)表示之重複單元(a3)構成之群組中之至少一者之聚醯亞胺前驅物及係該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種聚合物。換言之,上述聚合物(A)也可更具有下式(2’)表示之重複單元(a2’)、下式(2’)表示之重複單元(a2’)之醯亞胺化結構、下式(3)表示之重複單元(a3)、及下式(3)表示之重複單元(a3)之醯亞胺化結構中之至少任一者。 [化9]

Figure 02_image017
式(2’)、及式(3)中,X 2’、及X 3表示4價有機基,Y 2’表示下式(O2)表示之2價有機基,Y 3表示分子內具有基「-N(D)-(D表示胺甲酸酯系保護基。)」之碳數6~30之2價有機基。R、及Z各和上式(1)之R、及Z為同義。 [化10]
Figure 02_image019
式(O2)中,m表示0~2之整數。m為0時,Ar 2’表示苯環或萘環,m為1~2時,Ar 2’各自獨立地表示苯環。Ar 2’之環上之任意氫原子也可被1價基取代,該取代基可列舉在上式(o-1)~(o-14)中之苯環、聯苯結構或萘環之任意氫原子之取代基即1價基例示之結構。Q 2’表示單鍵、或-O-。Ar 2’、及Q 2’有多個存在時,多個Ar 2’、及Q 2’各自可相同也可不同。 With regard to the above-mentioned polymer (A), considering the viewpoint of ideally obtaining the effects of the present invention, it may be selected from the group consisting of repeating units (a2') represented by the following formula (2') and represented by the following formula (3). A polyimide precursor of at least one of the group consisting of repeating units (a3) and at least one polymerization of the group consisting of polyimides which are imides of the polyimide precursor thing. In other words, the above-mentioned polymer (A) may further have the repeating unit (a2') represented by the following formula (2'), the imidized structure of the repeating unit (a2') represented by the following formula (2'), the following formula At least any one of the repeating unit (a3) represented by (3) and the imidization structure of the repeating unit (a3) represented by the following formula (3). [chemical 9]
Figure 02_image017
In formula (2') and formula (3), X 2' and X 3 represent a 4-valent organic group, Y 2' represents a divalent organic group represented by the following formula (O2), and Y 3 represents a group in the molecule " -N(D)-(D represents a carbamate-based protecting group.)" is a divalent organic group with 6 to 30 carbon atoms. R, and Z are each synonymous with R, and Z in the above formula (1). [chemical 10]
Figure 02_image019
In the formula (O2), m represents an integer of 0-2. When m is 0, Ar 2' represents a benzene ring or a naphthalene ring, and when m is 1 to 2, Ar 2' each independently represent a benzene ring. Any hydrogen atom on the Ar 2' ring can also be substituted by a monovalent group. The substituent can be any of the benzene ring, biphenyl structure or naphthalene ring in the above formulas (o-1)~(o-14). The substituent of the hydrogen atom is the structure exemplified by the monovalent group. Q 2' represents a single bond, or -O-. When a plurality of Ar 2 ' and Q 2 ' exist, each of the plurality of Ar 2' and Q 2' may be the same or different.

針對上式(O2)表示之2價有機基,考量AC殘影之發生少之觀點,為從選自由對苯二胺、間苯二胺、2,5-二胺基甲苯、2,5-二胺基對二甲苯、1,4-二胺基三甲基苯、1,4-二胺基四甲基苯、1,4-二胺基-2,5-甲氧基苯、3,3’-二胺基二苯醚、3,4’-二胺基二苯醚、4,4’-二胺基二苯醚、3,3’-二甲基-4,4’-二胺基聯苯、2,2’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、2,2’-二甲氧基-4,4’-二胺基聯苯、3,3’-二羥基-4,4’-二胺基聯苯、2,2’-二羥基-4,4’-二胺基聯苯、3,3’-雙(三氟甲基)-4,4’-二胺基聯苯、2,2’-雙(三氟甲基)-4,4’-二胺基聯苯、3-三氟甲基-4,4’-二胺基聯苯、2-三氟甲基-4,4’-二胺基聯苯、3-氟-4,4’-二胺基聯苯、2-氟-4,4’-二胺基聯苯、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、2,6-二胺基萘及1,5-二胺基萘構成之群組中之二胺除去了2個胺基之2價有機基較佳。For the divalent organic group represented by the above formula (O2), considering the occurrence of less AC sticking, it is selected from p-phenylenediamine, m-phenylenediamine, 2,5-diaminotoluene, 2,5- Diamino-p-xylene, 1,4-diaminotrimethylbenzene, 1,4-diaminotetramethylbenzene, 1,4-diamino-2,5-methoxybenzene, 3, 3'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 4,4'-diaminodiphenyl ether, 3,3'-dimethyl-4,4'-diamine 2,2'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 2,2'- Dimethoxy-4,4'-diaminobiphenyl, 3,3'-dihydroxy-4,4'-diaminobiphenyl, 2,2'-dihydroxy-4,4'-diamine Biphenyl, 3,3'-bis(trifluoromethyl)-4,4'-diaminobiphenyl, 2,2'-bis(trifluoromethyl)-4,4'-diaminobiphenyl Benzene, 3-trifluoromethyl-4,4'-diaminobiphenyl, 2-trifluoromethyl-4,4'-diaminobiphenyl, 3-fluoro-4,4'-diaminobiphenyl Biphenyl, 2-fluoro-4,4'-diaminobiphenyl, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, The diamine in the group consisting of 2,6-diaminonaphthalene and 1,5-diaminonaphthalene is preferably a divalent organic group in which two amine groups have been removed.

上述Y 3之D表示胺甲酸酯系保護基,胺甲酸酯系保護基例如:第三丁氧基羰基或9-茀基甲氧基羰基。 上述Y 3之具體例可列舉下式(Dx)表示之2價有機基。 D in Y3 above represents a carbamate-based protecting group, such as tert-butoxycarbonyl or 9-tertilylmethoxycarbonyl. Specific examples of the aforementioned Y 3 include divalent organic groups represented by the following formula (Dx).

[化11]

Figure 02_image021
[chemical 11]
Figure 02_image021

式(Dx)中,Q 5表示單鍵、-(CH 2) n-(n為1~20之整數)、或該-(CH 2) n-之任意-CH 2-被-O-、-Si(CH 3) 2-、-COO-、-OCO-、-NQ 9-、-NQ 9CO-、-CONQ 9-、-NQ 9CONQ 10-、-NQ 9COO-或-OCOO-取代之基,Q 9及Q 10各自獨立地表示氫原子或1價有機基; Q 6及Q 7各自獨立地表示-H、-NHD、-N(D) 2、具有-NHD之基、或具有-N(D) 2之基(D表示胺甲酸酯系保護基。)。惟m=0時,Q 6具有胺甲酸酯系保護基,m=1時,Q 5、Q 6及Q 7中之至少一者在基中具有胺甲酸酯系保護基。又,Q 6、及Q 7中,表示氫原子以外之基之情形,理想碳數為1~8。 上述Q 9及Q 10之1價有機基可列舉碳數1~3之烷基、碳數2~3之烯基、碳數2~3之炔基、含有氟原子之碳數1~3之1價有機基。 In formula (Dx), Q 5 represents a single bond, -(CH 2 ) n -(n is an integer from 1 to 20), or any -CH 2 - of -(CH 2 ) n - by -O-, - Si(CH 3 ) 2 -, -COO-, -OCO-, -NQ 9 -, -NQ 9 CO-, -CONQ 9 -, -NQ 9 CONQ 10 -, -NQ 9 COO- or -OCOO- Q 9 and Q 10 each independently represent a hydrogen atom or a monovalent organic group; Q 6 and Q 7 each independently represent -H, -NHD, -N(D) 2 , a base with -NHD, or a base with - The base of N(D) 2 (D represents a carbamate-based protecting group.). However, when m=0, Q 6 has a carbamate protecting group, and when m=1, at least one of Q 5 , Q 6 and Q 7 has a carbamate protecting group among the groups. Also, when Q 6 and Q 7 represent a group other than a hydrogen atom, the ideal carbon number is 1-8. The monovalent organic groups of Q 9 and Q 10 mentioned above include alkyl groups with 1 to 3 carbons, alkenyl groups with 2 to 3 carbons, alkynyl groups with 2 to 3 carbons, and 1 to 3 carbons containing fluorine atoms. 1-valent organic group.

針對Y 3之理想具體例,考量AC殘影少之觀點,可列舉下式(Y3-1)~(Y3-9)中之任一者表示之2價有機基。「Boc」表示第三丁氧基羰基。 Regarding the ideal specific example of Y3 , considering the viewpoint of less afterimage of AC, a divalent organic group represented by any one of the following formulas (Y3-1) to (Y3-9) can be mentioned. "Boc" means tert-butoxycarbonyl.

[化12]

Figure 02_image023
[chemical 12]
Figure 02_image023

針對上述X 1、X 2、X 2’、及X 3,可列舉來自非環族脂肪族四羧酸二酐或其衍生物、脂環族四羧酸二酐或其衍生物、或芳香族四羧酸二酐或其衍生物之4價有機基。 在此,四羧酸二酐之衍生物,例如可列舉:四羧醯二鹵化物、四羧酸二烷酯、及四羧酸二烷酯二鹵化物。 其中,係來自具有選自由環丁烷環結構、環戊烷環結構及環己烷環結構構成之群組中之至少一種次結構之四羧酸二酐或其衍生物的4價有機基更理想。若舉X 1、X 2、X 2’、及X 3 理想具體例,除了下式(g)表示之4價有機基以外,尚可列舉下式(X-1)~(X-25)中之任一者表示之4價有機基、來自芳香族四羧酸二酐之4價有機基等。考量理想地獲得本發明之效果之觀點,X 1、X 2、X 2’及X 3為下式(g)、(X-1)~(X-5)、(X-11)、(X-21)~(X-23)表示之4價有機基更佳,下式(g)表示之4價有機基又更佳。 For the above-mentioned X 1 , X 2 , X 2′ , and X 3 , there may be mentioned those derived from acyclic aliphatic tetracarboxylic dianhydride or derivatives thereof, alicyclic tetracarboxylic dianhydride or derivatives thereof, or aromatic A tetravalent organic group of tetracarboxylic dianhydride or derivatives thereof. Here, derivatives of tetracarboxylic dianhydride include, for example, tetracarboxylic acid dihalides, tetracarboxylic acid dialkyl esters, and tetracarboxylic acid dialkyl ester dihalides. Among them, the tetravalent organic group derived from tetracarboxylic dianhydride or derivatives thereof having at least one substructure selected from the group consisting of cyclobutane ring structure, cyclopentane ring structure and cyclohexane ring structure is more ideal. If the ideal specific examples of X 1 , X 2 , X 2' , and X 3 are mentioned, in addition to the tetravalent organic group represented by the following formula (g), the following formulas (X-1)~(X-25) can also be listed. A tetravalent organic group represented by any of them, a tetravalent organic group derived from an aromatic tetracarboxylic dianhydride, and the like. Considering the viewpoint of obtaining the effect of the present invention ideally, X 1 , X 2 , X 2' and X 3 are the following formulas (g), (X-1)~(X-5), (X-11), (X The tetravalent organic group represented by -21)~(X-23) is more preferable, and the tetravalent organic group represented by the following formula (g) is more preferable.

[化13]

Figure 02_image025
式(g)中,R 1~R 4各自獨立地表示氫原子、鹵素原子、碳數1~6之烷基、碳數2~6之烯基、碳數2~6之炔基、含有氟原子之碳數1~6之1價有機基、或苯基,R 1~R 4中之至少一者表示上述定義中之氫原子以外之基。 [chemical 13]
Figure 02_image025
In formula (g), R 1 to R 4 each independently represent a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbons, an alkenyl group having 2 to 6 carbons, an alkynyl group having 2 to 6 carbons, a fluorine-containing A monovalent organic group with 1 to 6 carbon atoms, or a phenyl group, at least one of R 1 to R 4 represents a group other than a hydrogen atom as defined above.

[化14]

Figure 02_image027
[化15]
Figure 02_image029
[chemical 14]
Figure 02_image027
[chemical 15]
Figure 02_image029

上式(g)中之R 1~R 4之碳數1~6之烷基之具體例,可列舉甲基、乙基、丙基、異丙基、正丁基、異丁基、第二丁基、第三丁基、正戊基等。上述R 1~R 4中之碳數2~6之烯基之具體例可列舉乙烯基、丙烯基、丁炔基等,它們可為直鏈狀也可為分支狀。上述R 1~R 4之碳數2~6之炔基之具體例,例如乙炔基、1-丙炔基、2-丙炔基等。上述R 1~R 4之含有氟原子之碳數1~6之1價有機基可列舉氟甲基、三氟甲基、五氟乙基、五氟丙基等。更理想的R 1~R 4之組合,考量光反應性高之觀點,宜為R 1~R 4係氫原子或甲基且R 1~R 4中之至少一者為甲基較佳,R 1~R 4中之至少二者為甲基更佳。又更佳為R 1及R 4為甲基且R 2及R 3為氫原子之態樣。 Specific examples of alkyl groups having 1 to 6 carbon atoms in R 1 to R 4 in the above formula (g) include methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, second Butyl, tertiary butyl, n-pentyl, etc. Specific examples of alkenyl groups having 2 to 6 carbon atoms in the above R 1 to R 4 include vinyl, propenyl, butynyl, etc., which may be linear or branched. Specific examples of the above-mentioned alkynyl groups having 2 to 6 carbon atoms in R 1 to R 4 include ethynyl, 1-propynyl, 2-propynyl and the like. Examples of monovalent organic groups having 1 to 6 carbon atoms containing fluorine atoms for R 1 to R 4 include fluoromethyl, trifluoromethyl, pentafluoroethyl, and pentafluoropropyl. A more ideal combination of R 1 ~ R 4 , considering the viewpoint of high photoreactivity, preferably R 1 ~ R 4 is a hydrogen atom or a methyl group and at least one of R 1 ~ R 4 is preferably a methyl group, and R It is more preferable that at least two of 1 to R 4 are methyl groups. Still more preferably, R 1 and R 4 are methyl groups and R 2 and R 3 are hydrogen atoms.

在此,芳香族四羧酸二酐,係指苯環、萘環等芳香環所鍵結之羧基進行分子內脫水而獲得之酸二酐。若舉具體例,可列舉下式(Xa-1)~(Xa-2)中之任一者表示之4價有機基、下式(Xr-1)~(Xr-7)中之任一者表示之4價有機基。Here, the aromatic tetracarboxylic dianhydride refers to an acid dianhydride obtained by intramolecular dehydration of a carboxyl group bonded to an aromatic ring such as a benzene ring or a naphthalene ring. If specific examples are given, any of the tetravalent organic groups represented by any of the following formulas (Xa-1) to (Xa-2), and any of the following formulas (Xr-1) to (Xr-7) Represents a 4-valent organic group.

[化16]

Figure 02_image031
式(Xa-1)及(Xa-2)中,x及y各自獨立地為單鍵、醚、羰基、酯、碳數1~10之烷二基、1,4-伸苯基、磺醯基或醯胺鍵。j及k為0或1之整數。 [chemical 16]
Figure 02_image031
In formulas (Xa-1) and (Xa-2), x and y are each independently a single bond, ether, carbonyl, ester, alkanediyl with 1 to 10 carbons, 1,4-phenylene, sulfonyl group or amide bond. j and k are integers of 0 or 1.

[化17]

Figure 02_image033
[chemical 17]
Figure 02_image033

上式(Xa-1)或(Xa-2)表示之4價有機基亦可為下式(Xa-3)~(Xa-19)中之任一者表示之結構。The tetravalent organic group represented by the above formula (Xa-1) or (Xa-2) may also have a structure represented by any one of the following formulas (Xa-3) to (Xa-19).

[化18]

Figure 02_image035
[chemical 18]
Figure 02_image035

[化19]

Figure 02_image037
[chemical 19]
Figure 02_image037

上述聚合物(A),也可為選自由具有上述重複單元(a1)、重複單元(a2)、重複單元(a2’)、及重複單元(a3)以外且更具有下式(4)表示之重複單元(a4)之聚醯亞胺前驅物及係該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種聚合物。The above-mentioned polymer (A) may also be selected from having the above-mentioned repeating unit (a1), repeating unit (a2), repeating unit (a2'), and repeating unit (a3) and further having the following formula (4) At least one polymer selected from the group consisting of a polyimide precursor of the repeating unit (a4) and a polyimide which is an imidized product of the polyimide precursor.

[化20]

Figure 02_image039
[chemical 20]
Figure 02_image039

式(4)中,X 4表示4價有機基,Y 4表示上式(H)表示之2價有機基、上式(o-1)~(o-14)表示之2價有機基、分子內具有上述基「-N(D)-(D表示胺甲酸酯系保護基。)」之碳數6~30之2價有機基、及上式(O2)表示之2價有機基以外之2價有機基。R、及Z各和上式(1)之R、及Z為同義。 In formula (4), X 4 represents a 4-valent organic group, Y 4 represents a divalent organic group represented by the above formula (H), a divalent organic group represented by the above formula (o-1)~(o-14), and a molecule A divalent organic group with 6 to 30 carbon atoms having the above-mentioned group "-N(D)-(D represents a carbamate-based protecting group.)" and a divalent organic group other than the divalent organic group represented by the above formula (O2) 2-valent organic group. R, and Z are each synonymous with R, and Z in the above formula (1).

X 4之具體例可列舉在上述X 1、X 2、X 2’、及X 3之說明例示之4價有機基。考量理想地獲得本發明之效果之觀點,X 4為上式(g)表示之4價有機基、或上式(X-1)~(X-25)中之任一者表示之4價有機基較理想,上式(g)、(X-1)~(X-5)、(X-11)、(X-21)~(X-23)表示之4價有機基更佳,上式(g)表示之4價有機基又更佳。 Specific examples of X 4 include the tetravalent organic groups exemplified in the description of X 1 , X 2 , X 2′ , and X 3 above. Considering the viewpoint of obtaining the effect of the present invention ideally, X 4 is a 4-valent organic group represented by the above formula (g), or a 4-valent organic group represented by any one of the above formulas (X-1) to (X-25). The group is ideal, the quaternary organic group represented by the above formula (g), (X-1)~(X-5), (X-11), (X-21)~(X-23) is better, the above formula The tetravalent organic group represented by (g) is more preferable.

Y 4表示上式(H)表示之2價有機基、上式(o-1)~(o-14)表示之2價有機基、分子內具有上述基「-N(D)-(D表示胺甲酸酯系保護基。)」之碳數6~30之2價有機基、及上式(O2)表示之2價有機基以外之2價有機基(以下亦稱為其他2價有機基),該其他2價有機基可列舉從以下之二胺除去了2個胺基之2價有機基。 可列舉從4,4’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、3,3’-二甲基-4,4’-二胺基二苯基甲烷;下式(g-1)~(g-10)表示之二胺等具有光配向性基之二胺;下式(u-1)~(u-3)表示之二胺等具有脲鍵之二胺(惟該二胺在分子內不具有胺甲酸酯系保護基。);下式(u-4)~(u-8)表示之二胺等具有醯胺鍵之二胺(惟該二胺於分子內不具有胺甲酸酯系保護基。);具有選自由含氮原子之雜環、及基「* 21-NR-* 22」(* 21、及* 22表示和構成芳香族環之碳原子鍵結之原子鍵。惟該碳原子不和R所鍵結之氮原子形成環。R表示氫原子或1價有機基,上述1價有機基以羰基碳以外之碳原子和氮原子鍵結。)表示之胺基構成之群組中之至少一種含氮原子之結構(以下亦稱為含氮原子之結構。)之二胺;3,5-二胺基苯甲醇、2,4-二胺基苯甲醇;2,4-二胺基苯甲酸、2,5-二胺基苯甲酸、3,5-二胺基苯甲酸、4,4’-二胺基聯苯-3-羧酸、4,4’-二胺基二苯基甲烷-3-羧酸、4,4’-二胺基二苯基乙烷-3-羧酸、4,4’-二胺基聯苯-3,3’-二羧酸、4,4’-二胺基聯苯-2,2’-二羧酸、3,3’-二胺基聯苯-4,4’-二羧酸、3,3’-二胺基聯苯-2,4’-二羧酸、4,4’-二胺基二苯基甲烷-3,3’-二羧酸、4,4’-二胺基二苯基乙烷-3,3’-二羧酸及4,4’-二胺基二苯醚-3,3’-二羧酸等具有羧基之二胺;4-(2-(甲胺基)乙基)苯胺、4-(2-胺基乙基)苯胺、4,4’-二胺基二苯基酮、1-(4-胺基苯基)-1,3,3-三甲基-1H-二氫茚-5-胺、1-(4-胺基苯基)-2,3-二氫-1,3,3-三甲基-1H-茚-6-胺;甲基丙烯酸2-(2,4-二胺基苯氧基)乙酯及2,4-二胺基-N,N-二烯丙基苯胺等末端具有光聚合性基之二胺;膽甾烷基氧基-3,5-二胺基苯、膽甾烯基氧基-3,5-二胺基苯、膽甾烷基氧基-2,4-二胺基苯、3,5-二胺基苯甲酸膽甾烷酯、3,5-二胺基苯甲酸膽甾烯酯、3,5-二胺基苯甲酸羊毛甾烷酯及3,6-雙(4-胺基苯甲醯氧基膽甾烷等具有類固醇骨架之二胺;下式(V-1)~(V-6)表示之二胺;1,3-雙(3-胺基丙基)-四甲基二矽氧烷等具有矽氧烷鍵之二胺;下式(Ox-1)~(Ox-2)等具有㗁唑啉環結構之二胺;1-(4-(2,4-二胺基苯氧基)乙氧基)苯基)-2-羥基-2-甲基丙酮、2-(4-(2-羥基-2-甲基丙醯基)苯氧基)乙基-3,5-二胺基苯甲酸酯、4,4’-二胺基二苯基酮、3,3’-二胺基二苯基酮等具有自由基聚合起始劑機能之二胺等二胺除去了2個胺基之2價有機基、WO2018/117239號公報記載之式(Y-1)~(Y-167)中之任一者表示之基。 Y 4 represents the divalent organic group represented by the above formula (H), the divalent organic group represented by the above formula (o-1)~(o-14), and the above-mentioned group "-N(D)-(D represents Urethane-based protecting group.)" divalent organic groups with 6 to 30 carbon atoms, and divalent organic groups other than the divalent organic groups represented by the above formula (O2) (hereinafter also referred to as other divalent organic groups ), and the other divalent organic groups include divalent organic groups obtained by removing two amine groups from the following diamines. Can be listed from 4,4'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 3,3'-dimethyl-4,4'-diaminodiphenylmethane ; diamines represented by the following formulas (g-1)~(g-10) and other diamines with photoalignment groups; diamines represented by the following formulas (u-1)~(u-3) and other diamines with urea bonds Diamine (provided that the diamine does not have a urethane-based protecting group in the molecule); diamines represented by the following formulas (u-4)~(u-8) and other diamines with amide bonds (except that the diamine Diamine does not have a urethane-based protecting group in the molecule.); has a heterocyclic ring selected from a nitrogen-containing atom, and a group "* 21 -NR-* 22 " (* 21 , and * 22 represent and constitute aromatic The atomic bond bonded by the carbon atom of the ring. However, the carbon atom does not form a ring with the nitrogen atom bonded by R. R represents a hydrogen atom or a monovalent organic group, and the above monovalent organic group consists of carbon atoms other than carbonyl carbon and nitrogen At least one nitrogen atom-containing structure (hereinafter also referred to as a nitrogen atom-containing structure) in the group consisting of amine groups represented by diamine; 3,5-diaminobenzyl alcohol, 2, 4-Diaminobenzyl alcohol; 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid, 3,5-diaminobenzoic acid, 4,4'-diaminobiphenyl-3 -carboxylic acid, 4,4'-diaminodiphenylmethane-3-carboxylic acid, 4,4'-diaminodiphenylethane-3-carboxylic acid, 4,4'-diaminobiphenyl Benzene-3,3'-dicarboxylic acid, 4,4'-diaminobiphenyl-2,2'-dicarboxylic acid, 3,3'-diaminobiphenyl-4,4'-dicarboxylic acid , 3,3'-diaminobiphenyl-2,4'-dicarboxylic acid, 4,4'-diaminodiphenylmethane-3,3'-dicarboxylic acid, 4,4'-diamine Diamines with carboxyl groups such as diphenylethane-3,3'-dicarboxylic acid and 4,4'-diaminodiphenyl ether-3,3'-dicarboxylic acid; 4-(2-(methyl Amino)ethyl)aniline, 4-(2-aminoethyl)aniline, 4,4'-diaminodiphenylketone, 1-(4-aminophenyl)-1,3,3- Trimethyl-1H-inden-5-amine, 1-(4-aminophenyl)-2,3-dihydro-1,3,3-trimethyl-1H-inden-6-amine; 2-(2,4-diaminophenoxy)ethyl methacrylate and 2,4-diamino-N,N-diallylaniline and other diamines with photopolymerizable groups at the end; cholesteric acid Alkyloxy-3,5-diaminobenzene, cholestenyloxy-3,5-diaminobenzene, cholestanyloxy-2,4-diaminobenzene, 3,5- Cholesteryl diaminobenzoate, cholestenyl 3,5-diaminobenzoate, lanostyl 3,5-diaminobenzoate and 3,6-bis(4-aminobenzyl Diamines with a steroid skeleton such as acyloxycholestane; diamines represented by the following formulas (V-1)~(V-6); 1,3-bis(3-aminopropyl)-tetramethyldiamine Diamines with siloxane bonds such as siloxane; diamines with oxazoline ring structure such as the following formula (Ox-1)~(Ox-2); 1-(4-(2,4-diamino Phenoxy) Ethoxy) Phenyl)-2-hydroxy-2-methylacetone, 2-(4-(2-hydroxy-2-methylpropionyl)phenoxy)ethyl-3,5-diaminobenzoate , 4,4'-diaminobenzophenone, 3,3'-diaminobenzophenone, and other diamines that have the function of radical polymerization initiators. An organic group, a group represented by any one of the formulas (Y-1) to (Y-167) described in WO2018/117239.

[化21]

Figure 02_image041
[化22]
Figure 02_image043
[化23]
Figure 02_image045
[chem 21]
Figure 02_image041
[chem 22]
Figure 02_image043
[chem 23]
Figure 02_image045

上式(V-1)~(V-6)中,X v1~X v4、及X p1~X p2各自獨立地表示-(CH 2) a-(a為1~15之整數。)、-CONH-、-NHCO-、-CO-N(CH 3)-、-NH-、-O-、-CH 2O-、-CH 2-OCO-、-COO-、或-OCO-,X v5表示-O-、-CH 2O-、-CH 2-OCO-、-COO-、或-OCO-。X a表示單鍵、-O-、-NH-、-O-(CH 2) m-O-(m表示1~6之整數。)、-C(CH 3) 2-、-CO-、-(CH 2) m-(m表示1~6之整數。)、-SO 2-、-O-C(CH 3) 2-、-CO-(CH 2) m-(m表示1~6之整數。)、-NH-(CH 2) m-(m表示1~6之整數。)、-SO 2-(CH 2) m-(m表示1~6之整數。)、-CONH-(CH 2) m-(m表示1~6之整數。)、-CONH-(CH 2) m-NHCO-(m表示1~6之整數。)、-COO-(CH 2) m-OCO-(m表示1~6之整數。)、-CONH-、-NH-(CH 2) m-NH-(m表示1~6之整數。)、或-SO 2-(CH 2) m-SO 2-(m表示1~6之整數。),R v1~R v4、及R 1a~R 1b各自獨立地表示碳數1~20之烷基、碳數1~20之烷氧基或碳數2~20之烷氧基烷基。 In the above formulas (V-1) to (V-6), X v1 to X v4 and X p1 to X p2 each independently represent -(CH 2 ) a -(a is an integer of 1 to 15.), - CONH-, -NHCO-, -CO-N(CH 3 )-, -NH-, -O-, -CH 2 O-, -CH 2 -OCO-, -COO-, or -OCO-, X v5 means -O-, -CH2O- , -CH2 -OCO-, -COO-, or -OCO-. X a represents a single bond, -O-, -NH-, -O-(CH 2 ) m -O- (m represents an integer from 1 to 6.), -C(CH 3 ) 2 -, -CO-, - (CH 2 ) m -(m represents an integer from 1 to 6.), -SO 2 -, -OC(CH 3 ) 2 -, -CO-(CH 2 ) m -(m represents an integer from 1 to 6.) , -NH-(CH 2 ) m -(m represents an integer from 1 to 6.), -SO 2 -(CH 2 ) m -(m represents an integer from 1 to 6.), -CONH-(CH 2 ) m -(m represents an integer of 1~6.), -CONH-(CH 2 ) m -NHCO-(m represents an integer of 1~6.), -COO-(CH 2 ) m -OCO-(m represents 1~ Integer of 6.), -CONH-, -NH-(CH 2 ) m -NH-(m represents an integer of 1 to 6.), or -SO 2 -(CH 2 ) m -SO 2 -(m represents 1 ~6 integers.), R v1 ~R v4 , and R 1a ~ R 1b each independently represent an alkyl group with 1 to 20 carbons, an alkoxy group with 1 to 20 carbons, or an alkoxy group with 2 to 20 carbons base alkyl.

[化24]

Figure 02_image047
[chem 24]
Figure 02_image047

上述含氮原子之雜環,例如:吡咯、咪唑、吡唑、三唑、吡啶、嘧啶、嗒𠯤、吡𠯤、吲哚、苯并咪唑、嘌呤、喹啉、異喹啉、㖠啶、喹㗁啉、酞𠯤、三𠯤、咔唑、吖啶、哌啶、哌𠯤、吡咯啶、六亞甲基亞胺等。其中,吡啶、嘧啶、吡𠯤、哌啶、哌𠯤、喹啉、咔唑或吖啶較佳。Heterocyclic rings containing the above-mentioned nitrogen atoms, such as: pyrrole, imidazole, pyrazole, triazole, pyridine, pyrimidine, pyridine, pyridine, indole, benzimidazole, purine, quinoline, isoquinoline, pyridine, quinol㗁line, phthalein, tris, carbazole, acridine, piperidine, piperidine, pyrrolidine, hexamethyleneimine, etc. Among them, pyridine, pyrimidine, pyridine, piperidine, piperidine, quinoline, carbazole or acridine are preferred.

上述基「* 21-NR-* 22」之R之1價有機基,代表碳數1~10之1價烴基、於該烴基之碳-碳鍵間之一部分插入-O-或-C(=O)-而成之1價基、或上述烴基及上述1價基擁有之氫原子之一部分被鹵素原子、羥基取代之1價有機基。R較佳為氫原子或甲基。 The monovalent organic group of R in the above-mentioned group "* 21 -NR-* 22 " represents a monovalent hydrocarbon group with 1 to 10 carbons, and -O- or -C (= O)-a monovalent group formed, or a monovalent organic group in which part of the hydrogen atoms possessed by the above-mentioned hydrocarbon group and the above-mentioned monovalent group is replaced by a halogen atom or a hydroxyl group. R is preferably a hydrogen atom or a methyl group.

具有含氮原子之結構之二胺之具體例,例如:2,6-二胺基吡啶、3,4-二胺基吡啶、2,4-二胺基嘧啶、3,6-二胺基咔唑、N-甲基-3,6-二胺基咔唑、N-乙基-3,6-二胺基咔唑、N-苯基-3,6-二胺基咔唑、1,4-雙-(4-胺基苯基)-哌𠯤、3,6-二胺基吖啶、下式(Dp-1)~(Dp-8)表示之化合物、或下式(z-1)~式(z-13)表示之化合物。 [化25]

Figure 02_image049
[化26]
Figure 02_image051
[化27]
Figure 02_image053
Specific examples of diamines with structures containing nitrogen atoms, such as: 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminocarba Azole, N-methyl-3,6-diaminocarbazole, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminocarbazole, 1,4 -Bis-(4-aminophenyl)-piperone, 3,6-diaminoacridine, compounds represented by the following formula (Dp-1)~(Dp-8), or the following formula (z-1) ~ the compound represented by formula (z-13). [chem 25]
Figure 02_image049
[chem 26]
Figure 02_image051
[chem 27]
Figure 02_image053

考量理想地獲得本發明之效果之觀點,上述其他2價有機基宜為不具有碳數4以上之側鏈結構之2價有機基較佳,該不具有碳數4以上之側鏈結構之2價有機基,可列舉:從下列二胺除去了2個胺基之2價有機基,即從「選自由從上述其他二胺排除甲基丙烯酸2-(2,4-二胺基苯氧基)乙酯、2,4-二胺基-N,N-二烯丙基苯胺、上述具有類固醇骨架之二胺、上式(V-1)~(V-6)表示之二胺、1-(4-(2-(2,4-二胺基苯氧基)乙氧基)苯基)-2-羥基-2-甲基丙酮、2-(4-(2-羥基-2-甲基丙醯基)苯氧基)乙基-3,5-二胺基苯甲酸酯、N-苯基-3,6-二胺基咔唑、(z-4)及(z-6)表示之二胺等之二胺構成之群組中之二胺」除去了2個胺基之2價有機基。Considering the viewpoint of ideally obtaining the effects of the present invention, the above-mentioned other divalent organic groups are preferably divalent organic groups that do not have a side chain structure with a carbon number of 4 or more. A valent organic group can be exemplified: a divalent organic group with two amine groups removed from the following diamines, that is, a divalent organic group selected from the group consisting of 2-(2,4-diaminophenoxy methacrylic acid from the other diamines mentioned above) ) ethyl ester, 2,4-diamino-N,N-diallylaniline, the above-mentioned diamines having a steroid skeleton, diamines represented by the above formulas (V-1)~(V-6), 1- (4-(2-(2,4-diaminophenoxy)ethoxy)phenyl)-2-hydroxy-2-methylacetone, 2-(4-(2-hydroxy-2-methyl Propyl)phenoxy)ethyl-3,5-diaminobenzoate, N-phenyl-3,6-diaminocarbazole, (z-4) and (z-6) "Diamine in the group consisting of diamines such as diamines" is a divalent organic group in which two amine groups have been removed.

考量理想地獲得本發明之效果之觀點,聚合物(A)中,重複單元(a1)與重複單元(a1)之醯亞胺化結構之合計含量為全部重複單元之5~100莫耳%較佳,10~100莫耳%較佳。又,在此之合計也包括重複單元(a1)及重複單元(a1)之醯亞胺化結構中之任一者為0莫耳%的情形。以下稱合計時,也包括構成要素之1或2以上為0莫耳%的情形。 聚合物(A)含有重複單元(a1)及重複單元(a1)之醯亞胺化結構以外之重複單元時,聚合物(A)中,重複單元(a1)與重複單元(a1)之醯亞胺化結構之合計含量為全部重複單元之95莫耳%以下較佳,90莫耳%以下更佳,80莫耳%以下又更佳。 Considering the viewpoint of obtaining the effects of the present invention ideally, in the polymer (A), the total content of the repeating unit (a1) and the imidized structure of the repeating unit (a1) is 5 to 100 mol% of the total repeating unit. Good, preferably 10~100 mole %. In addition, the sum here also includes the case where either one of the repeating unit (a1) and the imidization structure of the repeating unit (a1) is 0 mol%. Hereinafter, when referred to as "total", the case where 1 or more of the constituent elements are 0 mol% is also included. When the polymer (A) contains repeating units other than the repeating unit (a1) and the imidization structure of the repeating unit (a1), in the polymer (A), the repeating unit (a1) and the imidization structure of the repeating unit (a1) The total content of the aminated structure is preferably not more than 95 mol%, more preferably not more than 90 mol%, and more preferably not more than 80 mol%, of all repeating units.

考量理想地獲得本發明之效果之觀點,聚合物(A)中,重複單元(a2)與重複單元(a2)之醯亞胺化結構之合計含量為全部重複單元之5莫耳%以上較佳,10莫耳%以上更佳,20莫耳%以上又更佳。又,其上限值為90莫耳%較佳,85莫耳%更佳。Considering the ideal effect of the present invention, in the polymer (A), the total content of the repeating unit (a2) and the imidized structure of the repeating unit (a2) is preferably 5 mol% or more of the total repeating units , more than 10 mol%, more preferably 20 mol% or more. Also, the upper limit thereof is preferably 90 mol%, more preferably 85 mol%.

考量理想地獲得本發明之效果之觀點,聚合物(A)中,重複單元(a1)及重複單元(a2)及它們的醯亞胺化結構之合計含量為全部重複單元之10莫耳%以上較佳,20莫耳%以上更佳。聚合物(A)含有重複單元(a1)及重複單元(a2)及它們的醯亞胺化結構以外之重複單元時,重複單元(a1)及重複單元(a2)及它們的醯亞胺化結構之合計含量之上限為95莫耳%較佳,90莫耳%更理想。Considering that the effects of the present invention are ideally obtained, in the polymer (A), the total content of the repeating unit (a1) and the repeating unit (a2) and their imidized structures is 10 mol% or more of the total repeating units Preferably, more than 20 mol%. When the polymer (A) contains repeating units (a1) and repeating units (a2) and repeating units other than their imidized structures, the repeating units (a1) and repeating units (a2) and their imidized structures The upper limit of the total content is preferably 95 mol%, more preferably 90 mol%.

聚合物(A)含有重複單元(a2’)及重複單元(a2’)之醯亞胺化結構中之至少任一者時,考量理想地獲得本發明之效果之觀點,聚合物(A)中之重複單元(a2’)與重複單元(a2’)之醯亞胺化結構之合計含量為全部重複單元之1~50莫耳%較佳,1~40莫耳%更佳,1~30莫耳%又更佳。聚合物(A)含有重複單元(a1)及其醯亞胺化結構中之至少任一者、及重複單元(a2’)及其醯亞胺化結構中之至少任一者時,重複單元(a1)及重複單元(a2’)及它們的醯亞胺化結構之合計含量之下限值為5莫耳%較佳,10莫耳%更理想。 考量理想地獲得本發明之效果之觀點,聚合物(A)中含有重複單元(a1)及其醯亞胺化結構中之至少任一者、重複單元(a2)及其醯亞胺化結構中之至少任一者、及重複單元(a2’)及其醯亞胺化結構中之至少任一者,且重複單元(a1)、重複單元(a2)及重複單元(a2’)及它們的醯亞胺化結構之合計含量為全部重複單元之30莫耳%以上較佳,40莫耳%以上更佳。聚合物(A)含有重複單元(a1)、重複單元(a2)及重複單元(a2’)及它們的醯亞胺化結構以外之重複單元時,重複單元(a1)、重複單元(a2)及重複單元(a2’)及它們的醯亞胺化結構之合計含量之上限為95莫耳%較佳,90莫耳%更理想。 When the polymer (A) contains at least any one of the repeating unit (a2') and the imidized structure of the repeating unit (a2'), considering that the effect of the present invention is ideally obtained, in the polymer (A) The total content of the repeating unit (a2') and the imidized structure of the repeating unit (a2') is preferably 1-50 mol% of the total repeating unit, more preferably 1-40 mol%, 1-30 mol% Ear% is even better. When the polymer (A) contains at least any one of the repeating unit (a1) and its imidized structure, and at least any one of the repeating unit (a2') and its imidized structure, the repeating unit ( The lower limit of the total content of a1), repeating unit (a2') and their imidized structures is preferably 5 mol%, more preferably 10 mol%. From the viewpoint of ideally obtaining the effects of the present invention, the polymer (A) contains at least any one of the repeating unit (a1) and its imidized structure, the repeating unit (a2) and its imidized structure At least any one of, and at least any one of the repeating unit (a2') and its imidization structure, and the repeating unit (a1), repeating unit (a2) and repeating unit (a2') and their acyl The total content of imidized structures is preferably 30 mol% or more of all repeating units, more preferably 40 mol% or more. When the polymer (A) contains repeating units (a1), repeating units (a2) and repeating units (a2') and repeating units other than their imidized structures, repeating units (a1), repeating units (a2) and The upper limit of the total content of the repeating unit (a2') and their imidized structures is preferably 95 mol%, more preferably 90 mol%.

聚合物(A)含有重複單元(a3)及重複單元(a3)之醯亞胺化結構中之至少任一者時,考量理想地獲得本發明之效果之觀點,聚合物(A)中之重複單元(a3)及重複單元(a3)之醯亞胺化結構之合計含量為全部重複單元之1~40莫耳%較佳,1~30莫耳%更佳,1~25莫耳%又更佳。When the polymer (A) contains at least any one of the repeating unit (a3) and the imidization structure of the repeating unit (a3), considering the ideal effect of the present invention, the repeating in the polymer (A) The total content of the imidized structure of the unit (a3) and the repeating unit (a3) is preferably 1-40 mol%, more preferably 1-30 mol%, and more preferably 1-25 mol% of the total repeating unit good.

聚合物(A)也可含有重複單元(a2’)及重複單元(a3)及它們的醯亞胺化結構中之至少任一者。The polymer (A) may contain at least any one of repeating unit (a2'), repeating unit (a3), and their imidized structures.

<聚合物(B)> 本發明之液晶配向劑中,除了上述聚合物(A)以外,也可含有分子內不具有上述重複單元(a1)及其醯亞胺化結構之聚合物(B)。又,聚合物(B)可由1種或2種以上構成。考量理想地獲得本發明之效果之觀點,聚合物(B)可列舉具有下式(5)表示之重複單元或其醯亞胺化結構之聚合物。又,構成聚合物(B)之重複單元或其醯亞胺化結構,可由1種也可由2種以上構成。 [化28]

Figure 02_image055
式(5)中,X 5為4價有機基,Y 5為2價有機基。R、及Z各和上式(1)之R、及Z為同義。 <Polymer (B)> The liquid crystal alignment agent of the present invention may contain, in addition to the above-mentioned polymer (A), a polymer (B) that does not have the above-mentioned repeating unit (a1) and its imidized structure in the molecule. . Moreover, a polymer (B) may consist of 1 type, or 2 or more types. From the viewpoint of ideally obtaining the effect of the present invention, examples of the polymer (B) include a repeating unit represented by the following formula (5) or a polymer having an imidized structure thereof. In addition, the repeating unit constituting the polymer (B) or its imidized structure may be composed of one type or two or more types. [chem 28]
Figure 02_image055
In formula (5), X 5 is a tetravalent organic group, and Y 5 is a divalent organic group. R, and Z are each synonymous with R, and Z in the above formula (1).

上述X 5之4價有機基,可列舉來自非環族脂肪族四羧酸二酐或其衍生物之4價有機基、來自脂環族四羧酸二酐或其衍生物之4價有機基或來自芳香族四羧酸二酐或其衍生物之4價有機基,具體例可列舉上述X 1例示之4價有機基。考量理想地獲得本發明之效果之觀點,上述非環族脂肪族或脂環族四羧酸二酐或其衍生物當中,又以考量提高液晶配向性之效果高之觀點,具有選自由環丁烷環結構、環戊烷環結構及環己烷環結構構成之群組中之至少一種次結構之四羧酸二酐或其衍生物較佳。更理想之X 5為上式(g)表示之4價有機基、上式(X-1)~(X-25)中之任一者表示之4價有機基、上式(Xa-1)~(Xa-2)表示之4價有機基或上式(Xr-1)~(Xr-7)表示之4價有機基(它們也總稱為特定4價有機基。)。 The tetravalent organic group of the above-mentioned X5 includes a tetravalent organic group derived from acyclic aliphatic tetracarboxylic dianhydride or a derivative thereof, a tetravalent organic group derived from an alicyclic tetracarboxylic dianhydride or a derivative thereof Or a tetravalent organic group derived from an aromatic tetracarboxylic dianhydride or a derivative thereof. Specific examples include the tetravalent organic group exemplified above for X1. Considering the viewpoint of obtaining the effect of the present invention ideally, among the above-mentioned non-cyclic aliphatic or alicyclic tetracarboxylic dianhydrides or their derivatives, and considering the high effect of improving the liquid crystal alignment, there are selected from cyclobutyl Tetracarboxylic dianhydride or derivatives thereof of at least one substructure in the group consisting of an alkane ring structure, a cyclopentane ring structure and a cyclohexane ring structure are preferred. A more desirable X5 is a quaternary organic group represented by the above formula (g), a 4 -valent organic group represented by any one of the above formulas (X-1) to (X-25), a 4-valent organic group represented by the above formula (Xa-1) 4-valent organic groups represented by ~(Xa-2) or 4-valent organic groups represented by the above formulas (Xr-1)~(Xr-7) (they are also collectively referred to as specific 4-valent organic groups.).

針對聚合物(B),考量理想地獲得本發明之效果之觀點,X 5為上述特定之4價有機基的式(5)表示之重複單元或其醯亞胺化結構之含量宜為聚合物(B)中含有的全部重複單元之5莫耳%以上較佳,10莫耳%以上更佳。 For the polymer (B), considering the viewpoint of obtaining the effects of the present invention ideally, X 5 is the repeating unit represented by the formula (5) of the above-mentioned specific 4-valent organic group or the content of the imidized structure of the polymer is preferably The total repeating units contained in (B) are preferably 5 mol% or more, more preferably 10 mol% or more.

上述Y 5之2價有機基可列舉在上述Y 4例示之2價有機基。考量來自殘留DC之殘影少之觀點,聚合物(B)宜為含有Y 5係從上述具有脲鍵之二胺、上述具有醯胺鍵之二胺、上述具有含氮原子之結構之二胺、2,4-二胺基苯酚、3,5-二胺基苯酚、3,5-二胺基苯甲醇、2,4-二胺基苯甲醇、4,6-二胺基間苯二酚、上述具有羧基之二胺、4,4’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、3,3’-二甲基-4,4’-二胺基二苯基甲烷、對苯二胺及間苯二胺除去了2個胺基之2價有機基(它們也總稱為特定之2價有機基。)的式(5)表示之重複單元或其醯亞胺化結構的聚合物較佳。 The divalent organic group of the above-mentioned Y 5 includes the divalent organic groups exemplified in the above-mentioned Y 4 . In consideration of less image sticking from residual DC, the polymer (B) is preferably a diamine containing Y5 from the above - mentioned diamine having a urea bond, the above-mentioned diamine having an amide bond, or the above-mentioned diamine having a structure containing a nitrogen atom. , 2,4-diaminobenzyl alcohol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminoresorcinol , the above-mentioned diamines with carboxyl groups, 4,4'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 3,3'-dimethyl-4,4'-diamine Diphenylmethane, p-phenylenediamine, and m-phenylenediamine are divalent organic groups with two amino groups removed (they are also collectively referred to as specific divalent organic groups.) The repeating unit represented by formula (5) or its A polymer having an imidized structure is preferable.

針對聚合物(B),考量提高透射率之觀點,具有2種以上之上式(5)表示之重複單元或其醯亞胺化結構,且含有具有係從上述具有脲鍵之二胺、上述具有醯胺鍵之二胺、或上述具有含氮原子之結構之二胺除去了2個胺基之2價有機基即Y 5之式(5)表示之重複單元及其醯亞胺化結構中之至少任一者、及具有從其他二胺除去了2個胺基之2價有機基即Y 5之式(5)表示之重複單元及其醯亞胺化結構中之至少任一者更佳。 The polymer (B) has two or more repeating units represented by the above formula (5) or its imidized structure from the viewpoint of improving the transmittance, and contains a diamine having a urea bond from the above, the above-mentioned A diamine having an amide bond, or a diamine having a structure containing a nitrogen atom mentioned above is a repeating unit represented by the formula (5) of Y 5 and its imidization structure. At least any one of them, and at least any one of the repeating unit represented by the formula (5) having a divalent organic group with two amine groups removed from other diamines, that is, Y 5 , and its imidization structure is more preferable .

針對聚合物(B),考量來自殘留DC之殘影少之觀點,Y 5為上述特定之2價有機基的式(5)表示之重複單元及其醯亞胺化結構之合計含量,可為聚合物(B)中含有的全部重複單元之1莫耳%以上,也可為5莫耳%以上。更佳為10莫耳%以上,又更佳為20莫耳%以上。 Regarding the polymer (B), considering the viewpoint of less image sticking due to residual DC, Y5 is the total content of the repeating unit represented by the formula ( 5 ) of the above-mentioned specific divalent organic group and its imidized structure, which can be The total repeating units contained in the polymer (B) may be 1 mol% or more, and may be 5 mol% or more. More preferably, it is at least 10 mol%, and more preferably at least 20 mol%.

考量來自殘留DC之殘影少之觀點,液晶配向劑中之聚合物(A)與聚合物(B)之含有比例,按[聚合物(A)]/[聚合物(B)]之質量比可為10/90~90/10,也可為20/80~90/10,也可為20/80~80/20。Considering the viewpoint of less image sticking from residual DC, the content ratio of polymer (A) and polymer (B) in the liquid crystal alignment agent is based on the mass ratio of [polymer (A)]/[polymer (B)] It can be 10/90~90/10, 20/80~90/10, or 20/80~80/20.

<聚醯胺酸、聚醯胺酸酯及聚醯亞胺之製造方法> 本發明中使用的係聚醯亞胺前驅物之聚醯胺酸酯、及聚醯胺酸和係該等醯亞胺化物之聚醯亞胺,例如可按如WO2013/157586號公報記載之公知方法合成。 <Manufacturing method of polyamide acid, polyamide ester and polyimide> The polyamide esters, polyamide acids, and polyimides that are polyimide precursors used in the present invention can be known, for example, as described in WO2013/157586. method synthesis.

更具體而言,藉由使二胺成分、與四羧酸衍生物成分在溶劑中進行(縮聚合)反應以實施。上述四羧酸衍生物成分可列舉四羧酸二酐及其衍生物(四羧酸二鹵化物、四羧酸二酯、或四羧酸二酯二鹵化物)。聚合物(A)或(B)之一部分含有醯胺酸結構時,例如藉由使四羧酸二酐成分與二胺成分反應,以獲得具有醯胺酸結構之聚合物(聚醯胺酸)。溶劑只要是生成之聚合物會溶解的溶劑即無特殊限制。 上述溶劑之具體例可列舉N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、γ-丁內酯、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、二甲基亞碸、1,3-二甲基-2-咪唑啶酮。又,聚合物之溶劑溶解性高時,可使用甲乙酮、環己酮、環戊酮、4-羥基-4-甲基-2-戊酮、或下列式[D-1]~式[D-3]表示之溶劑。 [化29]

Figure 02_image057
式[D-1]中,D 1表示碳數1~3之烷基,式[D-2]中,D 2表示碳數1~3之烷基,式[D-3]中,D 3表示碳數1~4之烷基。 More specifically, it implement|achieves by carrying out (condensation polymerization) reaction of a diamine component, and a tetracarboxylic-acid derivative component in a solvent. As the said tetracarboxylic-acid derivative component, tetracarboxylic dianhydride and derivatives thereof (tetracarboxylic dihalide, tetracarboxylic diester, or tetracarboxylic diester dihalide) are mentioned. When a part of the polymer (A) or (B) contains an amide acid structure, for example, by reacting a tetracarboxylic dianhydride component with a diamine component, a polymer (polyamic acid) having an amide acid structure is obtained . The solvent is not particularly limited as long as it dissolves the polymer to be formed. Specific examples of the above-mentioned solvents include N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, γ-butyrolactone, N,N-dimethylformamide, N,N-dimethylacetamide Amide, dimethylsulfoxide, 1,3-dimethyl-2-imidazolidinone. Also, when the solvent solubility of the polymer is high, methyl ethyl ketone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methyl-2-pentanone, or the following formula [D-1] ~ formula [D- 3] The solvent indicated. [chem 29]
Figure 02_image057
In formula [D-1], D 1 represents an alkyl group with 1 to 3 carbons; in formula [D-2], D 2 represents an alkyl group with 1 to 3 carbons; in formula [D-3], D 3 Indicates an alkyl group with 1 to 4 carbon atoms.

此等溶劑可單獨使用也可混合使用。再者,即使是聚合物不溶解之溶劑,也可在生成之聚合物不析出之範圍下,混合在上述溶劑並使用。 使二胺成分與四羧酸衍生物成分在溶劑中反應時,反應可於任意濃度進行,較佳為1~50質量%,更佳為5~30質量%。反應初期於高濃度進行,之後追加溶劑亦可。 反應中,二胺成分之合計莫耳數與四羧酸衍生物成分之合計莫耳數之比為0.8~1.2較佳。和通常的縮聚合反應同樣,此莫耳比越接近1.0則生成之聚合物(A)、聚合物(B)之分子量越大。 These solvents may be used alone or in combination. In addition, even if it is a solvent in which a polymer does not dissolve, it can be mixed with the said solvent and used in the range which the produced polymer does not precipitate. When reacting the diamine component and the tetracarboxylic acid derivative component in a solvent, the reaction can be performed at any concentration, preferably 1 to 50% by mass, more preferably 5 to 30% by mass. The reaction may be carried out at a high concentration in the initial stage, and a solvent may be added thereafter. During the reaction, the ratio of the total number of moles of the diamine components to the total number of moles of the tetracarboxylic acid derivative components is preferably 0.8 to 1.2. Similar to the usual polycondensation reaction, the closer the molar ratio is to 1.0, the larger the molecular weights of the polymer (A) and polymer (B) produced will be.

聚醯胺酸酯,可藉由例如:[I]使上述方法獲得之聚醯胺酸與酯化劑反應之方法、[II]使四羧酸二酯與二胺反應之方法、[III]使四羧酸二酯二鹵化物與二胺反應之方法等既知之方法獲得。Polyamic acid ester can be obtained by, for example: [I] a method of reacting the polyamic acid obtained by the above method with an esterifying agent, [II] a method of reacting a tetracarboxylic acid diester with a diamine, [III] It can be obtained by a known method such as a method of reacting a tetracarboxylic diester dihalide with a diamine.

獲得聚醯亞胺之方法,可列舉將上述反應獲得之聚合物之溶液直接加熱之熱醯亞胺化、或在聚合物之溶液中添加觸媒之觸媒醯亞胺化等既知之方法。As a method for obtaining polyimide, known methods such as thermal imidization in which the polymer solution obtained by the above reaction is directly heated, or catalytic imidization in which a catalyst is added to the polymer solution can be mentioned.

本發明之聚合物(A)、聚合物(B)中之聚醯亞胺,係上述聚醯亞胺前驅物具有之重複單元一部分或全部閉環。上述聚醯亞胺中,醯亞胺化率較佳為20~95%,較佳為30~95%,更佳為50~95%。The polyimide in the polymer (A) and the polymer (B) of the present invention is part or all of the repeating units of the polyimide precursor mentioned above that are ring-closed. Among the above polyimides, the imidization rate is preferably 20-95%, more preferably 30-95%, more preferably 50-95%.

<聚合物之溶液黏度、分子量> 本發明使用之聚醯胺酸、聚醯胺酸酯及聚醯亞胺,當製成濃度10~15質量%之溶液時,例如帶有10~1000mPa・s之溶液黏度時於作業性之觀點較理想,但無特殊限制。又,上述聚合物之溶液黏度(mPa・s),係使用該聚合物之良溶劑(例如:γ-丁內酯、N-甲基-2-吡咯烷酮等)製備成濃度10~15質量%之聚合物溶液,使用E型旋轉黏度計於25℃測定之值。 上述聚醯胺酸、聚醯胺酸酯及聚醯亞胺利用凝膠滲透層析(GPC)測定之聚苯乙烯換算之重量平均分子量(Mw)較佳為1,000~500,000,更佳為2,000~300,000。又,Mw與利用GPC測定之聚苯乙烯換算之數量平均分子量(Mn)之比表示之分子量分布(Mw/Mn),較佳為15以下,更佳為10以下。藉由在如此的分子量範圍,能夠確保液晶顯示元件之良好配向性及安定性。 <Polymer solution viscosity, molecular weight> The polyamic acid, polyamic acid ester and polyimide used in the present invention, when made into a solution with a concentration of 10-15% by mass, for example, have a solution viscosity of 10-1000mPa·s from the viewpoint of workability Ideal, but no special restrictions. In addition, the solution viscosity (mPa·s) of the above-mentioned polymer is obtained by using a good solvent for the polymer (such as: γ-butyrolactone, N-methyl-2-pyrrolidone, etc.) to prepare a concentration of 10-15 mass%. Polymer solution, the value measured at 25°C using an E-type rotational viscometer. The weight average molecular weight (Mw) in terms of polystyrene as measured by gel permeation chromatography (GPC) of the above-mentioned polyamic acid, polyamic acid ester, and polyimide is preferably 1,000 to 500,000, more preferably 2,000 to 500,000. 300,000. Also, the molecular weight distribution (Mw/Mn) represented by the ratio of Mw to the polystyrene-equivalent number average molecular weight (Mn) measured by GPC is preferably 15 or less, more preferably 10 or less. By being in such a molecular weight range, good alignment and stability of the liquid crystal display element can be ensured.

<封端劑> 合成本發明之聚合物(A)、聚合物(B)時,可使用如上述四羧酸衍生物成分、及二胺成分,以及適當的封端劑,合成末端密封型之聚合物。末端密封型之聚合物,具有使由塗膜獲得之液晶配向膜之膜硬度提升、密封劑與液晶配向膜之密合特性提升的效果。 本發明中之聚合物(A)、聚合物(B)之末端,例如胺基、羧基、酸酐基或來自後述封端劑之基。胺基、羧基、酸酐基可藉由通常之縮合反應獲得、或藉由使用以下之封端劑將末端予以密封以獲得。 <Blocking agent> When synthesizing the polymers (A) and (B) of the present invention, the above-mentioned tetracarboxylic acid derivative components, diamine components, and appropriate end-capping agents can be used to synthesize end-sealed polymers. End-sealed polymers have the effects of improving the film hardness of the liquid crystal alignment film obtained from the coating film and improving the adhesion between the sealant and the liquid crystal alignment film. The terminals of the polymer (A) and polymer (B) in the present invention are, for example, amino groups, carboxyl groups, acid anhydride groups, or groups derived from end-capping agents described later. Amino groups, carboxyl groups, and acid anhydride groups can be obtained by a common condensation reaction, or by sealing the ends with the following blocking agents.

封端劑,例如:乙酸酐、馬來酸酐、奈地酸酐、鄰苯二甲酸酐、衣康酸酐、環己烷二羧酸酐、3-羥基鄰苯二甲酸酐、偏苯三甲酸酐、3-(3-三甲氧基矽基)丙基)-3,4-二氫呋喃-2,5-二酮、4,5,6,7-四氟異苯并呋喃-1,3-二酮、4-乙炔基鄰苯二甲酸酐等酸一酐;二碳酸二第三丁酯、二碳酸二烯丙酯等二碳酸二酯化合物;丙烯醯氯、甲基丙烯醯氯、菸鹼醯氯等氯羰基化合物;苯胺、2-胺基苯酚、3-胺基苯酚、4-胺基水楊酸、5-胺基水楊酸、6-胺基水楊酸、2-胺基苯甲酸、3-胺基苯甲酸、4-胺基苯甲酸、環己胺、正丁胺、正戊胺、正己胺、正庚胺、正辛胺等單胺化合物;異氰酸乙酯、異氰酸苯酯、異氰酸萘酯、2-丙烯醯氧基乙基異氰酸酯及2-甲基丙烯醯氧乙基異氰酸酯等具有不飽和鍵之異氰酸酯等單異氰酸酯化合物;異硫氰酸乙酯、異硫氰酸烯丙酯等異硫氰酸酯化合物等。Capping agents, such as: acetic anhydride, maleic anhydride, nedylic anhydride, phthalic anhydride, itaconic anhydride, cyclohexanedicarboxylic anhydride, 3-hydroxyphthalic anhydride, trimellitic anhydride, 3- (3-trimethoxysilyl)propyl)-3,4-dihydrofuran-2,5-dione, 4,5,6,7-tetrafluoroisobenzofuran-1,3-dione, Acid monoanhydrides such as 4-ethynyl phthalic anhydride; di-tert-butyl dicarbonate, diallyl dicarbonate and other dicarbonate diester compounds; acryl chloride, methacryl chloride, nicotinyl chloride, etc. Chlorocarbonyl compounds; aniline, 2-aminophenol, 3-aminophenol, 4-aminosalicylic acid, 5-aminosalicylic acid, 6-aminosalicylic acid, 2-aminobenzoic acid, 3 -Aminobenzoic acid, 4-aminobenzoic acid, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine and other monoamine compounds; ethyl isocyanate, benzene isocyanate Monoisocyanate compounds such as esters, naphthyl isocyanate, 2-acryloxyethyl isocyanate and 2-methacryloxyethyl isocyanate and other isocyanates with unsaturated bonds; ethyl isothiocyanate, isothiocyanate Isothiocyanate compounds such as allyl acrylate, etc.

封端劑之使用比例,相對於使用之二胺成分之合計100莫耳份為0.01~20莫耳份較理想,0.01~10莫耳份更理想。The usage ratio of the end-capping agent is preferably 0.01-20 mole parts, more preferably 0.01-10 mole parts, relative to the total 100 mole parts of the diamine components used.

<液晶配向劑> 本發明之液晶配向劑,含有聚合物(A)並視需要含有聚合物(B)。本發明之液晶配向劑,除了聚合物(A)、聚合物(B)也可含有其他聚合物。若舉其他聚合物之具體例,可列舉選自由聚矽氧烷、聚酯、聚醯胺、聚脲、聚胺甲酸酯、聚有機矽氧烷、纖維素衍生物、聚縮醛、聚苯乙烯衍生物、聚(苯乙烯-馬來酸酐)共聚物、聚(異丁烯-馬來酸酐)共聚物、聚(乙烯醚-馬來酸酐)共聚物、聚(苯乙烯-苯基馬來醯亞胺)衍生物、聚(甲基)丙烯酸酯構成之群組中之聚合物等。 聚(苯乙烯-馬來酸酐)共聚物之具體例可列舉SMA1000、2000、3000(Cray Valley公司製)、GSM301(GIFUSHELLAC製造所公司製)等,聚(異丁烯-馬來酸酐)共聚物之具體例可列舉ISOBAM-600(可樂麗公司製),聚(乙烯醚-馬來酸酐)共聚物之具體例可列舉Gantrez AN-139(甲基乙烯醚馬來酸酐樹脂、ASHLAND公司製)。其他聚合物可單獨使用一種也可將二種以上組合使用。 其他聚合物之含有比例相對於液晶配向劑中含有的聚合物之合計100質量份宜為90質量份以下較理想,10~90質量份更佳,20~80質量份更理想。 <Liquid crystal alignment agent> The liquid crystal alignment agent of the present invention contains a polymer (A) and optionally a polymer (B). The liquid crystal alignment agent of the present invention may also contain other polymers besides polymer (A) and polymer (B). Specific examples of other polymers include polysiloxanes, polyesters, polyamides, polyureas, polyurethanes, polyorganosiloxanes, cellulose derivatives, polyacetals, and polyamides. Styrene derivatives, poly(styrene-maleic anhydride) copolymers, poly(isobutylene-maleic anhydride) copolymers, poly(vinyl ether-maleic anhydride) copolymers, poly(styrene-phenylmaleic anhydride) imine) derivatives, polymers in the group consisting of poly(meth)acrylates, etc. Specific examples of poly(styrene-maleic anhydride) copolymers include SMA1000, 2000, and 3000 (manufactured by Cray Valley Co.), GSM301 (manufactured by GIFUSHELLAC Manufacturing Co., Ltd.), and specific examples of poly(isobutylene-maleic anhydride) copolymers Examples include ISOBAM-600 (manufactured by Kuraray Co., Ltd.), and specific examples of poly(vinyl ether-maleic anhydride) copolymers include Gantrez AN-139 (methyl vinyl ether maleic anhydride resin, manufactured by ASHLAND). Other polymers may be used alone or in combination of two or more. The proportion of other polymers is preferably not more than 90 parts by mass, more preferably 10 to 90 parts by mass, and more preferably 20 to 80 parts by mass, based on 100 parts by mass of the total polymers contained in the liquid crystal alignment agent.

液晶配向劑係為了製作液晶配向膜而使用,考量形成均勻薄膜之觀點,採取塗佈液之形態。本發明之液晶配向劑亦宜為含有上述聚合物成分及有機溶劑之塗佈液較佳。此時,液晶配向劑中之聚合物之濃度,可依欲形成之塗膜之厚度之設定而適當變更。考量形成均勻且無缺陷之塗膜之觀點,液晶配向劑中之聚合物之濃度為1質量%以上較理想,考量溶液之保存安定性之觀點,為10質量%以下較佳。尤其理想聚合物之濃度為2~8質量%。The liquid crystal alignment agent is used for making a liquid crystal alignment film, and it takes the form of a coating liquid in consideration of forming a uniform thin film. The liquid crystal alignment agent of the present invention is also preferably a coating solution containing the above-mentioned polymer component and an organic solvent. At this time, the concentration of the polymer in the liquid crystal alignment agent can be appropriately changed according to the setting of the thickness of the coating film to be formed. From the viewpoint of forming a uniform and defect-free coating film, the concentration of the polymer in the liquid crystal alignment agent is preferably 1% by mass or more, and from the viewpoint of storage stability of the solution, it is preferably 10% by mass or less. In particular, the concentration of the ideal polymer is 2 to 8% by mass.

液晶配向劑含有之有機溶劑,只要聚合物成分會均勻溶解即無特殊限制。其具體例可列舉N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N,N-二甲基乳醯胺、N,N-二甲基丙醯胺、四甲基脲、N,N-二乙基甲醯胺、N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、二甲基亞碸、γ-丁內酯、γ-戊內酯、1,3-二甲基-2-咪唑啶酮、甲乙酮、環己酮、環戊酮、3-甲氧基-N,N-二甲基丙烷醯胺、3-丁氧基-N,N-二甲基丙烷醯胺、N-(正丙基)-2-吡咯烷酮、N-異丙基-2-吡咯烷酮、N-(正丁基)-2-吡咯烷酮、N-(第三丁基)-2-吡咯烷酮、N-(正戊基)-2-吡咯烷酮、N-甲氧基丙基-2-吡咯烷酮、N-乙氧基乙基-2-吡咯烷酮、N-甲氧基丁基-2-吡咯烷酮、N-環己基-2-吡咯烷酮(它們也總稱「良溶劑」)。其中,N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、3-甲氧基-N,N-二甲基丙烷醯胺、3-丁氧基-N,N-二甲基丙烷醯胺或γ-丁內酯較佳。良溶劑之含量為液晶配向劑中含有的溶劑全體的20~99質量%較佳,20~90質量%更佳,30~80質量%尤佳。The organic solvent contained in the liquid crystal alignment agent is not particularly limited as long as the polymer components are uniformly dissolved. Specific examples thereof include N,N-dimethylformamide, N,N-dimethylacetamide, N,N-dimethyllactamide, N,N-dimethylacrylamide, tetra Methylurea, N,N-diethylformamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, dimethylsulfoxide, γ-butyrolactone, γ-valerolactone , 1,3-Dimethyl-2-imidazolidinone, methyl ethyl ketone, cyclohexanone, cyclopentanone, 3-methoxy-N,N-dimethylpropanamide, 3-butoxy-N, N-Dimethylpropanamide, N-(n-propyl)-2-pyrrolidone, N-isopropyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(tert-butyl )-2-pyrrolidone, N-(n-pentyl)-2-pyrrolidone, N-methoxypropyl-2-pyrrolidone, N-ethoxyethyl-2-pyrrolidone, N-methoxybutyl- 2-pyrrolidone, N-cyclohexyl-2-pyrrolidone (these are also collectively referred to as "good solvent"). Among them, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, 3-methoxy-N,N-dimethylpropanamide, 3-butoxy-N,N-dimethyl Propanamide or γ-butyrolactone is preferred. The content of the good solvent is preferably 20-99% by mass, more preferably 20-90% by mass, and most preferably 30-80% by mass of the total solvent contained in the liquid crystal alignment agent.

又,液晶配向劑含有之有機溶劑,宜使用除了上述溶劑尚併用為了使塗佈液晶配向劑時之塗佈性、塗膜之表面平滑性提升之溶劑(亦稱不良溶劑)之混合溶劑較佳。不良溶劑之含量為液晶配向劑中含有的溶劑全體的1~80質量%較理想,10~80質量%更佳,20~70質量%尤佳。不良溶劑之種類及含量可因應液晶配向劑之塗佈裝置、塗佈條件、塗佈環境等適當選擇。 併用之不良溶劑之具體例如下但不限定於此等。 例如:二異丙醚、二異丁醚、二異丁基甲醇(2,6-二甲基-4-庚醇)、乙二醇二甲醚、乙二醇二乙醚、乙二醇二丁醚、1,2-二丁氧基乙烷、二乙二醇二甲醚、二乙二醇二乙醚、4-羥基-4-甲基-2-戊酮、二乙二醇甲基乙醚、二乙二醇二丁醚、3-乙氧基丁基乙酸酯、1-甲基戊基乙酸酯、2-乙基丁基乙酸酯、2-乙基己基乙酸酯、乙二醇單乙酸酯、乙二醇二乙酸酯、碳酸伸丙酯、碳酸伸乙酯、乙二醇單丁醚、乙二醇單異戊醚、乙二醇單己醚、丙二醇單甲醚、丙二醇單丁醚、1-(2-丁氧基乙氧基)-2-丙醇、2-(2-丁氧基乙氧基)-1-丙醇、丙二醇單甲醚乙酸酯、丙二醇二乙酸酯、二丙二醇單甲醚、二丙二醇單乙醚、二丙二醇二甲醚、乙二醇單丁醚乙酸酯、二乙二醇單丙醚、二乙二醇單乙醚乙酸酯、二乙二醇單丁醚乙酸酯、2-(2-乙氧基乙氧基)乙基乙酸酯、二乙二醇乙酸酯、丙二醇二乙酸酯、乙酸正丁酯、乙酸丙二醇單乙醚、乙酸環己酯、乙酸4-甲基-2-戊酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸乙酯、3-甲氧基丙酸乙酯、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、乳酸正丁酯、乳酸異戊酯、二乙二醇單乙醚、二異丁基酮(2,6-二甲基-4-庚酮)等。 In addition, the organic solvent contained in the liquid crystal alignment agent should be mixed with a solvent (also known as a poor solvent) to improve the coatability and surface smoothness of the coating film in addition to the above-mentioned solvents. . The content of the poor solvent is preferably 1 to 80% by mass, more preferably 10 to 80% by mass, and most preferably 20 to 70% by mass, of the entire solvent contained in the liquid crystal alignment agent. The type and content of the poor solvent can be properly selected according to the liquid crystal alignment agent coating device, coating conditions, coating environment, etc. Specific examples of poor solvents used together are as follows but not limited thereto. For example: diisopropyl ether, diisobutyl ether, diisobutylmethanol (2,6-dimethyl-4-heptanol), ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, 1,2-dibutoxyethane, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, 4-hydroxy-4-methyl-2-pentanone, diethylene glycol methyl ether, Diethylene glycol dibutyl ether, 3-ethoxybutyl acetate, 1-methylpentyl acetate, 2-ethylbutyl acetate, 2-ethylhexyl acetate, ethylene diacetate Alcohol monoacetate, ethylene glycol diacetate, propylene carbonate, ethylene carbonate, ethylene glycol monobutyl ether, ethylene glycol monoisopentyl ether, ethylene glycol monohexyl ether, propylene glycol monomethyl ether , propylene glycol monobutyl ether, 1-(2-butoxyethoxy)-2-propanol, 2-(2-butoxyethoxy)-1-propanol, propylene glycol monomethyl ether acetate, Propylene glycol diacetate, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol dimethyl ether, ethylene glycol monobutyl ether acetate, diethylene glycol monopropyl ether, diethylene glycol monoethyl ether acetate , Diethylene glycol monobutyl ether acetate, 2-(2-ethoxyethoxy) ethyl acetate, diethylene glycol acetate, propylene glycol diacetate, n-butyl acetate, acetic acid Propylene glycol monoethyl ether, cyclohexyl acetate, 4-methyl-2-pentyl acetate, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-methoxypropyl propionate, 3-methoxybutyl propionate, n-butyl lactate, isoamyl lactate, diethylene glycol monoethyl ether, diisobutyl ketone (2,6-dimethyl -4-heptanone), etc.

其中,宜為二異丁基甲醇、丙二醇單丁醚、丙二醇二乙酸酯、二乙二醇二乙醚、二丙二醇單甲醚、二丙二醇二甲醚、4-羥基-4-甲基-2-戊酮、乙二醇單丁醚、乙二醇單丁醚乙酸酯、或二異丁基酮較佳。Among them, diisobutylmethanol, propylene glycol monobutyl ether, propylene glycol diacetate, diethylene glycol diethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol dimethyl ether, 4-hydroxyl-4-methyl-2 - Pentanone, ethylene glycol monobutyl ether, ethylene glycol monobutyl ether acetate, or diisobutyl ketone are preferred.

良溶劑與不良溶劑之理想溶劑之組合,可列舉:N-甲基-2-吡咯烷酮與乙二醇單丁醚、N-甲基-2-吡咯烷酮與γ-丁內酯與乙二醇單丁醚、N-甲基-2-吡咯烷酮與γ-丁內酯與丙二醇單丁醚、N-乙基-2-吡咯烷酮與丙二醇單丁醚、N-乙基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮、N-乙基-2-吡咯烷酮與丙二醇二乙酸酯、N,N-二甲基乳醯胺與二異丁基酮、N-甲基-2-吡咯烷酮與3-乙氧基丙酸乙酯、N-乙基-2-吡咯烷酮與3-乙氧基丙酸乙酯、N-甲基-2-吡咯烷酮與3-乙氧基丙酸乙酯與二丙二醇單甲醚、N-乙基-2-吡咯烷酮與3-乙氧基丙酸乙酯與丙二醇單丁醚、N-甲基-2-吡咯烷酮與3-乙氧基丙酸乙酯與二乙二醇單丙醚、N-乙基-2-吡咯烷酮與3-乙氧基丙酸乙酯與二乙二醇單丙醚、N-甲基-2-吡咯烷酮與乙二醇單丁醚乙酸酯、N-乙基-2-吡咯烷酮與二丙二醇二甲醚、N,N-二甲基乳醯胺與乙二醇單丁醚、N,N-二甲基乳醯胺與丙二醇二乙酸酯、N-乙基-2-吡咯烷酮與二乙二醇二乙醚、N-乙基-2-吡咯烷酮與二乙二醇單乙醚與丁基賽珞蘇乙酸酯、N-甲基-2-吡咯烷酮與二乙二醇單甲醚與丁基賽珞蘇乙酸酯、N,N-二甲基乳醯胺與二乙二醇二乙醚、N-甲基-2-吡咯烷酮與γ-丁內酯與4-羥基-4-甲基-2-戊酮與二乙二醇二乙醚、N-乙基-2-吡咯烷酮與N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮、N-乙基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與丙二醇單丁醚、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與二異丁基酮、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與二丙二醇單甲醚、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與丙二醇單丁醚、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與丙二醇二乙酸酯、N-乙基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與二丙二醇二甲醚、γ-丁內酯與4-羥基-4-甲基-2-戊酮與二異丁基酮、γ-丁內酯與4-羥基-4-甲基-2-戊酮與丙二醇二乙酸酯、N-甲基-2-吡咯烷酮與γ-丁內酯與丙二醇單丁醚與二異丁基酮、N-甲基-2-吡咯烷酮與γ-丁內酯與丙二醇單丁醚與二異丙醚、N-甲基-2-吡咯烷酮與γ-丁內酯與丙二醇單丁醚與二異丁基甲醇、N-甲基-2-吡咯烷酮與γ-丁內酯與二丙二醇二甲醚、N-甲基-2-吡咯烷酮與丙二醇單丁醚與二丙二醇二甲醚、N-乙基-2-吡咯烷酮與丙二醇單丁醚與二丙二醇單甲醚、N-乙基-2-吡咯烷酮與二乙二醇二乙醚與二丙二醇單甲醚、N-乙基-2-吡咯烷酮與丙二醇單丁醚與丙二醇二乙酸酯、N-乙基-2-吡咯烷酮與丙二醇單丁醚與二異丁基酮、N-乙基-2-吡咯烷酮與γ-丁內酯與二異丁基酮、N-乙基-2-吡咯烷酮與N,N-二甲基乳醯胺與二異丁基酮、N-甲基-2-吡咯烷酮與乙二醇單丁醚與乙二醇單丁醚乙酸酯、γ-丁內酯與乙二醇單丁醚乙酸酯與二丙二醇二甲醚、N-乙基-2-吡咯烷酮與乙二醇單丁醚乙酸酯與丙二醇二甲醚、N-甲基-2-吡咯烷酮與乙酸4-甲基-2-戊酯與乙二醇單丁醚、N-乙基-2-吡咯烷酮與乙酸環己酯與二丙酮醇環己酮與丙二醇單甲醚、環戊酮與丙二醇單甲醚、N-甲基-2-吡咯烷酮與環己酮與丙二醇單甲醚等。The combination of ideal solvents for good solvents and poor solvents can include: N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether, N-methyl-2-pyrrolidone and γ-butyrolactone and ethylene glycol monobutyl ether ether, N-methyl-2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether, N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether, N-ethyl-2-pyrrolidone and 4-hydroxy-4 -Methyl-2-pentanone, N-ethyl-2-pyrrolidone and propylene glycol diacetate, N,N-dimethyl lactamide and diisobutyl ketone, N-methyl-2-pyrrolidone and Ethyl 3-ethoxypropionate, N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate, N-methyl-2-pyrrolidone and ethyl 3-ethoxypropionate and dipropylene glycol Monomethyl ether, N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate and propylene glycol monobutyl ether, N-methyl-2-pyrrolidone and ethyl 3-ethoxypropionate and diethylene glycol Alcohol monopropyl ether, N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate and diethylene glycol monopropyl ether, N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether acetate , N-ethyl-2-pyrrolidone and dipropylene glycol dimethyl ether, N,N-dimethyl lactamide and ethylene glycol monobutyl ether, N,N-dimethyl lactamide and propylene glycol diacetate , N-ethyl-2-pyrrolidone and diethylene glycol diethyl ether, N-ethyl-2-pyrrolidone and diethylene glycol monoethyl ether and butyl cellothracetate, N-methyl-2-pyrrolidone Diethylene glycol monomethyl ether and butyl cellothracetate, N,N-dimethyl lactamide and diethylene glycol diethyl ether, N-methyl-2-pyrrolidone and γ-butyrolactone With 4-hydroxy-4-methyl-2-pentanone and diethylene glycol diethyl ether, N-ethyl-2-pyrrolidone and N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2 -pentanone, N-ethyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone and propylene glycol monobutyl ether, N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl- 2-pentanone and diisobutyl ketone, N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone and dipropylene glycol monomethyl ether, N-methyl-2-pyrrolidone and 4 -Hydroxy-4-methyl-2-pentanone and propylene glycol monobutyl ether, N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone and propylene glycol diacetate, N-ethyl Base-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone and dipropylene glycol dimethyl ether, γ-butyrolactone and 4-hydroxy-4-methyl-2-pentanone and diisobutyl Ketone, γ-butyrolactone and 4-hydroxy-4-methyl-2-pentanone and propylene glycol diacetate, N-methyl-2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether and diiso Butyl ketone, N-methyl-2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether and diisopropyl ether, N-methyl-2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether and diisopropyl ether Isobutyl carbinol, N-methyl-2-pyrrolidone and γ-butyrolactone and dipropylene glycol dimethyl ether, N-methyl-2-pyrrolidone and propylene glycol monobutyl ether and dipropylene glycol dimethyl ether, N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether and dipropylene glycol monomethyl ether, N-ethyl-2-pyrrolidone and diethylene glycol diethyl ether and dipropylene glycol monomethyl ether, N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether and propylene glycol diacetate, N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether and diisobutyl ketone, N-ethyl-2-pyrrolidone and γ-butyrolactone and diisobutyl Base ketone, N-ethyl-2-pyrrolidone and N,N-dimethyl lactamide and diisobutyl ketone, N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether and ethylene glycol monobutyl Ether acetate, γ-butyrolactone and ethylene glycol monobutyl ether acetate and dipropylene glycol dimethyl ether, N-ethyl-2-pyrrolidone and ethylene glycol monobutyl ether acetate and propylene glycol dimethyl ether , N-methyl-2-pyrrolidone and 4-methyl-2-pentyl acetate and ethylene glycol monobutyl ether, N-ethyl-2-pyrrolidone and cyclohexyl acetate and diacetone alcohol cyclohexanone and propylene glycol Monomethyl ether, cyclopentanone and propylene glycol monomethyl ether, N-methyl-2-pyrrolidone, cyclohexanone and propylene glycol monomethyl ether, etc.

本發明之液晶配向劑亦可追加地含有聚合物成分及有機溶劑以外之成分(以下亦稱添加劑成分)。如此的添加劑成分可列舉:用以使液晶配向膜與基板之密合性、液晶配向膜與密封劑之密合性提高之密合助劑、用以使液晶配向膜之強度提高之化合物(以下亦稱交聯性化合物)、用以促進醯亞胺化之化合物、用以調整液晶配向膜之介電常數、電阻之介電體、導電物質等。The liquid crystal alignment agent of the present invention may additionally contain components other than polymer components and organic solvents (hereinafter also referred to as additive components). Examples of such additive components include: adhesion aids for improving the adhesion between the liquid crystal alignment film and the substrate, the adhesion between the liquid crystal alignment film and the sealant, and compounds for improving the strength of the liquid crystal alignment film (hereinafter Also known as cross-linking compounds), compounds used to promote imidization, dielectrics used to adjust the dielectric constant and resistance of liquid crystal alignment films, conductive substances, etc.

針對上述交聯性化合物,考量對於AC殘影展現良好的耐性且膜強度之提升高之觀點,也可為選自由下列構成之群組中之至少1種化合物:具有選自由環氧乙烷基、環氧丙烷基、保護異氰酸酯基、保護異硫氰酸酯基、含有㗁唑啉環結構之基、含有米氏酸(Meldrum’s acid)結構之基、環碳酸酯基及羥基烷基醯胺鍵構成之群組中之至少1種基之化合物、及具有烷氧基甲基及羥甲基中之至少一者之苯酚化合物。The above-mentioned crosslinkable compound may be at least one compound selected from the group consisting of: , epoxypropylene group, protected isocyanate group, protected isothiocyanate group, group containing zozoline ring structure, group containing Meldrum's acid structure, ring carbonate group and hydroxyalkylamide bond A compound of at least one group in the group consisting of, and a phenol compound having at least one of an alkoxymethyl group and a hydroxymethyl group.

針對具有環氧乙烷基之化合物之具體例,可列舉:乙二醇二環氧丙醚、聚乙二醇二環氧丙醚、丙二醇二環氧丙醚、三丙二醇二環氧丙醚、聚丙二醇二環氧丙醚、新戊二醇二環氧丙醚、1,6-己烷二醇二環氧丙醚、甘油二環氧丙醚、2,2-二溴新戊二醇二環氧丙醚、1,3,5,6-四環氧丙基-2,4-己烷二醇、EPIKOTE828(三菱化學公司製)等雙酚A型環氧樹脂、EPIKOTE807(三菱化學公司製)等雙酚F型環氧樹脂、YX-8000(三菱化學公司製)等氫化雙酚A型環氧樹脂、YX6954BH30(三菱化學公司製)等含聯苯骨架之環氧樹脂、EPPN-201(日本化藥公司製)等苯酚酚醛清漆型環氧樹脂、EOCN-102S(日本化藥公司製)等(鄰位、間位、對位)甲酚酚醛清漆型環氧樹脂、TEPIC(日產化學公司製)等異氰尿酸三環氧丙酯、CELLOXIDE 2021P(大賽璐化學工業公司製)等脂環族環氧樹脂、N,N,N’,N’-四環氧丙基間二甲苯二胺、1,3-雙(N,N-二環氧丙胺基甲基)環己烷、N,N,N’,N’-四環氧丙基-4,4’-二胺基二苯基甲烷、肆(環氧丙氧基甲基)甲烷。Specific examples of compounds having an oxirane group include: ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, Polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerin diglycidyl ether, 2,2-dibromoneopentyl glycol di Bisphenol A epoxy resins such as glycidyl ether, 1,3,5,6-tetraglycidyl-2,4-hexanediol, EPIKOTE828 (manufactured by Mitsubishi Chemical Corporation), EPIKOTE807 (manufactured by Mitsubishi Chemical Corporation) ) and other bisphenol F-type epoxy resins, YX-8000 (manufactured by Mitsubishi Chemical Corporation) and other hydrogenated bisphenol A-type epoxy resins, YX6954BH30 (manufactured by Mitsubishi Chemical Corporation) and other epoxy resins containing a biphenyl skeleton, EPPN-201 ( Nippon Kayaku Co., Ltd.) and other phenol novolac epoxy resins, EOCN-102S (Nippon Kayaku Co., Ltd.) and other (ortho, meta, para) cresol novolac epoxy resins, TEPIC (Nissan Chemical Corporation) Triglycidyl isocyanurate, etc., CELLOXIDE 2021P (manufactured by Daicel Chemical Industry Co., Ltd.) and other alicyclic epoxy resins, N,N,N',N'-tetraglycidyl-m-xylylenediamine , 1,3-bis(N,N-diepoxypropylaminomethyl)cyclohexane, N,N,N',N'-tetraepoxypropyl-4,4'-diaminodiphenyl Methane, tetrakis(glycidoxymethyl)methane.

具有環氧丙烷基之化合物之具體例可列舉:WO2011/132751號公報之段落[0170]~[0175]記載之具有2個以上之環氧丙烷基之化合物等。Specific examples of the compound having a propylene oxide group include compounds having two or more propylene oxide groups described in paragraphs [0170] to [0175] of WO2011/132751.

具有保護異氰酸酯基之化合物之具體例,可列舉:日本特開2014-224978號公報之段落[0046]~[0047]記載之具有2個以上之保護異氰酸酯基之化合物、WO2015/141598號公報之段落[0119]~[0120]記載之具有3個以上之保護異氰酸酯基之化合物等,市售品例如可理想地使用CORONATE AP Stable M、CORONATE2503、2515、2507、2513、2555、MILLIONATE MS-50(以上為東曹公司製)、TAKENATE B-830、B-815N、B-820NSU、B-842N、B-846N、B-870N、B-874N、B-882N(以上為三井化學公司製)等。Specific examples of compounds having protected isocyanate groups include compounds having two or more protected isocyanate groups described in paragraphs [0046] to [0047] of JP-A-2014-224978 and paragraphs of WO2015/141598 [0119]~[0120] The compound etc. with more than 3 protected isocyanate groups described in the record, commercially available products such as can ideally use CORONATE AP Stable M, CORONATE2503, 2515, 2507, 2513, 2555, MILLIONATE MS-50 (above manufactured by Tosoh Corporation), TAKENATE B-830, B-815N, B-820NSU, B-842N, B-846N, B-870N, B-874N, B-882N (the above are manufactured by Mitsui Chemicals Corporation), etc.

具有保護異硫氰酸酯基之化合物之具體例,可列舉日本特開2016-200798號公報記載之具有2個以上之保護異硫氰酸酯基之化合物。 具有含有㗁唑啉環結構之基之化合物之具體例,可列舉日本特開2007-286597號公報之段落[0115]記載之含有2個以上之㗁唑啉環結構之化合物。 具有含有米氏酸結構之基之化合物之具體例,可列舉WO2012/091088號公報記載之具有2個以上之米氏酸結構之化合物。 具有環碳酸酯基之化合物之具體例可列舉WO2011/155577號公報記載之化合物。 Specific examples of compounds having protected isothiocyanate groups include compounds having two or more protected isothiocyanate groups described in JP-A-2016-200798. Specific examples of compounds having a group having a oxazoline ring structure include compounds containing two or more oxazoline ring structures described in paragraph [0115] of JP-A-2007-286597. Specific examples of compounds having a group having a Michaelis acid structure include compounds having two or more Michaelis acid structures described in WO2012/091088. As a specific example of the compound which has a cyclocarbonate group, the compound described in WO2011/155577 is mentioned.

上述具有羥基烷基醯胺鍵之化合物之具體例,可列舉WO2015/072554號公報、日本特開2016-118753號公報之段落[0058]記載之具有2個以上之下式(d)表示之基之化合物、日本特開2016-200798號公報記載之化合物等。 [化30]

Figure 02_image059
R 2及R 3各自獨立地為氫原子、碳數1~3之烷基或「*-CH 2-OH」。 Specific examples of the above compound having a hydroxyalkylamide bond include groups having two or more groups represented by the following formula (d) as described in WO2015/072554 and paragraph [0058] of JP-A-2016-118753. Compounds, compounds described in Japanese Patent Application Laid-Open No. 2016-200798, etc. [chem 30]
Figure 02_image059
R 2 and R 3 are each independently a hydrogen atom, an alkyl group having 1 to 3 carbons, or "*-CH 2 -OH".

上述具有烷氧基烷基及羥甲基中之至少一者之苯酚化合物之具體例,可列舉WO2010/074269號公報記載之化合物。Specific examples of the above-mentioned phenol compound having at least one of an alkoxyalkyl group and a hydroxymethyl group include compounds described in WO2010/074269.

上述化合物係交聯性化合物之一例,不限於此等。例如:WO2015/060357號公報之53頁[0105]~55頁[0116]揭示之上述以外之成分等。又,交聯性化合物也可將2種以上組合。The above-mentioned compound is an example of a crosslinkable compound and is not limited thereto. For example: ingredients other than the above disclosed on page 53 [0105] to page 55 [0116] of WO2015/060357. Moreover, you may combine 2 or more types of crosslinkable compounds.

上述交聯性化合物之中,N,N,N’,N’-四環氧丙基間二甲苯二胺、1,3-雙(N,N-二環氧丙胺基甲基)環己烷、N,N,N’,N’-四環氧丙基-4,4’-二胺基二苯基甲烷、TAKENATE B-830、B-815N、B-820NSU、B-842N、B-846N、B-870N、B-874N、B-882N、1,3,5-參(2-羥基乙基)異三聚氰酸酯、異三聚氰酸三環氧丙酯、N,N,N’,N’-肆(2-羥基乙基)己二醯胺、2,2-雙(4-羥基-3,5-二羥基甲基苯基)丙烷、2,2-雙(4-羥基-3,5-二甲氧基甲基苯基)丙烷、2,2-雙(4-羥基-3,5-二羥基甲基苯基)-1,1,1,3,3,3-六氟丙烷較佳。Among the above-mentioned cross-linking compounds, N,N,N',N'-tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N-diecidylaminomethyl)cyclohexane , N,N,N',N'-tetraepoxypropyl-4,4'-diaminodiphenylmethane, TAKENATE B-830, B-815N, B-820NSU, B-842N, B-846N , B-870N, B-874N, B-882N, 1,3,5-ginseng (2-hydroxyethyl) isocyanurate, triglycidyl isocyanurate, N,N,N ',N'-tetra(2-hydroxyethyl)adipamide, 2,2-bis(4-hydroxy-3,5-dihydroxymethylphenyl)propane, 2,2-bis(4-hydroxy -3,5-dimethoxymethylphenyl)propane, 2,2-bis(4-hydroxy-3,5-dihydroxymethylphenyl)-1,1,1,3,3,3- Hexafluoropropane is preferred.

本發明之液晶配向劑中,交聯性化合物之含量相對於液晶配向劑中含有的聚合物成分100質量份為0.5~20質量份較佳,考量交聯反應進行且對於AC殘影展現良好的耐性的觀點,更佳為1~15質量份。In the liquid crystal alignment agent of the present invention, the content of the cross-linking compound is preferably 0.5 to 20 parts by mass relative to 100 parts by mass of the polymer component contained in the liquid crystal alignment agent, considering that the cross-linking reaction proceeds and the AC sticking effect is good. From the viewpoint of tolerance, it is more preferably 1 to 15 parts by mass.

上述密合助劑,例如3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、3-胺基丙基二乙氧基甲基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、2-(3,4-環氧環己基)乙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二甲氧基矽烷、3-環氧丙氧基丙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二乙氧基矽烷、3-環氧丙氧基丙基三乙氧基矽烷、對苯乙烯基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二乙氧基矽烷、3-甲基丙烯醯氧基丙基三乙氧基矽烷、3-丙烯醯氧基丙基三甲氧基矽烷、參(三甲氧基矽基丙基)異氰尿酸酯、3-巰基丙基甲基二甲氧基矽烷、3-巰基丙基三甲氧基矽烷、3-異氰酸酯丙基三乙氧基矽烷等矽烷偶聯劑。使用矽烷偶聯劑時,考量對於AC殘影展現良好的耐性的觀點,相對於液晶配向劑中含有的聚合物成分100質量份為0.1~30質量份較佳,0.1~20質量份更佳。The above adhesion aids, such as 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-aminopropyldiethoxymethylsilane, 2-aminopropyl Trimethoxysilane, 2-aminopropyltriethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl)- 3-aminopropylmethyldimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, N-ethoxycarbonyl-3-aminopropyl Trimethoxysilane, Vinyltrimethoxysilane, Vinyltriethoxysilane, 2-(3,4-Epoxycyclohexyl)ethyltrimethoxysilane, 3-Glycidoxypropylmethyl Dimethoxysilane, 3-Glycidoxypropyltrimethoxysilane, 3-Glycidoxypropylmethyldiethoxysilane, 3-Glycidoxypropyltriethoxy Silane, p-Styryltrimethoxysilane, 3-Methacryloxypropylmethyldimethoxysilane, 3-Methacryloxypropyltrimethoxysilane, 3-Methacryl Oxypropylmethyldiethoxysilane, 3-methacryloxypropyltriethoxysilane, 3-acryloxypropyltrimethoxysilane, ginseng (trimethoxysilylpropyl ) isocyanurate, 3-mercaptopropylmethyldimethoxysilane, 3-mercaptopropyltrimethoxysilane, 3-isocyanatepropyltriethoxysilane and other silane coupling agents. When a silane coupling agent is used, it is preferably 0.1 to 30 parts by mass, more preferably 0.1 to 20 parts by mass, based on 100 parts by mass of the polymer component contained in the liquid crystal alignment agent, in consideration of exhibiting good resistance to AC image sticking.

上述用以促進醯亞胺化之化合物,可列舉:具有鹼性部位(例:第一級胺基、脂肪族雜環(例:吡咯啶骨架)、芳香族雜環(例:咪唑環、吲哚環)、或胍基等)之化合物(惟排除上述交聯性化合物及密合助劑。)、或煅燒時會產生上述鹼性部位之化合物較佳。更佳為煅燒時會產生上述鹼性部位之化合物,若舉具體例,可列舉下式(B-1)~(B-17)表示之化合物。用以促進醯亞胺化之化合物之含量,相對於聚合物(A)擁有之醯胺酸、或醯胺酸酯部位1莫耳份,較佳為2莫耳份以下,更佳為1莫耳份以下,又更佳為0.5莫耳份以下。 [化31]

Figure 02_image061
D表示因加熱而脫離之有機基,較佳為第三丁氧基羰基、或9-茀基甲氧基羰基。 The above-mentioned compounds for promoting imidization include: having a basic site (for example: first-level amino group, aliphatic heterocycle (for example: pyrrolidine skeleton), aromatic heterocycle (for example: imidazole ring, indol Inole ring), or guanidino group, etc.) (excluding the above-mentioned cross-linking compounds and adhesion aids), or compounds that generate the above-mentioned basic sites during calcination are preferred. More preferably, it is a compound that generates the above-mentioned basic site during calcination, and specific examples include compounds represented by the following formulas (B-1) to (B-17). The content of the compound for promoting imidization is preferably 2 mole parts or less, more preferably 1 mole part with respect to 1 mole part of the amino acid or amido ester moiety possessed by the polymer (A). It is less than an ear part, more preferably less than 0.5 molar part. [chem 31]
Figure 02_image061
D represents an organic group detached by heating, preferably tert-butoxycarbonyl or 9-tertilylmethoxycarbonyl.

液晶配向劑中之固體成分濃度(液晶配向劑之溶劑以外之成分之合計質量佔液晶配向劑之全部質量之比例),可考慮黏性、揮發性等而適當選擇,較佳為1~10質量%之範圍。The solid content concentration in the liquid crystal alignment agent (the ratio of the total mass of the components other than the solvent of the liquid crystal alignment agent to the total mass of the liquid crystal alignment agent) can be appropriately selected in consideration of viscosity, volatility, etc., preferably 1 to 10 mass % range.

尤其理想之固體成分濃度之範圍,取決於在基板塗佈液晶配向劑時使用之方法而異。例如使用旋塗法時,固體成分濃度為1.5~4.5質量%之範圍尤佳。利用印刷法時,固體成分濃度為3~9質量%之範圍,藉此使溶液黏度成為12~50mPa・s之範圍尤佳。利用噴墨法時,固體成分濃度為1~5質量%之範圍,藉此使溶液黏度成為3~15mPa・s之範圍尤佳。製備聚合物組成物時之溫度較佳為10~50℃,更佳為20~30℃。The particularly desirable range of solid content concentration varies depending on the method used when coating the liquid crystal alignment agent on the substrate. For example, when the spin coating method is used, the solid content concentration is particularly preferably in the range of 1.5 to 4.5% by mass. When using the printing method, the solid content concentration is in the range of 3 to 9% by mass, and the viscosity of the solution is preferably in the range of 12 to 50 mPa·s. When using the inkjet method, the solid content concentration is in the range of 1 to 5% by mass, and the viscosity of the solution is preferably in the range of 3 to 15 mPa·s. The temperature for preparing the polymer composition is preferably 10-50°C, more preferably 20-30°C.

<液晶配向膜、液晶顯示元件> 本發明之液晶配向膜係由上述液晶配向劑獲得。本發明之液晶配向膜可使用於水平配向型或垂直配向型(VA型)之液晶配向膜,其中,係適合IPS方式或FFS方式等水平配向型之液晶顯示元件之液晶配向膜。又,本發明之液晶配向膜,更適合使用於光配向處理法用之液晶配向膜。此外,本發明之液晶配向膜能有效地採用在各種技術用途,例如上述用途以外之液晶配向膜(相位差薄膜用之液晶配向膜、掃描天線、液晶陣列天線用之液晶配向膜或透射散射型之液晶調光元件用之液晶配向膜)、或其他用途,例如:保護膜(例:彩色濾光片用之保護膜)、間隔件膜、層間絕緣膜、抗反射膜、配線被覆膜、抗靜電薄膜、電動機絕緣膜(可撓性顯示器之閘絕緣膜)等。本發明之液晶顯示元件具備上述液晶配向膜。本發明之液晶顯示元件可藉由例如包括以下之步驟(1)~(3)之方法製造。本發明之液晶顯示元件,例如可藉由包括以下之步驟(1)~(3)及(5)或步驟(1)~(2)及(5)之方法製造。更佳為藉由包括步驟(1)~(5)之方法製造。 <Liquid crystal alignment film, liquid crystal display element> The liquid crystal alignment film of the present invention is obtained from the above-mentioned liquid crystal alignment agent. The liquid crystal alignment film of the present invention can be used in horizontal alignment type or vertical alignment type (VA type) liquid crystal alignment film, among which, it is a liquid crystal alignment film suitable for horizontal alignment type liquid crystal display elements such as IPS method or FFS method. In addition, the liquid crystal alignment film of the present invention is more suitable for use as a liquid crystal alignment film for photo-alignment treatment. In addition, the liquid crystal alignment film of the present invention can be effectively used in various technical purposes, such as liquid crystal alignment films other than the above-mentioned purposes (liquid crystal alignment film for retardation film, scanning antenna, liquid crystal alignment film for liquid crystal array antenna or transmission scattering type Liquid crystal alignment film for liquid crystal dimming elements), or other uses, such as: protective film (for example: protective film for color filters), spacer film, interlayer insulating film, anti-reflection film, wiring coating film, Antistatic film, motor insulation film (gate insulation film for flexible displays), etc. The liquid crystal display element of the present invention includes the above-mentioned liquid crystal alignment film. The liquid crystal display element of the present invention can be manufactured by, for example, a method including the following steps (1) to (3). The liquid crystal display element of the present invention can be manufactured, for example, by a method including the following steps (1) to (3) and (5) or steps (1) to (2) and (5). More preferably, it is produced by a method comprising steps (1) to (5).

<步驟(1):將液晶配向劑塗佈在基板上之步驟> 步驟(1),係將本發明之液晶配向劑塗佈在基板上之步驟。步驟(1)之具體例如下。 在設有經圖案化之透明導電膜之基板之一面利用例如輥塗佈法、旋塗法、印刷法、噴墨法等適當塗佈方法塗佈本發明之液晶配向劑。在此,基板只要是透明性高之基板即不特別限定,也可將玻璃基板、氮化矽基板和壓克力基板、聚碳酸酯基板等塑膠基板等一起使用。又,反射型之液晶顯示元件若僅是單側基板,則亦可使用矽晶圓等不透明物,此時之電極亦可使用鋁等會反射光之材料。又,在製造IPS型或FFS型之液晶顯示元件時,係使用設有由圖案化為梳齒型之透明導電膜或金屬膜構成之電極之基板、與未設電極之對向基板。 <Step (1): The step of coating the liquid crystal alignment agent on the substrate> Step (1) is a step of coating the liquid crystal alignment agent of the present invention on the substrate. The specific example of step (1) is as follows. The liquid crystal alignment agent of the present invention is coated on one side of the substrate provided with the patterned transparent conductive film by appropriate coating methods such as roll coating method, spin coating method, printing method, and inkjet method. Here, the substrate is not particularly limited as long as it is highly transparent, and a plastic substrate such as a glass substrate, a silicon nitride substrate, an acrylic substrate, or a polycarbonate substrate may be used together. In addition, if the reflective liquid crystal display element has only one side substrate, opaque objects such as silicon wafers can also be used, and the electrodes at this time can also use materials that reflect light such as aluminum. Also, when manufacturing IPS-type or FFS-type liquid crystal display elements, a substrate provided with electrodes made of a comb-shaped transparent conductive film or metal film and an opposite substrate without electrodes are used.

將液晶配向劑塗佈基板並成膜之方法,可列舉網版印刷、平版印刷、柔版印刷、噴墨法、或噴塗法等。其中,宜利用噴墨法所為之塗佈、成膜法。The method of coating the liquid crystal alignment agent on the substrate and forming a film includes screen printing, offset printing, flexographic printing, inkjet method, or spraying method. Among them, the coating and film-forming methods by the inkjet method are preferable.

<步驟(2):將已塗佈之液晶配向劑進行煅燒之步驟> 步驟(2),係將已塗佈在基板上之液晶配向劑煅燒並形成膜之步驟。步驟(2)之具體例如下。 步驟(1)中將液晶配向劑塗佈在基板上後,可藉由熱板、熱循環型烘箱或IR(紅外線)型烘箱等加熱手段使溶劑蒸發、或進行聚醯胺酸或聚醯胺酸酯之熱醯亞胺化。塗佈本發明之液晶配向劑之後之乾燥、煅燒步驟,可選擇任意之溫度及時間,也可進行多次。煅燒溫度,例如可於40~180℃進行。考量縮短處理之觀點,也可於40~150℃進行。此時之煅燒時間不特別限定,例如1~10分或1~5分。進行聚醯胺酸或聚醯胺酸酯之熱醯亞胺化時,可於上述去除有機溶劑之步驟之後,追加例如於150~300℃、或150~250℃之溫度範圍進行煅燒之步驟。此時之煅燒時間不特別限定,可列舉5~40分、或5~30分之煅燒時間。 煅燒後之膜狀物若過薄,有時液晶顯示元件之可靠性會降低,故5~300nm較理想,10~200nm更理想。 <Step (2): The step of calcining the coated liquid crystal alignment agent> Step (2) is a step of calcining the liquid crystal alignment agent coated on the substrate to form a film. The specific example of step (2) is as follows. After coating the liquid crystal alignment agent on the substrate in step (1), the solvent can be evaporated by means of heating such as a hot plate, a thermal cycle oven, or an IR (infrared) oven, or polyamide acid or polyamide Thermal imidization of esters. The drying and calcining steps after coating the liquid crystal alignment agent of the present invention can be performed at any temperature and time, and can also be performed multiple times. Calcination temperature can be performed at, for example, 40-180°C. Considering the viewpoint of shortening treatment, it can also be carried out at 40~150°C. The calcination time at this time is not particularly limited, for example, 1 to 10 minutes or 1 to 5 minutes. When performing thermal imidization of polyamic acid or polyamic acid ester, after the above-mentioned step of removing the organic solvent, a step of calcining at a temperature range of 150-300°C or 150-250°C can be added. The calcination time at this time is not particularly limited, and may be 5 to 40 minutes or 5 to 30 minutes. If the calcined film is too thin, sometimes the reliability of the liquid crystal display element will be reduced, so 5~300nm is more ideal, and 10~200nm is more ideal.

<步驟(3):配向處理之步驟> 步驟(3),係視情形對於步驟(2)獲得之煅燒膜(塗膜)進行配向處理之步驟。亦即IPS方式或FFS方式等水平配向型之液晶顯示元件中,對於該塗膜施加配向能力賦予處理。另一方面,VA方式或PSA模式等垂直配向型之液晶顯示元件中,可將形成之塗膜直接作為液晶配向膜使用,但也可對於該塗膜實施配向能力賦予處理。液晶配向膜之配向處理方法可列舉摩擦處理法、光配向處理法,光配向處理法較理想。光配向處理法,可列舉對於上述膜狀物之表面照射沿一定方向偏向之放射線,並視情形,較佳為於150~250℃之溫度進行加熱處理,並賦予液晶配向性(亦稱為液晶配向能力)之方法。放射線可使用具有100~800nm之波長之紫外線或可見光線。其中,較佳為具有100~400nm,更佳為具有200~400nm之波長之紫外線。 <Step (3): Steps of Alignment Processing> Step (3) is a step of performing alignment treatment on the calcined film (coating film) obtained in step (2) as the case may be. That is, in a liquid crystal display element of a horizontal alignment type such as an IPS system or an FFS system, an alignment ability imparting process is applied to the coating film. On the other hand, in a vertical alignment type liquid crystal display element such as VA mode or PSA mode, the formed coating film can be used as a liquid crystal alignment film as it is, but the coating film can also be subjected to alignment ability imparting treatment. The alignment treatment methods of the liquid crystal alignment film include rubbing treatment and photo-alignment treatment, and photo-alignment treatment is more ideal. The photo-alignment treatment method can include irradiating the surface of the above-mentioned membranous object with radiation deflected in a certain direction, and depending on the situation, preferably heat treatment at a temperature of 150-250°C, and endows liquid crystal alignment (also known as liquid crystal alignment). alignment ability) method. As the radiation, ultraviolet rays or visible rays having a wavelength of 100 to 800 nm can be used. Among them, ultraviolet rays having a wavelength of 100 to 400 nm are preferable, and ultraviolet rays having a wavelength of 200 to 400 nm are more preferable.

上述放射線之照射量為1~10,000mJ/cm 2較理想,100~5,000mJ/cm 2更佳,100~1,500mJ/cm 2又更理想,100~1,000mJ/cm 2尤佳,100~400mJ/cm 2更理想。使用通常之液晶配向劑時,配向處理之光照射量為100~5,000mJ/cm 2,但本發明之液晶配向劑,即使減少配向處理之光照射量,也能獲得液晶配向膜面內之液晶配向性之變異(不均勻性)受抑制之液晶配向膜。 The irradiation dose of the above-mentioned radiation is ideally 1~10,000mJ/cm 2 , more preferably 100~5,000mJ/cm 2 , more ideally 100~1,500mJ/cm 2 , more preferably 100~1,000mJ/cm 2 , 100~400mJ / cm2 is more ideal. When using a common liquid crystal alignment agent, the amount of light irradiation in the alignment treatment is 100~5,000mJ/cm 2 , but the liquid crystal alignment agent of the present invention can obtain liquid crystals in the surface of the liquid crystal alignment film even if the light irradiation amount of the alignment treatment is reduced. A liquid crystal alignment film in which alignment variation (non-uniformity) is suppressed.

又,照射放射線時,為了改善液晶配向性,也可邊將上述具有膜狀物之基板於50~250℃加熱邊照射。依此方式製作之上述液晶配向膜,能使液晶分子沿一定的方向安定配向。 又,也可對以上述方法照射了經偏光之放射線之液晶配向膜,使用水、溶劑進行接觸處理、或將已照射放射線之液晶配向膜進行加熱處理。 Moreover, when irradiating radiation, in order to improve liquid crystal alignment, you may irradiate while heating the said board|substrate which has a membranous thing at 50-250 degreeC. The above-mentioned liquid crystal alignment film manufactured in this way can make the liquid crystal molecules align stably along a certain direction. Also, the liquid crystal alignment film irradiated with polarized radiation by the above method may be subjected to contact treatment with water or a solvent, or the liquid crystal alignment film irradiated with radiation may be heat-treated.

上述接觸處理使用之溶劑,只要是會溶解因放射線之照射而從膜狀物生成之分解物的溶劑即無特殊限制。具體例可列舉水、甲醇、乙醇、2-丙醇、丙酮、甲乙酮、1-甲氧基-2-丙醇、1-甲氧基-2-丙醇乙酸酯、丁基賽珞蘇、乳酸乙酯、乳酸甲酯、二丙酮醇、3-甲氧基丙酸甲酯、3-乙氧基丙酸乙酯、乙酸丙酯、乙酸丁酯、乙酸環己酯等。其中,考量泛用性、溶劑之安全性之觀點,為水、2-丙醇、1-甲氧基-2-丙醇或乳酸乙酯較佳。更佳為水、1-甲氧基-2-丙醇或乳酸乙酯。溶劑可為1種也可將2種以上組合。The solvent used in the above-mentioned contact treatment is not particularly limited as long as it dissolves the decomposed product generated from the film-like material by irradiation with radiation. Specific examples include water, methanol, ethanol, 2-propanol, acetone, methyl ethyl ketone, 1-methoxy-2-propanol, 1-methoxy-2-propanol acetate, butylcylonol, Ethyl lactate, methyl lactate, diacetone alcohol, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, propyl acetate, butyl acetate, cyclohexyl acetate, etc. Among them, water, 2-propanol, 1-methoxy-2-propanol, or ethyl lactate are preferable from the viewpoint of versatility and safety of the solvent. More preferred are water, 1-methoxy-2-propanol or ethyl lactate. A solvent may be used alone or in combination of two or more.

<步驟(4):進行加熱處理之步驟> 步驟(4),係對於在步驟(3)經配向處理之液晶配向膜實施加熱處理之步驟。 也可對於上述經放射線照射之照射膜(塗膜)實施加熱處理。 對於上述經放射線照射之塗膜進行加熱處理之溫度,為50~300℃較理想,120~250℃更理想。加熱處理之時間為1~30分較佳。 <Step (4): The step of heat treatment> Step (4) is a step of heat-treating the liquid crystal alignment film that has been aligned in step (3). Heat treatment may also be performed on the above-mentioned irradiated film (coating film) irradiated with radiation. The temperature for heat treatment of the coating film irradiated with radiation is preferably 50-300°C, more preferably 120-250°C. The heat treatment time is preferably 1 to 30 minutes.

<步驟(5):製作液晶胞之步驟> 準備2片如上述形成了液晶配向膜之基板,在對向配置之2片基板間配置液晶。具體而言,可列舉以下2種方法。 第一方法,係首先,以各自的液晶配向膜面對的方式,隔著間隙(晶胞隙)將2片基板予以對向配置。然後,將2片基板的周邊部彼此使用密封劑予以貼合,對於由基板表面及密封劑區隔出的晶胞隙內注入填充液晶組成物而和膜面接觸後,將注入孔予以密封。 <Step (5): Steps for making liquid crystal cells> Two substrates on which the liquid crystal alignment film was formed as described above were prepared, and liquid crystals were arranged between the two substrates facing each other. Specifically, the following two methods can be mentioned. In the first method, first, two substrates are arranged facing each other with a gap (cell gap) in such a manner that the respective liquid crystal alignment films face each other. Then, the peripheral parts of the two substrates are bonded together using a sealant, and the liquid crystal composition is injected into the cell gap partitioned by the substrate surface and the sealant to make contact with the film surface, and then the injection hole is sealed.

又,第二方法,係稱為ODF(One Drop Fill)方式之方法。在已形成液晶配向膜之2片基板中之其中之一之基板上之預定處,塗佈例如紫外光硬化性密封劑,再於液晶配向膜面上之預定之數處滴加液晶組成物。之後,以液晶配向膜面對的方式,貼合另一基板而將液晶組成物推開在基板之全面而使其和膜面接觸。然後,對於基板之全面照射紫外光而使密封劑硬化。在利用任一方法時,皆更加熱直到使用之液晶組成物成為採等向相之溫度後,緩慢冷卻到室溫,以去除液晶填充時之流動配向較理想。 又,對於塗膜進行摩擦處理時,係將2片基板以各塗膜之摩擦方向彼此成預定角度,例如:成直交或逆平行的方式予以對向配置。 密封劑,例如可使用含有硬化劑及作為間隔件之氧化鋁球之環氧樹脂等。上述液晶組成物無特殊限制,可使用係含有至少一種液晶化合物(液晶分子)且介電常數異向性為正或負之各種液晶組成物。又,以下將介電常數異向性為正之液晶組成物也稱為正型液晶,介電異向性為負之液晶組成物也稱為負型液晶。液晶組成物可列舉呈向列相之液晶組成物、呈層列相之液晶組成物及呈膽固醇相之液晶組成物,其中,呈向列相之液晶組成物較佳。 上述液晶組成物亦可含有具有氟原子、羥基、胺基、含氟原子之基(例如:三氟甲基)、氰基、烷基、烷氧基、烯基、異硫氰酸酯基、雜環、環烷、環烯、類固醇骨架、苯環、或萘環之液晶化合物,也可含有分子內有2個以上之展現液晶性之剛直部位(液晶原(mesogen)骨架)之化合物(例如:剛直的二個聯苯結構、或聯三苯結構以烷基連結成之雙液晶原化合物)。 上述液晶組成物中,考量使液晶配向性提升之觀點,也可更添加添加物。如此的添加物可列舉具有聚合性基之化合物等光聚合性單體;光學活性的化合物(例:默克(股)公司製之S-811等);抗氧化劑;紫外線吸收劑;色素;消泡劑;聚合起始劑;或聚合抑制劑等。 正型液晶例如默克公司製之ZLI-2293、ZLI-4792、MLC-2003、MLC-2041、MLC-3019、或MLC-7081等。 負型液晶,例如默克公司製之MLC-6608、MLC-6609、MLC-6610、或MLC-7026-100等。 又,含有具有聚合性基之化合物之液晶,可列舉默克公司製之MLC-3023。 Also, the second method is a method called ODF (One Drop Fill) method. On one of the two substrates on which the liquid crystal alignment film has been formed, apply, for example, a UV-curable sealant on predetermined positions, and then drop liquid crystal composition on several predetermined positions on the surface of the liquid crystal alignment film. Then, with the liquid crystal alignment film facing the other substrate, the liquid crystal composition is pushed out on the entire surface of the substrate to make it contact with the film surface. Then, the entire surface of the substrate is irradiated with ultraviolet light to harden the sealant. When using either method, it is more heated until the liquid crystal composition used becomes the temperature of the isotropic phase, and then slowly cooled to room temperature to remove the flow alignment when filling the liquid crystal is ideal. In addition, when rubbing the coating film, two substrates are arranged facing each other so that the rubbing directions of the respective coating films form a predetermined angle, for example, perpendicularly or antiparallel. As the sealing agent, for example, an epoxy resin containing a hardener and alumina balls as spacers can be used. The above-mentioned liquid crystal composition is not particularly limited, and various liquid crystal compositions containing at least one liquid crystal compound (liquid crystal molecule) and having positive or negative dielectric anisotropy can be used. Hereinafter, a liquid crystal composition having a positive dielectric anisotropy is also referred to as a positive type liquid crystal, and a liquid crystal composition having a negative dielectric anisotropy is also referred to as a negative type liquid crystal. Examples of the liquid crystal composition include a liquid crystal composition in a nematic phase, a liquid crystal composition in a smectic phase, and a liquid crystal composition in a cholesteric phase. Among them, a liquid crystal composition in a nematic phase is preferred. The above-mentioned liquid crystal composition may also contain fluorine atoms, hydroxyl groups, amino groups, groups containing fluorine atoms (for example: trifluoromethyl), cyano groups, alkyl groups, alkoxy groups, alkenyl groups, isothiocyanate groups, Liquid crystal compounds of heterocycles, cycloalkanes, cycloalkenes, steroid skeletons, benzene rings, or naphthalene rings may also contain compounds with two or more rigid sites (mesogen skeletons) exhibiting liquid crystallinity in the molecule (such as : Two straight biphenyl structures, or a double mesogen compound formed by linking a terphenyl structure with an alkyl group). In the above-mentioned liquid crystal composition, additives may be further added in consideration of improving the alignment of liquid crystals. Examples of such additives include photopolymerizable monomers such as compounds having polymerizable groups; optically active compounds (for example: S-811 manufactured by Merck & Co., Ltd.); antioxidants; ultraviolet absorbers; pigments; foaming agent; polymerization initiator; or polymerization inhibitor, etc. Examples of positive liquid crystals include ZLI-2293, ZLI-4792, MLC-2003, MLC-2041, MLC-3019, or MLC-7081 manufactured by Merck & Co., Ltd. Negative type liquid crystal, for example, MLC-6608, MLC-6609, MLC-6610, or MLC-7026-100 manufactured by Merck & Co., Ltd. Moreover, as a liquid crystal containing the compound which has a polymeric group, MLC-3023 by Merck & Co. is mentioned.

並且,視需要可藉由於液晶胞之外側表面貼合偏光板以獲得液晶顯示元件。貼合在液晶胞外表面的偏光板,可列舉:以乙酸纖維素保護膜夾持邊將聚乙烯醇延伸配向邊使其吸收碘而得之稱為「H膜」之偏光薄膜而成的偏光板或H膜本身構成的偏光板。In addition, if necessary, a liquid crystal display element can be obtained by attaching a polarizing plate to the outer surface of the liquid crystal cell. The polarizing plate attached to the outer surface of the liquid crystal cell can be exemplified: a polarizing film made of a polarizing film called "H film" obtained by sandwiching a cellulose acetate protective film while stretching and aligning polyvinyl alcohol while absorbing iodine. Polarizing plate composed of plate or H film itself.

係IPS方式(模式)使用之梳齒電極基板的IPS基板,具有:基材;形成於基材上且配置成梳齒狀之多個線狀電極;及在基材上以被覆線狀電極之方式形成之液晶配向膜。 又,係FFS方式(模式)使用之梳齒電極基板的FFS基板,具有:基材;形成於基材上之面電極;形成於面電極上之絕緣膜;形成在絕緣膜上且配置成梳齒狀之多個線狀電極;及在絕緣膜上以被覆線狀電極之方式形成之液晶配向膜。 The IPS substrate, which is a comb-teeth electrode substrate used in the IPS method (mode), has: a base material; a plurality of linear electrodes formed on the base material and arranged in a comb-like shape; Liquid crystal alignment film formed by this method. Also, the FFS substrate, which is a comb electrode substrate used in the FFS method (mode), has: a base material; a surface electrode formed on the base material; an insulating film formed on the surface electrode; A plurality of tooth-shaped linear electrodes; and a liquid crystal alignment film formed on the insulating film to cover the linear electrodes.

圖1係顯示本發明之橫電場液晶顯示元件之一例之概略剖面圖,為IPS模式液晶顯示元件之例。 圖1例示之橫電場液晶顯示元件1中,在具備液晶配向膜2c之梳齒電極基板2與具備液晶配向膜4a之對向基板4之間夾持著液晶3。梳齒電極基板2具有:基材2a;形成在基材2a上且配置成梳齒狀之多個線狀電極2b;在基材2a上以被覆線狀電極2b之方式形成之液晶配向膜2c。對向基板4,具有基材4b及形成在基材4b上之液晶配向膜4a。液晶配向膜2c,例如為本發明之液晶配向膜。液晶配向膜4c也同樣是本發明之液晶配向膜。 此橫電場液晶顯示元件1中,若對於線狀電極2b施加電壓,會如電力線L所示,在線狀電極2b間產生電場。 Fig. 1 is a schematic cross-sectional view showing an example of a transverse electric field liquid crystal display element of the present invention, which is an example of an IPS mode liquid crystal display element. In the transverse electric field liquid crystal display element 1 illustrated in FIG. 1 , a liquid crystal 3 is sandwiched between a comb-shaped electrode substrate 2 provided with a liquid crystal alignment film 2c and a counter substrate 4 provided with a liquid crystal alignment film 4a. The comb electrode substrate 2 has: a base material 2a; a plurality of linear electrodes 2b formed on the base material 2a and arranged in a comb shape; a liquid crystal alignment film 2c formed on the base material 2a to cover the linear electrodes 2b . The opposite substrate 4 has a base material 4b and a liquid crystal alignment film 4a formed on the base material 4b. The liquid crystal alignment film 2c is, for example, the liquid crystal alignment film of the present invention. The liquid crystal alignment film 4c is also the liquid crystal alignment film of the present invention. In this transverse electric field liquid crystal display element 1 , when a voltage is applied to the linear electrodes 2 b , an electric field is generated between the linear electrodes 2 b as shown by lines of electric force L .

圖2係顯示本發明之橫電場液晶顯示元件之另一例之概略剖面圖,為FFS模式液晶顯示元件之例。 圖2例示之橫電場液晶顯示元件1中,在具備液晶配向膜2h之梳齒電極基板2與具備液晶配向膜4a之對向基板4之間,夾持著液晶3。梳齒電極基板2,具有:基材2d;形成在基材2d上之面電極2e;形成在面電極2e上之絕緣膜2f;及形成在絕緣膜2f上且配置成梳齒狀之多個線狀電極2g;及在絕緣膜2f上以被覆線狀電極2g之方式形成之液晶配向膜2h。對向基板4,具有:基材4b,及形成在基材4b上之液晶配向膜4a。液晶配向膜2h,例如為本發明之液晶配向膜。液晶配向膜4a也同樣為本發明之液晶配向膜。 此橫電場液晶顯示元件1中,若對於面電極2e及線狀電極2g施加電壓,則會如電力線L所示,在面電極2e及線狀電極2g間產生電場。 [實施例] Fig. 2 is a schematic sectional view showing another example of a transverse electric field liquid crystal display element of the present invention, which is an example of an FFS mode liquid crystal display element. In the transverse electric field liquid crystal display element 1 illustrated in FIG. 2 , a liquid crystal 3 is sandwiched between a comb-shaped electrode substrate 2 provided with a liquid crystal alignment film 2 h and an opposing substrate 4 provided with a liquid crystal alignment film 4 a. The comb electrode substrate 2 has: a substrate 2d; a surface electrode 2e formed on the substrate 2d; an insulating film 2f formed on the surface electrode 2e; and a plurality of comb-shaped electrodes formed on the insulating film 2f. a linear electrode 2g; and a liquid crystal alignment film 2h formed on the insulating film 2f to cover the linear electrode 2g. The opposite substrate 4 has: a base material 4b, and a liquid crystal alignment film 4a formed on the base material 4b. The liquid crystal alignment film 2h is, for example, the liquid crystal alignment film of the present invention. The liquid crystal alignment film 4a is also the liquid crystal alignment film of the present invention. In this transverse electric field liquid crystal display element 1, when a voltage is applied to the surface electrode 2e and the line electrode 2g, an electric field is generated between the surface electrode 2e and the line electrode 2g as indicated by lines of force L. [Example]

以下舉實施例對於本發明更詳細說明,但本發明不限於此等而解釋。使用之化合物之簡稱及各物性之測定方法如下。又,「Boc」代表第三丁氧基羰基。The following examples are given to describe the present invention in more detail, but the present invention is not limited thereto. The abbreviations of the compounds used and the measurement methods of the respective physical properties are as follows. Also, "Boc" represents tertiary butoxycarbonyl.

(特定二胺) WA-1~WA-2:各為下式(WA-1)~(WA-2)表示之化合物 [化32]

Figure 02_image063
(Specific diamines) WA-1 to WA-2: Each is a compound represented by the following formula (WA-1) to (WA-2) [Chemical 32]
Figure 02_image063

(其他二胺) A1~A8:各為下式(A1)~(A8)表示之化合物 [化33]

Figure 02_image065
式A4、A5表示之化合物係依WO2020/080477號公報記載之合成法合成。 (Other diamines) A1 to A8: Each is a compound represented by the following formula (A1) to (A8) [Chemical 33]
Figure 02_image065
The compounds represented by formulas A4 and A5 were synthesized according to the synthesis method described in WO2020/080477.

(四羧酸二酐) B1~B2:各為下式(B1)~(B2)表示之化合物 [化34]

Figure 02_image067
(Tetracarboxylic dianhydride) B1~B2: Each is a compound represented by the following formula (B1)~(B2) [Chemical 34]
Figure 02_image067

(添加劑) AD-1~AD-2:各為下式(AD-1)~(AD-2)表示之化合物 [化35]

Figure 02_image069
(Additives) AD-1~AD-2: Each is a compound represented by the following formula (AD-1)~(AD-2) [Chemical 35]
Figure 02_image069

(溶劑) NMP:N-甲基-2-吡咯烷酮 BCS:乙二醇單丁醚 DMF:二甲基甲醯胺 DMAc:二甲基乙醯胺 THF:四氫呋喃 (solvent) NMP: N-methyl-2-pyrrolidone BCS: Ethylene glycol monobutyl ether DMF: Dimethylformamide DMAc: Dimethylacetamide THF: Tetrahydrofuran

(黏度之測定) 溶液之黏度係使用E型黏度計TVE-22H(東機產業公司製),樣本量1.1mL,使用錐形轉子TE-1(1°34’、R24),於溫度25℃測定。 (Determination of viscosity) The viscosity of the solution was measured using an E-type viscometer TVE-22H (manufactured by Toki Sangyo Co., Ltd.), with a sample volume of 1.1 mL, and a conical rotor TE-1 (1°34’, R24), at a temperature of 25°C.

(分子量之測定) 聚醯胺酸之分子量,係使用常溫凝膠滲透層析(GPC)裝置(GPC-101)(昭和電工公司製)、管柱(KD-803,KD-805之串聯)(昭和電工公司製),依以下方式測定。 管柱溫度:50℃ 溶析液:N,N-二甲基甲醯胺(添加劑為溴化鋰一水合物(LiBr・H 2O)30mmol/L(公升)、磷酸無水結晶(正磷酸)30mmol/L、四氫呋喃(THF)10mL/L) 流速:1.0ml/分 檢量線製作用標準樣本:TSK標準聚環氧乙烷(分子量;約900,000、150,000、100,000及30,000)(東曹公司製)及聚乙二醇(分子量;約12,000、4,000及1,000)(Polymer Laboratory Corporation製)。 (Determination of Molecular Weight) The molecular weight of polyamic acid was obtained by using a normal temperature gel permeation chromatography (GPC) device (GPC-101) (manufactured by Showa Denko Co., Ltd.), a column (KD-803, KD-805 in series) ( Showa Denko Co., Ltd.) was measured in the following manner. Column temperature: 50°C Eluent: N,N-dimethylformamide (additive is lithium bromide monohydrate (LiBr·H 2 O) 30mmol/L (liter), phosphoric acid anhydrous crystal (orthophosphoric acid) 30mmol/ L, Tetrahydrofuran (THF) 10mL/L) Flow rate: 1.0ml/min Standard sample for assay line production: TSK standard polyethylene oxide (molecular weight; about 900,000, 150,000, 100,000, and 30,000) (manufactured by Tosoh Corporation) and Polyethylene glycol (molecular weight; about 12,000, 4,000, and 1,000) (manufactured by Polymer Laboratory Corporation).

<特定二胺(WA-1)~(WA-2)之合成> 特定二胺(WA-1)~(WA-2)之合成法如以下詳述。又,二胺(WA-2)係文獻等未公開之新穎化合物。 <Synthesis of specific diamines (WA-1)~(WA-2)> The synthesis methods of the specific diamines (WA-1)~(WA-2) are described in detail below. Moreover, diamine (WA-2) is a novel compound which is not disclosed in literature etc.

( 1H-NMR之測定) 裝置:傅利葉變換型超傳導核磁共振裝置(FT-NMR)「AVANCE III」(BRUKER製)500MHz。 溶劑:氘化二甲基亞碸(DMSO-d 6、標準物質:四甲基矽烷)、 (Measurement of 1 H-NMR) Apparatus: Fourier transform type superconducting nuclear magnetic resonance apparatus (FT-NMR) "AVANCE III" (manufactured by BRUKER) 500 MHz. Solvent: deuterated dimethylsulfoxide (DMSO-d 6 , standard substance: tetramethylsilane),

(單體合成例1:(WA-1)之合成) 依下列所示之路徑合成二胺(WA-1)。 [化36]

Figure 02_image071
於1L4口燒瓶中使6-溴-2-萘酚(31.1g、140mmol)、碳酸鉀(38.7g、280mmol)、及碘化鉀(1.16g、7mmol)溶解於DMF(249g),升溫到100℃並攪拌。於其中緩慢添加1,4-二氯丁烷(8.8g、70mmol)溶於DMF(63g)之溶液,攪拌15小時。以HPLC確認反應結束後,冷卻到室溫,加入純水(620g),攪拌1小時。分濾析出之結晶,將獲得之固體以甲醇洗淨後,進行減壓乾燥,獲得WA-1-1(產量28.7g、57.4mmol、產率82%、白色固體)。 1H-NMR(500MHz,DMSO-d 6);δ(ppm)=8.10(2H,s)、7.83-7.75(4H,m)、7.56-7.54(2H,m)、7.38(2H,s)、7.23-7.22(2H,m)、4.19(4H,t)、1.99-1.95(4H,m) (Monomer Synthesis Example 1: Synthesis of (WA-1)) Diamine (WA-1) was synthesized according to the following route. [chem 36]
Figure 02_image071
Dissolve 6-bromo-2-naphthol (31.1g, 140mmol), potassium carbonate (38.7g, 280mmol), and potassium iodide (1.16g, 7mmol) in DMF (249g) in a 1L 4-neck flask, heat up to 100°C and Stir. A solution in which 1,4-dichlorobutane (8.8 g, 70 mmol) was dissolved in DMF (63 g) was slowly added thereto, and stirred for 15 hours. After confirming completion of reaction by HPLC, it cooled to room temperature, added pure water (620g), and stirred for 1 hour. The precipitated crystals were separated by filtration, the obtained solid was washed with methanol, and then dried under reduced pressure to obtain WA-1-1 (yield: 28.7 g, 57.4 mmol, 82% yield, white solid). 1 H-NMR (500MHz, DMSO-d 6 ); 7.23-7.22(2H,m), 4.19(4H,t), 1.99-1.95(4H,m)

於1L4口燒瓶中,加入WA-1-1(20.0g、40mmol)、二苯基酮亞胺(15.9g、88mmol)、參(二亞苄基丙酮)二鈀(Pd 2(dba) 3)(0.7g、0.8mmol)、2-二環己基膦基-2’,4’,6’-三異丙基-1,1’-聯苯(XPhos)(1.52g、3.2mmol)、第三丁醇鈉(10.8g、112mmol)及THF(400g),升溫到70℃,攪拌1小時。將反應液濃縮至成為200g後,加入純水(200g),攪拌1小時。將析出之結晶以減壓過濾回收,移到4口燒瓶後,溶於DMAc(256g),緩慢添加三氟乙酸(12.5g、110mmol),升溫到50℃。攪拌30分鐘後,將溶液回到室溫,添加N,N,N’,N’-四甲基乙二胺(TMEDA)(16.9g、146mmol),進行中和。反應溶液濃縮至成為128g後,加入甲醇(256g),攪拌1小時。分濾析出之結晶,將獲得之固體以甲醇洗淨後,使其減壓乾燥,獲得WA-1(產量13.0g、34.9mmol、產率88%、淺茶色固體)。 由以下所示之 1H-NMR之結果,確認此固體為二胺(WA-1)。 1H-NMR(500MHz,DMSO-d 6);δ(ppm)=7.49-7.47(2H,m)、7.44-7.42(2H,m)、7.10(2H,d)、6.99-6.97(2H,m)、6.90-6.88(2H,m)、6.79(2H,d)、5.08-5.06(4H,m)、4.08(4H,t)、1.96-1.92(4H,m) In a 1L 4-neck flask, add WA-1-1 (20.0g, 40mmol), diphenylketimine (15.9g, 88mmol), ginseng (dibenzylideneacetone) dipalladium (Pd 2 (dba) 3 ) (0.7g, 0.8mmol), 2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl (XPhos) (1.52g, 3.2mmol), the third Sodium butoxide (10.8 g, 112 mmol) and THF (400 g) were heated up to 70° C. and stirred for 1 hour. After concentrating the reaction liquid to 200 g, pure water (200 g) was added, and it stirred for 1 hour. The precipitated crystals were recovered by filtration under reduced pressure, transferred to a 4-neck flask, dissolved in DMAc (256 g), and trifluoroacetic acid (12.5 g, 110 mmol) was added slowly, and the temperature was raised to 50°C. After stirring for 30 minutes, the solution was returned to room temperature, and N,N,N',N'-tetramethylethylenediamine (TMEDA) (16.9 g, 146 mmol) was added for neutralization. After the reaction solution was concentrated to 128 g, methanol (256 g) was added and stirred for 1 hour. The precipitated crystals were separated by filtration, and the obtained solid was washed with methanol, and then dried under reduced pressure to obtain WA-1 (13.0 g, 34.9 mmol, 88% yield, light brown solid). This solid was confirmed to be diamine (WA-1) from the result of 1 H-NMR shown below. 1 H-NMR (500MHz, DMSO-d 6 ); ), 6.90-6.88(2H,m), 6.79(2H,d), 5.08-5.06(4H,m), 4.08(4H,t), 1.96-1.92(4H,m)

(單體合成例2:(WA-2)之合成) 依下列所示之路徑合成二胺(WA-2)。 [化37]

Figure 02_image073
(Monomer Synthesis Example 2: Synthesis of (WA-2)) Diamine (WA-2) was synthesized according to the following route. [chem 37]
Figure 02_image073

於300mL4口燒瓶中,使1,4-二氯丁烷(63.5g、500mmol)溶解於DMF(86g),加入碳酸鉀(13.8g、100mmol),升溫到100℃並攪拌。於其中,加入4-溴-4’-羥基聯苯(12.4g、50mmol)溶於DMF(38g)之溶液,攪拌2小時。以HPLC確認反應結束後,冷卻到室溫,去除析出的鹽。將溶液濃縮至成為64g,加入甲醇(180g)、及純水(180g),攪拌1小時。分濾析出之結晶,將獲得之固體以甲醇洗淨後,使其減壓乾燥,以獲得WA-2-1(產量14.6g、43.0mmol、產率86%、白色固體)。 1H-NMR(500MHz,DMSO-d 6);δ(ppm)=7.61-7.58(6H,m)、7.02(2H,d)、4.05(2H,t)、3.72(2H,t)、1.88-1.87(4H,m) In a 300 mL 4-neck flask, 1,4-dichlorobutane (63.5 g, 500 mmol) was dissolved in DMF (86 g), potassium carbonate (13.8 g, 100 mmol) was added, and the temperature was raised to 100° C. and stirred. A solution of 4-bromo-4'-hydroxybiphenyl (12.4 g, 50 mmol) dissolved in DMF (38 g) was added thereto, followed by stirring for 2 hours. After confirming the completion of the reaction by HPLC, it was cooled to room temperature, and the precipitated salt was removed. The solution was concentrated until it became 64 g, methanol (180 g) and pure water (180 g) were added, and it stirred for 1 hour. The precipitated crystals were separated by filtration, and the obtained solid was washed with methanol, and then dried under reduced pressure to obtain WA-2-1 (yield: 14.6 g, 43.0 mmol, 86% yield, white solid). 1 H-NMR (500MHz, DMSO-d 6 ); 1.87(4H,m)

於500mL4口燒瓶中加入WA-2-1(13.6g、40mmol)、6-溴-2-萘酚(8.9g、40mmol)、碳酸鉀(13.8g、100mmol)及DMF(135g),升溫到100℃,攪拌18小時。以HPLC確認反應之結束後,將溶液回到室溫,加入純水(202g),攪拌1小時。分濾析出的結晶,將獲得之固體以乙腈洗淨後,進行減壓乾燥,以獲得WA-2-2(產量19.5g、37.1mmol、產率93%、白色固體)。 1H-NMR(500MHz,DMSO-d 6);δ(ppm)=8.11(1H,m)、7.83-7.75(2H,m)、7.61-7.55(7H,m)、7.37(1H,m)、7.23(1H,m)、7.04-7.03(2H,m)、4.17-4.11(4H,m)、1.04-1.03(4H,m) Add WA-2-1 (13.6g, 40mmol), 6-bromo-2-naphthol (8.9g, 40mmol), potassium carbonate (13.8g, 100mmol) and DMF (135g) in a 500mL 4-necked flask, and heat up to 100 °C and stirred for 18 hours. After confirming the completion of the reaction by HPLC, the solution was returned to room temperature, pure water (202 g) was added, and the mixture was stirred for 1 hour. The precipitated crystals were separated by filtration, and the obtained solid was washed with acetonitrile, and then dried under reduced pressure to obtain WA-2-2 (19.5 g, 37.1 mmol, 93% yield, white solid). 1 H-NMR (500MHz, DMSO-d 6 ); 7.23(1H,m), 7.04-7.03(2H,m), 4.17-4.11(4H,m), 1.04-1.03(4H,m)

於1L4口燒瓶中加入WA-2-2(19.4g、37mmol)、二苯基酮亞胺(14.7g、81mmol)、參(二亞苄基丙酮)二鈀(Pd 2(dba) 3)(0.6g、0.7mmol)、2-二環己基膦基-2’,4’,6’-三異丙基-1,1’-聯苯(XPhos)(1.41g、2.9mmol)、第三丁醇鈉(9.9g、103mmol)及THF(389g),升溫到70℃,攪拌1小時。將反應液濃縮至成為190g後,加入純水(200g),攪拌1小時。將析出之結晶以減壓過濾回收,移到4口燒瓶後,使其溶於THF(537g),緩慢添加三氟乙酸(12.6g、111mmol),升溫到50℃。攪拌30分鐘後,將溶液回到室溫,加入N,N,N’,N’-四甲基乙二胺(TMEDA)(17.2g、148mmol)並進行中和。將反應溶液濃縮至成為260g後,加入甲醇(260g),攪拌1小時。分濾析出之結晶,將獲得之固體以甲醇洗淨後,使其減壓乾燥,獲得WA-2(產量13.3g、33.4mmol、產率90%、淺茶色固體)。 由以下所示之 1H-NMR之結果,確認此固體為二胺(WA-2)。 1H-NMR(500MHz,DMSO-d 6);δ(ppm)=7.49-7.42(4H,m)、7.28-7.27(2H,m)、7.09(1H,d)、6.99-6.88(4H,m)、6.79(1H,d)、6.622-6.60(2H,m)、5.11-5.10(4H,m)、4.07-4.05(4H,m)、1.98-1.90(4H,m) WA-2-2 (19.4g, 37mmol), diphenylketimine (14.7g, 81mmol), ginseng (dibenzylideneacetone) dipalladium (Pd 2 (dba) 3 ) ( 0.6g, 0.7mmol), 2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl (XPhos) (1.41g, 2.9mmol), tert-butyl Sodium alkoxide (9.9 g, 103 mmol) and THF (389 g) were heated up to 70° C. and stirred for 1 hour. After concentrating the reaction liquid to 190 g, pure water (200 g) was added, and it stirred for 1 hour. The precipitated crystals were recovered by filtration under reduced pressure, transferred to a 4-neck flask, dissolved in THF (537 g), trifluoroacetic acid (12.6 g, 111 mmol) was added slowly, and the temperature was raised to 50°C. After stirring for 30 minutes, the solution was returned to room temperature, and N,N,N',N'-tetramethylethylenediamine (TMEDA) (17.2 g, 148 mmol) was added for neutralization. After concentrating the reaction solution until it became 260 g, methanol (260 g) was added, and it stirred for 1 hour. The precipitated crystals were separated by filtration, and the obtained solid was washed with methanol, and then dried under reduced pressure to obtain WA-2 (13.3 g, 33.4 mmol, 90% yield, light brown solid). From the result of 1 H-NMR shown below, it was confirmed that this solid was diamine (WA-2). 1 H-NMR (500MHz, DMSO-d 6 ); ), 6.79(1H,d), 6.622-6.60(2H,m), 5.11-5.10(4H,m), 4.07-4.05(4H,m), 1.98-1.90(4H,m)

<聚合物之合成> (合成例1) 於附攪拌裝置及附氮氣導入管之100mL四口燒瓶中加入A1(0.973g、9.00mmol)、A2(2.20g、9.00mmol)、WA-1(2.23g、6.00mmol)、A7(2.39g、6.00mmol)、B1(6.39g、28.5mmol)及NMP(104g),於40℃攪拌20小時,獲得固體成分濃度12質量%之聚醯胺酸(A-1)之溶液(黏度:379mPa・s)。此聚醯胺酸之數量平均分子量(Mn)為13,242、重量平均分子量(Mw)為34,231。 <Synthesis of Polymer> (Synthesis Example 1) Add A1 (0.973g, 9.00mmol), A2 (2.20g, 9.00mmol), WA-1 (2.23g, 6.00mmol), A7 (2.39g, 6.00mmol), B1 (6.39g, 28.5mmol) and NMP (104g), stirred at 40°C for 20 hours to obtain a solution of polyamic acid (A-1) with a solid content concentration of 12% by mass (viscosity: 379mPa·s ). The number average molecular weight (Mn) of this polyamide acid was 13,242, and the weight average molecular weight (Mw) was 34,231.

(合成例2) 於附攪拌裝置及附氮氣導入管之100mL四口燒瓶中加入A1(0.973g、9.00mmol)、A2(2.20g、9.00mmol)、WA-2(2.39g、6.00mmol)、A7(2.39g、6.00mmol)、B1(6.42g、28.7mmol)及NMP(105g),於40℃攪拌20小時,獲得固體成分濃度12質量%之聚醯胺酸(A-2)之溶液(黏度:398mPa・s)。此聚醯胺酸之Mn為12,019、Mw為33,291。 (Synthesis Example 2) Add A1 (0.973g, 9.00mmol), A2 (2.20g, 9.00mmol), WA-2 (2.39g, 6.00mmol), A7 (2.39g, 6.00mmol), B1 (6.42g, 28.7mmol) and NMP (105g), stirred at 40°C for 20 hours to obtain a solution of polyamic acid (A-2) with a solid content concentration of 12% by mass (viscosity: 398mPa·s ). The Mn of this polyamide acid is 12,019, and the Mw is 33,291.

(合成例3) 於附攪拌裝置及附氮氣導入管之100mL四口燒瓶中加入A1(0.649g、6.00mmol)、A8(4.78g、24.0mmol)、B2(5.59g、28.5mmol)及NMP(99.2g),於室溫攪拌5小時,獲得固體成分濃度10質量%之聚醯胺酸(B-1)之溶液(黏度:338mPa・s)。此聚醯胺酸之Mn為15,932、Mw為39,013。 (Synthesis Example 3) A1 (0.649g, 6.00mmol), A8 (4.78g, 24.0mmol), B2 (5.59g, 28.5mmol) and NMP (99.2g) were added to a 100mL four-necked flask with a stirring device and a nitrogen inlet tube, and Stir at room temperature for 5 hours to obtain a solution of polyamic acid (B-1) with a solid content concentration of 10% by mass (viscosity: 338 mPa·s). The Mn of this polyamide acid was 15,932, and the Mw was 39,013.

(合成例4(比較)) 於附攪拌裝置及附氮氣導入管之100mL四口燒瓶中加入A1(0.973g、9.00mmol)、A2(2.20g、9.00mmol)、A3(1.92g、6.00mmol)、A7(2.39g、6.00mmol)、B1(6.42g、28.7mmol)及NMP(101g),於40℃攪拌20小時,獲得固體成分濃度12質量%之聚醯胺酸(RA-1)之溶液(黏度:382mPa・s)。此聚醯胺酸之Mn為11,912、Mw為33,413。 (Synthesis example 4 (comparison)) Add A1 (0.973g, 9.00mmol), A2 (2.20g, 9.00mmol), A3 (1.92g, 6.00mmol), A7 (2.39g, 6.00mmol) into a 100mL four-necked flask with a stirring device and a nitrogen inlet tube ), B1 (6.42g, 28.7mmol) and NMP (101g), stirred at 40°C for 20 hours to obtain a solution of polyamic acid (RA-1) with a solid content concentration of 12% by mass (viscosity: 382mPa·s). The Mn of this polyamide acid is 11,912, and the Mw is 33,413.

(合成例5(比較)) 於附攪拌裝置及附氮氣導入管之100mL四口燒瓶中加入A1(0.973g、9.00mmol)、A2(2.20g、9.00mmol)、A4(2.07g、6.00mmol)、A7(2.39g、6.00mmol)、B1(6.38g、28.4mmol)及NMP(102g),於40℃攪拌20小時,獲得固體成分濃度12質量%之聚醯胺酸(RA-2)之溶液(黏度:411mPa・s)。此聚醯胺酸之Mn為12,018、Mw為37,021。 (Synthesis example 5 (comparison)) Add A1 (0.973g, 9.00mmol), A2 (2.20g, 9.00mmol), A4 (2.07g, 6.00mmol), A7 (2.39g, 6.00mmol) into a 100mL four-necked flask with a stirring device and a nitrogen inlet tube ), B1 (6.38g, 28.4mmol) and NMP (102g), stirred at 40°C for 20 hours to obtain a solution of polyamic acid (RA-2) with a solid content concentration of 12% by mass (viscosity: 411mPa·s). The Mn of this polyamide acid was 12,018, and the Mw was 37,021.

(合成例6(比較)) 於附攪拌裝置及附氮氣導入管之100mL四口燒瓶中加入A1(0.973g、9.00mmol)、A2(2.20g、9.00mmol)、A5(2.22g、6.00mmol)、A7(2.39g、6.00mmol)、B1(6.38g、28.4mmol)及NMP(103g),於40℃攪拌20小時,獲得固體成分濃度12質量%之聚醯胺酸(RA-3)之溶液(黏度:404mPa・s)。此聚醯胺酸之Mn為10,383、Mw為36,113。 (Synthesis example 6 (comparison)) Add A1 (0.973g, 9.00mmol), A2 (2.20g, 9.00mmol), A5 (2.22g, 6.00mmol), A7 (2.39g, 6.00mmol) into a 100mL four-neck flask with a stirring device and a nitrogen inlet tube ), B1 (6.38g, 28.4mmol) and NMP (103g), stirred at 40°C for 20 hours to obtain a solution of polyamic acid (RA-3) with a solid content concentration of 12% by mass (viscosity: 404mPa·s). The Mn of this polyamide acid is 10,383, and the Mw is 36,113.

(合成例7(比較)) 於附攪拌裝置及附氮氣導入管之100mL四口燒瓶中加入A1(0.973g、9.00mmol)、A2(2.20g、9.00mmol)、A6(2.15g、6.00mmol)、A7(2.39g、6.00mmol)、B1(6.46g、28.8mmol)及NMP(103g),於40℃攪拌20小時,獲得固體成分濃度12質量%之聚醯胺酸(RA-4)之溶液(黏度:401mPa・s)。此聚醯胺酸之Mn為10,099、Mw為36,030。 (Synthesis example 7 (comparison)) Add A1 (0.973g, 9.00mmol), A2 (2.20g, 9.00mmol), A6 (2.15g, 6.00mmol), A7 (2.39g, 6.00mmol) into a 100mL four-neck flask with a stirring device and a nitrogen inlet tube ), B1 (6.46g, 28.8mmol) and NMP (103g), stirred at 40°C for 20 hours to obtain a solution of polyamic acid (RA-4) with a solid content concentration of 12% by mass (viscosity: 401mPa·s). The Mn of this polyamide acid was 10,099, and the Mw was 36,030.

合成例1~7使用之二胺成分、及四羧酸成分之種類及量,彙整於表1。表中,括弧內之數值代表單體相對於各成分中之合計100莫耳份之使用量(莫耳份)。The types and amounts of diamine components and tetracarboxylic acid components used in Synthesis Examples 1-7 are summarized in Table 1. In the table, the numerical values in parentheses represent the usage-amount (mole part) of a monomer with respect to the total 100 mole parts in each component.

[表1] 合成例 聚醯胺酸 四羧酸成分 二胺成分 特定二胺 其他二胺 1 A-1 B1(100) WA-1(20) A1(30)A2(30)A7(20) 2 A-2 B1(100) WA-2(20) A1(30)A2(30)A7(20) 3 B-1 B2(100) - A1(20)A8(80) 4 RA-1 B1(100) - A1(30)A2(30)A3(20)A7(20) 5 RA-2 B1(100) - A1(30)A2(30)A4(20)A7(20) 6 RA-3 B1(100) - A1(30)A2(30)A5(20)A7(20) 7 RA-4 B1(100) - A1(30)A2(30)A6(20)A7(20) [Table 1] Synthesis example Polyamide Tetracarboxylic acid component Diamine component specific diamine Other diamines 1 A-1 B1(100) WA-1(20) A1(30)A2(30)A7(20) 2 A-2 B1(100) WA-2(20) A1(30)A2(30)A7(20) 3 B-1 B2(100) - A1(20)A8(80) 4 RA-1 B1(100) - A1(30)A2(30)A3(20)A7(20) 5 RA-2 B1(100) - A1(30)A2(30)A4(20)A7(20) 6 RA-3 B1(100) - A1(30)A2(30)A5(20)A7(20) 7 RA-4 B1(100) - A1(30)A2(30)A6(20)A7(20)

<液晶配向劑之製備> (實施例1) 於合成例1獲得之聚醯胺酸(A-1)溶液(6.67g)中加入NMP(9.33g)及BCS(4.00g),於室溫攪拌2小時,獲得液晶配向劑(V-1)。 <Preparation of liquid crystal alignment agent> (Example 1) Add NMP (9.33g) and BCS (4.00g) to the polyamic acid (A-1) solution (6.67g) obtained in Synthesis Example 1, and stir at room temperature for 2 hours to obtain a liquid crystal alignment agent (V-1) .

(實施例2) 於合成例1獲得之聚醯胺酸(A-1)溶液(5.30g)中,加入合成例3獲得之聚醯胺酸(B-1)溶液(9.54g)、NMP(3.78g)、BCS(9.00g)、AD-1之NMP 10質量%稀釋溶液(0.800g)及AD-2之NMP 1質量%稀釋溶液(1.59g),於室溫攪拌2小時,獲得液晶配向劑(V-2)。 (Example 2) In the polyamic acid (A-1) solution (5.30g) obtained in Synthesis Example 1, add the polyamic acid (B-1) solution (9.54g) obtained in Synthesis Example 3, NMP (3.78g), BCS (9.00g), the NMP 10 mass % diluted solution (0.800 g) of AD-1 and the NMP 1 mass % diluted solution (1.59 g) of AD-2 were stirred at room temperature for 2 hours to obtain the liquid crystal alignment agent (V-2 ).

(實施例3) 將使用之聚醯胺酸之溶液從(A-1)溶液變更為(A-2)溶液,除此以外和實施例2同樣操作,獲得液晶配向劑(V-3)。 (Example 3) A liquid crystal alignment agent (V-3) was obtained in the same manner as in Example 2 except that the solution of the polyamic acid used was changed from the (A-1) solution to the (A-2) solution.

(比較例1)~(比較例4) 將使用之聚醯胺酸之溶液從(A-1)溶液變更為(RA-1)~(RA-4)溶液,除此以外和實施例1同樣操作,獲得液晶配向劑(RV-1)~(RV-4)。 (Comparative Example 1)~(Comparative Example 4) The polyamic acid solution used was changed from (A-1) solution to (RA-1)~(RA-4) solution, except that the same operation as Example 1 was performed to obtain liquid crystal alignment agent (RV-1) ~(RV-4).

(比較例5)~(比較例6) 將使用之聚醯胺酸之溶液從(A-1)溶液變更為(RA-2)~(RA-3)溶液,除此以外和實施例2同樣操作,獲得液晶配向劑(RV-5)~(RV-6)。 (Comparative Example 5)~(Comparative Example 6) The polyamic acid solution used was changed from (A-1) solution to (RA-2) ~ (RA-3) solution, except that the same operation as in Example 2 was performed to obtain a liquid crystal alignment agent (RV-5) ~(RV-6).

上述實施例1~3及比較例1~6獲得之液晶配向劑之規格示於表2。聚合物成分之括弧內之數值,代表各聚合物成分相對於聚合物成分之合計100質量份之比例(質量份)。The specifications of the liquid crystal alignment agents obtained in the above-mentioned Examples 1-3 and Comparative Examples 1-6 are shown in Table 2. The numerical value in parentheses of a polymer component represents the ratio (mass part) of each polymer component with respect to the total 100 mass parts of polymer components.

[表2]    液晶配向劑 聚合物成分 添加劑成分 第1成分 第2成分 實施例1 V-1 A-1(100) - - 實施例2 V-2 A-1(40) B-1(60) AD-1,AD-2 實施例3 V-3 A-2(40) B-1(60) AD-1,AD-2 比較例1 RV-1 RA-1(100) - - 比較例2 RV-2 RA-2(100) - - 比較例3 RV-3 RA-3(100) - - 比較例4 RV-4 RA-4(100) - - 比較例5 RV-5 RA-2(40) B-1(60) AD-1,AD-2 比較例6 RV-6 RA-3(40) B-1(60) AD-1,AD-2 [Table 2] Liquid crystal alignment agent polymer composition Additives 1st ingredient 2nd component Example 1 V-1 A-1(100) - - Example 2 V-2 A-1(40) B-1(60) AD-1, AD-2 Example 3 V-3 A-2(40) B-1(60) AD-1,AD-2 Comparative example 1 RV-1 RA-1(100) - - Comparative example 2 RV-2 RA-2(100) - - Comparative example 3 RV-3 RA-3(100) - - Comparative example 4 RV-4 RA-4(100) - - Comparative Example 5 RV-5 RA-2(40) B-1(60) AD-1, AD-2 Comparative Example 6 RV-6 RA-3(40) B-1(60) AD-1, AD-2

使用上述獲得之液晶配向劑,按以下所示之程序製作FFS驅動液晶胞,並進行各種評價。Using the liquid crystal alignment agent obtained above, an FFS-driven liquid crystal cell was produced according to the procedure shown below, and various evaluations were performed.

<FFS驅動液晶胞之構成> 製作具備FFS模式液晶顯示元件之構成之液晶胞。 首先,準備附電極之基板。基板係使用30mm×50mm之長方形且厚度為0.7mm之玻璃基板。在基板上形成構成作為第1層之對向電極之具備一色(solid)狀之圖案之ITO電極。在第1層之對向電極之上,形成作為第2層之利用CVD(化學蒸鍍)法成膜之SiN(氮化矽)膜。第2層之SiN膜之膜厚為500nm,作為層間絕緣膜之作用。第2層之SiN膜之上,配置作為第3層之將ITO膜圖案化而形成之梳齒狀之畫素電極,形成第1畫素及第2畫素2個畫素。各畫素之尺寸為縱10mm、橫5mm。此時第1層之對向電極與第3層之畫素電極,利用第2層之SiN膜之作用而電絕緣。 第3層之畫素電極,具有中央部分以內角160°折曲之寬3μm之電極要素隔6μm之間隔而成平行之方式排列多個的梳齒形狀,1個畫素以連結多個電極要素之折曲之線為交界,具有第1區及第2區。 然後將上述實施例1~3及比較例1~6獲得之液晶配向劑(V-1)~(V-3)、(RV-1)~(RV-6)以孔徑1.0μm之濾器過濾後,以旋塗法塗佈在準備的上述附電極之基板(第1玻璃基板)與背面已形成ITO膜之具有高度4μm之柱狀間隔件之玻璃基板(第2玻璃基板)。於80℃之熱板上進行2分鐘乾燥後,於230℃之熱風循環式烘箱進行30分鐘煅燒,形成膜厚100nm之塗膜。對於此塗膜面,隔著偏光板各按表3所示的照射量分量照射消光比26:1之經直線偏光之波長254nm之紫外線而實施配向處理,獲得附液晶配向膜之基板。又,在上述附電極之基板形成之液晶配向膜,係進行配向處理使得將畫素折曲部之內角等分之方向與液晶之配向方向成直交,在第2玻璃基板形成之液晶配向膜係進行配向處理,使得製作液晶胞時第1玻璃基板上之液晶之配向方向與第2玻璃基板上之液晶之配向方向成一致。以上述2片基板作為一組,在基板上印刷密封劑(三井化學公司製XN-1500T),並貼合另一片基板,使得液晶配向膜面彼此面對的配向方向成為0°。之後於150℃進行60分鐘之加熱處理,使密封劑硬化,製成空胞。於此空胞中利用減壓注入法注入液晶MLC-3019(默克公司製),將注入口予以密封,獲得FFS驅動液晶胞。之後將獲得之液晶胞於120℃加熱1小時,放置一晩後使用於評價。 <The structure of FFS driving liquid crystal cell> Fabricate liquid crystal cells with the configuration of FFS mode liquid crystal display elements. First, the substrate with electrodes is prepared. As the substrate, a rectangular glass substrate of 30 mm×50 mm and a thickness of 0.7 mm was used. An ITO electrode having a solid pattern constituting a counter electrode of the first layer is formed on the substrate. On the counter electrode of the first layer, a SiN (silicon nitride) film formed by CVD (Chemical Vapor Deposition) is formed as the second layer. The SiN film of the second layer has a film thickness of 500nm and functions as an interlayer insulating film. On the SiN film of the second layer, a comb-shaped pixel electrode formed by patterning the ITO film as the third layer is arranged to form two pixels of the first pixel and the second pixel. The size of each pixel is 10mm in length and 5mm in width. At this time, the counter electrode of the first layer and the pixel electrode of the third layer are electrically insulated by the SiN film of the second layer. The pixel electrode of the third layer has the shape of a comb with multiple electrode elements with a width of 3 μm bent at an inner angle of 160° and arranged in parallel at intervals of 6 μm. One pixel connects multiple electrode elements. The zigzag line is the junction, which has the 1st area and the 2nd area. Then filter the liquid crystal alignment agents (V-1)~(V-3), (RV-1)~(RV-6) obtained in the above-mentioned Examples 1~3 and Comparative Examples 1~6 with a filter with a pore size of 1.0 μm A glass substrate having columnar spacers with a height of 4 μm (second glass substrate) on which an ITO film was formed on the back was coated by spin coating on the prepared substrate with electrodes (first glass substrate). After drying on a hot plate at 80°C for 2 minutes, it was calcined in a hot air circulation oven at 230°C for 30 minutes to form a coating film with a thickness of 100nm. The coating surface was irradiated with linearly polarized ultraviolet rays with a wavelength of 254nm at an extinction ratio of 26:1 through a polarizing plate according to the irradiation dose components shown in Table 3 for alignment treatment to obtain a substrate with a liquid crystal alignment film. In addition, the liquid crystal alignment film formed on the above-mentioned substrate with electrodes is aligned so that the direction that divides the inner corner of the pixel bending part into equal parts is perpendicular to the alignment direction of the liquid crystal, and the liquid crystal alignment film formed on the second glass substrate Alignment treatment is carried out so that the alignment direction of the liquid crystal on the first glass substrate is consistent with the alignment direction of the liquid crystal on the second glass substrate when making the liquid crystal cell. Using the above two substrates as a set, a sealant (XN-1500T manufactured by Mitsui Chemicals Co., Ltd.) was printed on the substrate, and the other substrate was bonded so that the alignment direction in which the liquid crystal alignment film surfaces faced each other became 0°. Then heat treatment at 150°C for 60 minutes to harden the sealant and form hollow cells. Liquid crystal MLC-3019 (manufactured by Merck & Co.) was injected into this ghost cell by a depressurized injection method, and the injection port was sealed to obtain an FFS-driven liquid crystal cell. Afterwards, the obtained liquid crystal cells were heated at 120° C. for 1 hour, and left overnight for evaluation.

<對比度之面內均一性之評價> 使用AXOMETRICS公司製AxoStep,進行液晶胞之扭轉角之變異之評價。將上述製作之液晶胞設置於測定台座,於無施加電壓之狀態,測定畫素面內之環狀相位差(Circular Retardance)之分布,算出標準偏差σ之3倍即3σ。針對面內均一性,此3σ之值越小則可說越良好。就評價基準而言,未達1.00時評為「優良」、1.00以上且1.10以下時評為「良好」、大於1.10時評為「不良」。 關於使用上述實施例及比較例之各液晶配向劑之液晶顯示元件實施評價之結果,示於表3。 <Evaluation of in-plane uniformity of contrast> The evaluation of the variation of the torsion angle of the liquid crystal cell was performed using AxoStep manufactured by AXOMETRICS. Set the above-made liquid crystal cell on the measurement stand, and measure the distribution of circular retardation (Circular Retardance) in the pixel plane in the state of no voltage applied, and calculate 3 times the standard deviation σ, which is 3σ. Regarding the in-plane uniformity, the smaller the value of this 3σ, the better. The evaluation criteria were evaluated as "excellent" when less than 1.00, "good" when 1.00 or more and 1.10 or less, and "bad" when greater than 1.10. Table 3 shows the results of evaluating liquid crystal display elements using the respective liquid crystal alignment agents of the above-mentioned examples and comparative examples.

<液晶配向之安定性之評價> 本評價,係評價由於長期交流驅動時液晶配向膜之配向性能降低所致產生之殘影(也稱為AC殘影。)。 對於上述製作之FFS驅動液晶胞,於60℃之恆溫環境下,施加頻率60Hz且±4V之交流電壓120小時。之後,使液晶胞之畫素電極與對向電極之間成為短路狀態,於此狀態在室溫放置一日。對於已實施上述處理之液晶胞,以角度算出無施加電壓狀態下的畫素之第1區之液晶之配向方向與第2區之液晶之配向方向的偏離。具體而言,在配置成偏光軸直交之2片偏光板之間設置液晶胞,將背光點燈,調整液晶胞之配置角度,使得畫素之第1區之透射光強度成為最小,然後,求出以畫素之第2區之透射光強度成為最小之方式使液晶胞旋轉時所需的旋轉角度。液晶配向之安定性係此旋轉角度之值越小則可說是越良好。就評價基準而言,未達0.05度時評為「優良」,0.05度以上且0.10度以下時評為「良」,比0.10度大時評為「不良」。 <Evaluation of the stability of liquid crystal alignment> This evaluation is to evaluate the afterimage (also called AC afterimage) caused by the decrease of the alignment performance of the liquid crystal alignment film during long-term AC driving. For the FFS-driven liquid crystal cell produced above, an AC voltage with a frequency of 60 Hz and ±4 V was applied for 120 hours in a constant temperature environment of 60°C. Thereafter, the pixel electrode and the counter electrode of the liquid crystal cell were short-circuited, and left at room temperature for one day in this state. For the liquid crystal cell that has been subjected to the above treatment, the deviation between the alignment direction of the liquid crystal in the first region of the pixel and the alignment direction of the liquid crystal in the second region of the pixel in the state where no voltage is applied is calculated in terms of angle. Specifically, a liquid crystal cell is arranged between two polarizers whose polarization axes are perpendicular to each other, the backlight is turned on, and the arrangement angle of the liquid crystal cell is adjusted so that the intensity of the transmitted light in the first area of the pixel becomes the minimum. Then, find The angle of rotation required to rotate the liquid crystal cell so that the transmitted light intensity of the second region of the pixel becomes the minimum is shown. The stability of liquid crystal alignment means that the smaller the value of the rotation angle is, the better it is. In terms of evaluation criteria, when it is less than 0.05 degrees, it is rated as "excellent", when it is more than 0.05 degrees and less than 0.10 degrees, it is rated as "good", and when it is greater than 0.10 degrees, it is rated as "bad".

關於使用上述實施例及比較例之各液晶配向劑之液晶顯示元件實施之評價結果,示於表3。Table 3 shows the evaluation results of the liquid crystal display elements using the liquid crystal alignment agents of the above-mentioned examples and comparative examples.

[表3]

Figure 02_image075
[table 3]
Figure 02_image075

如表3所示,由使用了特定二胺WA-1~WA-2之液晶配向劑獲得之液晶配向膜,相較由不含特定二胺之二胺成分所構成之液晶配向劑獲得之液晶配向膜,能以少光照射量獲得高面內均一性。再者,顯示和習知之液晶配向膜同等、或更高的液晶配向安定性。As shown in Table 3, the liquid crystal alignment films obtained from the liquid crystal alignment agents using specific diamines WA-1~WA-2, compared with the liquid crystal alignment films obtained from liquid crystal alignment agents composed of diamine components that do not contain specific diamines Alignment film can obtain high in-plane uniformity with less light exposure. Furthermore, it shows the same or higher liquid crystal alignment stability than conventional liquid crystal alignment films.

由本發明之液晶配向劑獲得之液晶配向膜,可適用於液晶顯示元件。且該等元件在以顯示為目的之液晶顯示器,進而在控制光之透射與遮斷之調光窗、光閘等亦有用。 [產業利用性] The liquid crystal alignment film obtained from the liquid crystal alignment agent of the present invention can be applied to liquid crystal display elements. And these devices are also useful in liquid crystal displays for display purposes, and in dimming windows and shutters that control the transmission and blocking of light. [Industrial Utilization]

藉由使用本發明之液晶配向劑,液晶配向膜面內之液晶之扭轉角度之變異(不均勻性)小,而使用以獲得液晶配向膜之光照射量之範圍擴大,能以良好效率獲得品質好之液晶配向膜。所以,能期待在要求高顯示品位之液晶顯示元件之利用。且該等元件在以顯示為目的之液晶顯示器,進而在控制光透射及遮斷之調光窗、光閘等亦有用。By using the liquid crystal alignment agent of the present invention, the variation (inhomogeneity) of the twist angle of the liquid crystal in the liquid crystal alignment film plane is small, and the range of the light irradiation amount used to obtain the liquid crystal alignment film is expanded, and the quality can be obtained with good efficiency Good liquid crystal alignment film. Therefore, it can be expected to be used in liquid crystal display elements requiring high display quality. And these devices are also useful in liquid crystal displays for display purposes, and further in dimming windows and shutters for controlling light transmission and blocking.

1:橫電場液晶顯示元件 2:梳齒電極基板 2a:基材 2b:線狀電極 2c:液晶配向膜 2d:基材 2e:面電極 2f:絕緣膜 2g:線狀電極 2h:液晶配向膜 3:液晶 4:對向基板 4a:液晶配向膜 4b:基材 L:電力線 1: Transverse electric field liquid crystal display element 2: Comb electrode substrate 2a: Substrate 2b: Wire electrode 2c: Liquid crystal alignment film 2d: Substrate 2e: surface electrode 2f: insulating film 2g: wire electrode 2h: Liquid crystal alignment film 3: LCD 4: Facing the substrate 4a: Liquid crystal alignment film 4b: Substrate L: power line

圖1顯示本發明之橫電場液晶顯示元件之一例之概略剖面圖。 圖2顯示本發明之橫電場液晶顯示元件之另一例之概略剖面圖。 Fig. 1 shows a schematic cross-sectional view of an example of a transverse electric field liquid crystal display element of the present invention. Fig. 2 shows a schematic cross-sectional view of another example of the transverse electric field liquid crystal display element of the present invention.

Figure 111107847-A0101-11-0002-3
Figure 111107847-A0101-11-0002-3

1:橫電場液晶顯示元件 1: Transverse electric field liquid crystal display element

2:梳齒電極基板 2: Comb electrode substrate

2a:基材 2a: Substrate

2b:線狀電極 2b: Wire electrode

2c:液晶配向膜 2c: Liquid crystal alignment film

3:液晶 3: LCD

4:對向基板 4: Facing the substrate

4a:液晶配向膜 4a: Liquid crystal alignment film

4b:基材 4b: Substrate

L:電力線 L: power line

Claims (17)

一種液晶配向劑,其特徵為含有聚合物(A),該聚合物(A)係選自由具有下式(1)表示之重複單元(a1)之聚醯亞胺前驅物及係該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種,
Figure 03_image001
式(1)中,X 1表示4價有機基,Y 1係以下式(H)表示且具有3個以上之苯環之2價有機基,R及Z各自獨立地表示氫原子或1價有機基,
Figure 03_image003
式(H)中,L 1、及L 1’各自獨立地表示單鍵、-O-、-S-、-C(=O)-、-O-C(=O)-、或-C(=O)-NR-(R表示氫原子或1價有機基), A表示碳數4~10之伸烷基, Ar 1、及Ar 1’各自獨立地表示苯環、聯苯結構、或萘環,Ar 1、及Ar 1’之環上之任意氫原子亦可被1價基取代;*表示原子鍵。
A liquid crystal alignment agent, characterized by containing a polymer (A), the polymer (A) is selected from a polyimide precursor having a repeating unit (a1) represented by the following formula (1) and the polyimide At least one of the group consisting of polyimides of imides of amine precursors,
Figure 03_image001
In formula (1), X 1 represents a tetravalent organic group, Y 1 is a divalent organic group represented by the following formula (H) and has 3 or more benzene rings, R and Z each independently represent a hydrogen atom or a monovalent organic group. base,
Figure 03_image003
In formula (H), L 1 and L 1' each independently represent a single bond, -O-, -S-, -C(=O)-, -OC(=O)-, or -C(=O )-NR-(R represents a hydrogen atom or a monovalent organic group), A represents an alkylene group with 4 to 10 carbons, Ar 1 and Ar 1' each independently represent a benzene ring, a biphenyl structure, or a naphthalene ring, Any hydrogen atom on the ring of Ar 1 and Ar 1' may also be substituted by a monovalent group; * represents an atomic bond.
如請求項1之液晶配向劑,其中,該式(H)中之基「*-L 1-A-L 1’-*」(*表示原子鍵)係基「*-(CH 2) n-*」、基「*-O-(CH 2) n-O-*」、基「*-C(=O)-(CH 2) n-C(=O)-*」、基「*-C(=O)-NR-(CH 2) n-O-*」、基「*-O-C(=O)-(CH 2) n-O-*」、基「*-O-C(=O)-(CH 2) n-O-C(=O)-*」、基「*-O-C(=O)-(CH 2) n-C(=O)-O-*」、基「*-S-(CH 2) n-S-*」、基「*-C(=O)-NR-(CH 2) n-NR-C(=O)-*」、基「*-C(=O)-O-(CH 2) n-O-C(=O)-*」、基「*-O-(CH 2) n-*」、基「*-S-(CH 2) n-*」、或基「*-NR-C(=O)-(CH 2) n-C(=O)-NR-*」表示之基,R表示氫原子或1價有機基,n為4~10之整數,*表示原子鍵。 The liquid crystal alignment agent according to Claim 1, wherein the group "*-L 1 -AL 1' -*" (* represents an atomic bond) in the formula (H) is the group "*-(CH 2 ) n -*" , group "*-O-(CH 2 ) n -O-*", group "*-C(=O)-(CH 2 ) n -C(=O)-*", group "*-C(= O)-NR-(CH 2 ) n -O-*”, group “*-OC(=O)-(CH 2 ) n -O-*”, group “*-OC(=O)-(CH 2 ) n -OC(=O)-*", group "*-OC(=O)-(CH 2 ) n -C(=O)-O-*", group "*-S-(CH 2 ) n -S-*", group "*-C(=O)-NR-(CH 2 ) n -NR-C(=O)-*", group "*-C(=O)-O-(CH 2 ) n -OC(=O)-*", group "*-O-(CH 2 ) n -*", group "*-S-(CH 2 ) n -*", or group "*-NR-C (=O)-(CH 2 ) n -C(=O)-NR-*" represents a group, R represents a hydrogen atom or a monovalent organic group, n is an integer from 4 to 10, and * represents an atomic bond. 如請求項1之液晶配向劑,其中,該式(1)中之Y 1係下式(h-1)~(h-4)中之任一者表示之2價有機基,
Figure 03_image009
式(h-1)~(h-4)中,R a1~R a4表示1價有機基,L表示上式(H)中之基「*-L 1-A-L 1’-*」(*表示原子鍵),m各自獨立地為0~6之整數,n各自獨立地為0~4之整數,R a1~R a4有多個存在時,各自可相同也可不同,*表示原子鍵。
Such as the liquid crystal alignment agent of claim item 1, wherein Y in the formula ( 1 ) is a divalent organic group represented by any one of the following formulas (h-1) to (h-4),
Figure 03_image009
In the formulas (h-1)~(h-4), R a1 ~R a4 represent monovalent organic groups, and L represents the group "*-L 1 -AL 1' -*" in the above formula (H) (* represents atomic bond), m each independently is an integer of 0 to 6, n each independently is an integer of 0 to 4, when there are multiple R a1 to R a4 , each may be the same or different, and * represents an atomic bond.
如請求項1之液晶配向劑,其中,該聚合物(A)係選自由更具有下式(2)表示之重複單元(a2)之聚醯亞胺前驅物及係該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種聚合物,
Figure 03_image011
式(2)中,X 2表示4價有機基,Y 2表示下式(o-1)~(o-14)表示之2價有機基,R、及Z各和上式(1)之R、及Z為同義,
Figure 03_image013
Figure 03_image015
式(o-1)~(o-14)中,*表示原子鍵,式(o-13)~式(o-14)中,2個m各自獨立;式(o-1)~(o-14)中之苯環、聯苯結構或萘環之環上之任意氫原子也可被1價基取代。
The liquid crystal alignment agent according to claim 1, wherein the polymer (A) is selected from polyimide precursors having repeating units (a2) represented by the following formula (2) and is the polyimide precursor At least one polymer in the group consisting of polyimides of amides,
Figure 03_image011
In formula (2), X 2 represents a 4-valent organic group, Y 2 represents a divalent organic group represented by the following formulas (o-1)~(o-14), R and Z are each the same as R in the above formula (1) , and Z are synonyms,
Figure 03_image013
Figure 03_image015
In formulas (o-1)~(o-14), * represents an atomic bond; in formulas (o-13)~(o-14), the two ms are independent; formulas (o-1)~(o- Any hydrogen atom on the benzene ring, biphenyl structure or naphthalene ring in 14) may be substituted by a monovalent group.
如請求項1之液晶配向劑,其中,該聚合物(A)係選自由更具有選自由下式(2’)表示之重複單元(a2’)及下式(3)表示之重複單元(a3)構成之群組中之至少一者之聚醯亞胺前驅物及係該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種之聚合物,
Figure 03_image017
式(2’)、及式(3)中,X 2’、及X 3表示4價有機基,Y 2’表示下式(O2)表示之2價有機基,Y 3表示分子內具有基「-N(D)-(D表示胺甲酸酯系保護基)」之碳數6~30之2價有機基,R、及Z各和上式(1)之R、及Z為同義,
Figure 03_image019
式(O2)中,m表示0~2之整數,m為0時,Ar 2’表示苯環或萘環,m為1~2時,Ar 2’各自獨立地表示苯環,Ar 2’之環上之任意氫原子也可被1價基取代,Q 2’表示單鍵、或-O-,*表示原子鍵,Ar 2’、及Q 2’有多個存在時,各自可相同也可不同。
The liquid crystal alignment agent according to Claim 1, wherein the polymer (A) is selected from the repeating unit (a2') represented by the following formula (2') and the repeating unit (a3) represented by the following formula (3) ) at least one polyimide precursor in the group consisting of and at least one polymer in the group consisting of polyimide which is an imide of the polyimide precursor,
Figure 03_image017
In formula (2') and formula (3), X 2' and X 3 represent a 4-valent organic group, Y 2' represents a divalent organic group represented by the following formula (O2), and Y 3 represents a group in the molecule " -N(D)-(D represents a carbamate-based protecting group)" is a divalent organic group with 6 to 30 carbon atoms, and R, and Z are synonymous with R and Z in the above formula (1),
Figure 03_image019
In the formula (O2), m represents an integer of 0 to 2. When m is 0, Ar 2' represents a benzene ring or a naphthalene ring. When m is 1 to 2, Ar 2 ' independently represents a benzene ring. Any hydrogen atom on the ring can also be substituted by a monovalent group. Q 2' represents a single bond or -O-, * represents an atomic bond. When there are multiple Ar 2' and Q 2' , each can be the same or can be different.
如請求項1之液晶配向劑,其中,該X 1係來自非環族脂肪族四羧酸二酐或其衍生物、脂環族四羧酸二酐或其衍生物、或芳香族四羧酸二酐或其衍生物之4價有機基,且係來自具有選自由環丁烷環結構、環戊烷環結構及環己烷環結構構成之群組中之至少一種次結構之四羧酸二酐或其衍生物的4價有機基。 As the liquid crystal alignment agent of claim 1 , wherein, the X1 is derived from acyclic aliphatic tetracarboxylic dianhydride or derivatives thereof, alicyclic tetracarboxylic dianhydride or derivatives thereof, or aromatic tetracarboxylic acid The 4-valent organic group of dianhydride or its derivatives is derived from tetracarboxylic dicarboxylic acid having at least one substructure selected from the group consisting of cyclobutane ring structure, cyclopentane ring structure and cyclohexane ring structure. A tetravalent organic group of an anhydride or a derivative thereof. 如請求項1之液晶配向劑,其中,該聚合物(A)中,該重複單元(a1)與該重複單元(a1)之醯亞胺化結構之合計含量為全部重複單元之5~100莫耳%。The liquid crystal alignment agent according to Claim 1, wherein, in the polymer (A), the total content of the repeating unit (a1) and the imidized structure of the repeating unit (a1) is 5 to 100 mo of all repeating units Ear%. 如請求項1之液晶配向劑,其中,該聚合物(A)中,該重複單元(a1)與該重複單元(a1)之醯亞胺化結構之合計含量為全部重複單元之5莫耳%以上且95莫耳%以下。The liquid crystal alignment agent according to Claim 1, wherein, in the polymer (A), the total content of the repeating unit (a1) and the imidized structure of the repeating unit (a1) is 5 mol% of all repeating units Above and below 95 mole%. 如請求項4之液晶配向劑,其中,該聚合物(A)中,該重複單元(a1)、及該重複單元(a2)及它們的醯亞胺化結構之合計含量,為全部重複單元之10莫耳%以上。The liquid crystal alignment agent according to claim 4, wherein, in the polymer (A), the total content of the repeating unit (a1), the repeating unit (a2) and their imidized structures is the total content of all repeating units More than 10 mol%. 如請求項1之液晶配向劑,其係在光配向處理法用之液晶配向膜之形成中使用。The liquid crystal alignment agent according to claim 1, which is used in the formation of liquid crystal alignment film for photo-alignment treatment. 一種液晶配向膜,係由如請求項1至10中任一項之液晶配向劑獲得。A liquid crystal alignment film obtained from the liquid crystal alignment agent according to any one of claims 1 to 10. 一種液晶顯示元件,具備如請求項11之液晶配向膜。A liquid crystal display element comprising the liquid crystal alignment film according to claim 11. 一種液晶顯示元件之製造方法,包括下列步驟(1)~(3): 步驟(1):將如請求項1至10中任一項之液晶配向劑塗佈在基板上 步驟(2):將已塗佈之液晶配向劑進行煅燒 步驟(3):對於步驟(2)獲得之煅燒膜進行配向處理。 A method for manufacturing a liquid crystal display device, comprising the following steps (1) to (3): Step (1): Coating the liquid crystal alignment agent according to any one of claims 1 to 10 on the substrate Step (2): Calcining the coated liquid crystal alignment agent Step (3): performing alignment treatment on the calcined film obtained in step (2). 如請求項13之液晶顯示元件之製造方法,其中,該配向處理係光配向處理。The method for manufacturing a liquid crystal display element according to claim 13, wherein the alignment treatment is photo-alignment treatment. 如請求項14之液晶顯示元件之製造方法,其中,該光配向處理中之放射線之照射量為100~1,500mJ/cm 2The method for manufacturing a liquid crystal display device according to claim 14, wherein the radiation dose in the photo-alignment treatment is 100-1,500 mJ/cm 2 . 如請求項13之液晶顯示元件之製造方法,其更包括下列步驟(4): 步驟(4):對於在步驟(3)經配向處理之煅燒膜更進行50~300℃之加熱處理。 The method for manufacturing a liquid crystal display element as claimed in item 13, further comprising the following step (4): Step (4): For the calcined film subjected to alignment treatment in step (3), heat treatment at 50-300°C is performed. 一種液晶顯示元件,係由如請求項13至16中任一項之液晶顯示元件之製造方法獲得。A liquid crystal display element obtained by the method for manufacturing a liquid crystal display element according to any one of claims 13 to 16.
TW111107847A 2021-03-09 2022-03-04 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element TW202246470A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021037320 2021-03-09
JP2021-037320 2021-03-09

Publications (1)

Publication Number Publication Date
TW202246470A true TW202246470A (en) 2022-12-01

Family

ID=83226763

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111107847A TW202246470A (en) 2021-03-09 2022-03-04 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Country Status (5)

Country Link
JP (1) JPWO2022190896A1 (en)
KR (1) KR20230153396A (en)
CN (1) CN116940888A (en)
TW (1) TW202246470A (en)
WO (1) WO2022190896A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3430705B2 (en) * 1994-04-28 2003-07-28 日産化学工業株式会社 Novel diaminobenzene derivative and polyimide using it
JP3893659B2 (en) 1996-03-05 2007-03-14 日産化学工業株式会社 Liquid crystal alignment treatment method
CN100430802C (en) 2002-12-09 2008-11-05 株式会社日立显示器 Liquid crystal display and method for manufacturing same
JP4665487B2 (en) * 2003-11-05 2011-04-06 チッソ株式会社 New diamine and polymer made from it
WO2020100918A1 (en) * 2018-11-14 2020-05-22 日産化学株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element using same

Also Published As

Publication number Publication date
KR20230153396A (en) 2023-11-06
WO2022190896A1 (en) 2022-09-15
CN116940888A (en) 2023-10-24
JPWO2022190896A1 (en) 2022-09-15

Similar Documents

Publication Publication Date Title
JP7447889B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element using the same
WO2021177080A1 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
WO2022176680A1 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI767970B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
WO2023286733A1 (en) Liquid crystal aligning agent, liquid crystal alignment film, method for producing liquid crystal display element, and liquid crystal display element
WO2020105561A1 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
JP7343059B2 (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW202246470A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW202037716A (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
JP7302744B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
WO2024029576A1 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP7318826B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
WO2024111498A1 (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
JP7494852B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element using the same
TWI830451B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
WO2022181311A1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
JP7428138B2 (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP7311047B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
WO2022085674A1 (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
WO2023210532A1 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
WO2022107640A1 (en) Polymer composition, liquid crystal aligning agent, resin film, liquid crystal alignment film, method for producing liquid crystal display element, and liquid crystal display element
TW202334380A (en) Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, compound and polymer
WO2023008203A1 (en) Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, compound and polymer
TW202317740A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP2024022213A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element